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ABSTRACT 
Nedd4 and Nedd4-2 are E3 ubiquitin ligases that are important components of the ubiquitin 
proteasome system (UPS). Abnormal activity in the UPS has been implicated to underlie a 
number of neurological disorders and so there is great interest in understanding the role of 
specific ligases and their involvement in neuronal processes. Initial characterization of Nedd4 
and Nedd4-2 found them to be most highly expressed during early neurodevelopment, with a 
subsequent decrease post-natally. Numerous studies have shown that the function of Nedd4 and 
Nedd4-2 are not restricted to development, with a number of targets now identified suggesting 
important functions in the mature brain. To date however, there is very little known in regards to 
the in vivo physiological implications within the CNS. 
Nedd4 and Nedd4-2 knockout mice are not viable, with lethality observed during gestation or 
shortly after birth. Studies into the physiological phenotypes must therefore be conducted in 
heterozygotes. Nedd4 and Nedd4-2 heterozygous mice are viable and survive into adulthood, 
and the only overt phenotype is a significant growth retardation in the Nedd4 heterozygotes. 
Behavioural testing can be conducted to examine motor function, gait and cognitive aspects of 
neuronal function. This study used well characterized tests to assess behaviour in heterozygotes 
and age-matched wild-type controls. Testing was conducted primarily in mice of 2 and 6 months 
of age, to determine if there are any age-related changes in behaviour. A small cohort of 12 
month old Nedd4 heterozygote mice were also assessed for motor function and gait. 
Results from this study found that reductions in brain levels of Nedd4 and Nedd4-2 produced 
distinct behavioural outcomes. For instance, Nedd4 heterozygous mice show an age-dependent 
change in gait assessed using DigiGait analysis, with very little effect on motor capacity 
(assessed with RotaRod). The heterozygous mice showed changes in several gait parameters, 
with an overall extension to gait illustrated by increased stride duration and stride length. This 
extension to gait is likely due to the contribution of GluR1-containing AMPA receptors 
(AMPARs), as previous studies have shown that in the absence of GluR1 severe ataxia is 
produced. This study showed that in the 6 month old Nedd4 heterozygous mice a significant 
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reduction in GluR1 levels were evident in the cerebellum, which is likely to contribute to the 
extended gait observed.  
Nedd4-2 heterozygous mice do not show any alterations in gait but at 6 months of age have 
reduced motor capacity illustrated by the reduced latency on the RotaRod. Due to the known 
interaction between Nedd4-2 and the dopamine transporter (DAT), dopamine mediated 
signalling was evaluated. Total levels of DAT were found to be unchanged in the heterozygotes 
compared to the age-matched controls, but immunohistochemistry showed increased staining 
intensity of DAT in striatal fibres. This suggests that membrane levels of DAT may be increased 
in the heterozygous mice due to reduced endocytosis by Nedd4-2. HPLC analysis also found 
reduced levels of striatal dopamine, with alterations in dopamine metabolism and turnover also 
evident. Further support for Nedd4-2 in dopaminergic signalling, comes from the high levels of 
Nedd4-2 expression in regions such as substantia nigra pars compacta (SNpc) and striatum.  
In addition to gait abnormalities observed in the Nedd4 heterozygous mice, cognitive 
abnormalities were also evident. Impaired spatial long-term learning and memory was 
accompanied by an increase in anxiety behaviours. GluR1-containing AMPARs were again 
investigated due to their importance during synaptic plasticity, LTP and memory. Although no 
change in total levels of GluR1 were observed in the hippocampus of the heterozygous mice, 
significant impairments were evident in long-term potentiation (LTP). This study did not 
identify whether changes in membrane levels of GluR1, or whether trafficking of GluR1-
containing AMPARs is altered in the heterozygous mice. The impairment in LTP in the 
heterozygous mice supports a role for Nedd4 in regulation of GluR1-containing AMPARs, and 
thus contribution to cognitive function. The contribution to anxiety is poorly understood, but 
there is evidence that GluR1-containing AMPARs may also be implicated. 
Cognitive assessment of Nedd4-2 heterozygous mice, showed subtle abnormalities in long-term 
spatial memory, and reduced levels of anxiety. This study did not investigate in depth the 
interaction between these behavioural outcomes and known targets, but highlights that important 
further work is necessary to elucidate the involvement of Nedd4-2 in cognitive function 
especially reduced anxiety. Altered dopamine neurotransmission may also be underlying the 
anxiety findings, but is yet to be determined. 
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The expression of Nedd4 and Nedd4-2 within the central nervous system was also investigated, 
as previous studies have never addressed expression within the CNS. Both proteins were found 
to be relative ubiquitous in their expression within the brain including; motor cortex, striatum, 
motor neurons of the spinal cord, cerebellum, hippocampus and amygdala. One major difference 
in expression is in the striatum and dopaminergic regions such as SNpc. Nedd4-2 was highly 
expressed within the SNpc region, with strong co-localization with tyrosine hydroxylase. Nedd4 
on the other hand showed low levels of expression with very little co-localization evident. 
Within the striatum, Nedd4-2 staining was highest in the cell bodies of medium spiny neurons, 
further suggesting a role for Nedd4-2 in dopaminergic system.  
The findings from this study are the first to illustrate the physiological outcome of reduced brain 
levels of Nedd4 and Nedd4-2 in vivo. Nedd4 and Nedd4-2 now appear to have distinct targets, 
with distinct physiological functions. The ubiquitous expression of these two proteins within the 
CNS suggests a wide range of neuronal function, however the discrete expression within certain 
regions such as SNpc also suggests specific roles. Further work is necessary to further elucidate 
the precise mechanism of action, and how Nedd4 and Nedd4-2 contribute to motor function, gait 
and cognitive function. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 INTRODUCTION AND BACKGROUND
Ubiquitin Proteasome System 
The removal of plasma membrane proteins is a crucial regulatory mechanism that provides a 
method of controlling the levels of specific proteins at the cell surface at any one time (Cho et 
al., 2005). Furthermore, within the cell, the degradation of misfolded and denatured proteins 
must also occur for normal physiological function. This regulatory mechanism is critical for 
cellular adaptation and controlling growth in response to environmental stimuli, which may be 
developmental, physiological or pathological (Lecker et al., 2006). Ubiquitin is a highly 
conserved 76 amino acid polypeptide that serves as a tag for the internalization and degradation 
of membrane proteins (Pickart et al., 2004a; Pickart et al., 2004b). The proteins controlled by 
ubiquitin proteasome system (UPS) are essential for cell cycle, DNA repair, cell signalling, gene 
transcription and apoptosis (Ciechanover et al., 2004), all responses of cellular niche stimuli. 
Ubiquitination of membrane proteins requires three enzymatic steps: first, ubiquitin activating 
enzyme (E1) which activates the ubiquitin molecule; second, the transfer of ubiquitin to the E2 
conjugating enzyme; and finally, the interaction between E2 and E3 ligases leads to the transfer 
of ubiquitin to the target molecule (Figure 1.1).  
Ubiquitination 
Ubiquitin can attach to a target molecule via seven lysine residues (K6, K11, K27, K29, K33, 
K48 and K63), with the lysine residue involved determining the fate of the protein (David et al., 
2011). For instance, whether the molecule is degraded by the proteasome or recycled and 
trafficked, largely depends on the lysine residue involved but also the type of ubiquitination (i.e 
mono- versus poly-ubiquitination) (Sadowski et al., 2012) (Figure 1.2). The determining factor 
in the formation of mono- versus poly-ubiquitination remains largely unknown, however it 
appears that the combination of specific E2/E3 interaction may be important (David et al., 2011; 
van Wijk et al., 2010). The specificity of this system is integral, as uncontrolled protein 
degradation can be detrimental to a cell. It is therefore not surprising that there are thousands of 
E3 ligases, which can interact with the substrate to transfer ubiquitin, but also hundreds of E2 
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ligases capable of interacting with the E3 ligases (Handley et al., 1991; Lecker et al., 2006). It is 
clear then that E2/E3 combinations can have a profound effect on protein outcome within a cell. 
Figure 1.1. Schematic representation of the three-enzymatic steps involved in ubiquitination of 
a substrate. Step 1 involves the activation of ubiquitin by the activating enzyme (E1). During 
step 2, the activated ubiquitin molecule interacts with the conjugating enzyme (E2), and finally 
step 3, the E2 enzyme interacts with the ubiquitin ligase (E3), which in turn binds to recognition 
motif on the target substrates and results in the transfer of the ubiquitin molecule to the target.  
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Figure 1.2. The type of ubiquitination determines the fate of a substrate. The conjugation of 
Ubiquitin (Ub) into a monomer or polymer can have a major impact on protein outcome. The 
formation of a single ubiquitin (Ub) monomer results in endocytosis and membrane trafficking 
of proteins (A). Ubiqutitin (Ub) molecules contain seven lysine residues that can be involved in 
substrate interactions. The involvement of lysine 48 residues predominantly results in 
proteasomal degradation of the substrate (B), where as lysine 63 linked chains results in 
trafficking and lysosomal degradation (C). 
Abnormal ubiquitination can contribute to neurological disorders 
Since ubiqutination plays a key role in the regulation a broad array of cellular functions, such as 
the activation and silencing of transcription, signal transduction, apoptosis, immune and 
inflammatory response, cell cycle, receptor-mediated endocytosis, and autophagy it is not 
surprising that disruption of these systems can lead to pathological states and conditions 
(Harvey et al., 1999).  
In neurons, impairment in the ubiquitin proteasome system (UPS) results in aggregation and 
accumulation of proteins ultimately disrupting normal cellular processes, and leading to 
neuronal cell death. Many neurodegenerative diseases have been implicated to arise in part due 
to abnormal function of the UPS, leading to abnormal protein folding and aggregation. These 
include Alzheimer ’s disease (Lehman, 2009), Parkinson’s disease (Dusonchet et al., 2009) and 
Amyotrophic Lateral Sclerosis (or motor neuron disease) (Kim et al., 2009; Lowe et al., 1988; 
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Matsumoto et al., 1993). The underlying cause of these neurological disorders share a common 
disruption of the UPS leading to the accumulation of mutant protein, and thus cell death 
(Ciechanover et al., 2003; Dennissen et al., 2012).  
There is also evidence that in some polyglutamine repeat diseases such as Huntington disease 
(Finkbeiner S et al., 2008; Iwata et al., 2009) and spinocerebellar ataxias (Hong et al., 2002; 
Riley et al., 2004), the UPS is unable to degrade the abnormal proteins again leading to 
accumulation of protein and thus neuronal cell death.  Accordingly it is important to study the 
function of the ubiquitin proteasome system both under physiological conditions but also in 
pathological states to better understand the contribution to pathophysiology of these 
neurodegenerative disorders. 
1.2 NEDD4 AND NEDD4-2 E3 LIGASES 
Nedd4 and the closely related protein Nedd4-2 (neuronal precursor cell-expressed 
developmentally down-regulated protein 4 and 4-2) are E3 ubiquitin ligases. Nedd4 was first 
identified as a mouse gene that is highly expressed during early embryonic development and 
vital for the differentiation of the central nervous system (Kumar et al., 1992). Nedd4 is 
ubiquitously expressed whereas Nedd4-2 is restricted to the heart, kidney, brain, lung and liver 
(Kumar et al., 1997). Nedd4 proteins in different mammalian species have similar structures 
(Shearwin-Whyatt et al., 2006) and are highly conserved in eukaryotic cells (Kumar et al., 
1992).  
Nedd4 and Nedd4-2 Structure 
Nedd4 and Nedd4-like proteins consist of a calcium/lipid binding (CaLB/C2) domain, three or 
four tryptophan-rich (WW) domains and an E6-AP C-terminal (HECT) domain that is similar to 
human papilloma virus (HPV) oncoprotein E6-associated protein (E6-AP) (Kumar et al., 1992) 
(Figure 3). The C2 (calcium-binding domain), is approximately 120 amino acids in length, and 
is believed to regulate the expression of proteins by translocating them to phospholipid 
membranes. This C2 domain has also been shown to mediate auto-inhibition in both Nedd4 and 
Nedd4-2, by binding to the HECT domain and rendering them inactive. Calcium can relieve the 
auto-inhibition by disrupting C2 and HECT domain binding and therefore may play a role in the 
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activation of Nedd4 and Nedd4-2 (Wang et al., 2010). The WW domains are composed of 35 to 
40 amino acids, with the two conserved tryptophan residues being 21 amino acids apart. These 
domains consist of a hydrophobic core surrounded by ȕ-sheets and interact with the PY motifs 
of substrate proteins (Kanelis et al., 2006), with the most common proline-rich sequence being 
the PPxY motif (Kay et al., 2000). However, WW domains are known to bind to alternative 
motifs; for example, Nedd4-2 is reported to bind to the amino acid sequence LPXY (Kumar et 
al., 1997). These studies show that Nedd4-like proteins interact with a number of different 
protein motifs via their WW domains. Finally, the HECT domain, which is approximately 350 
residues in length, transfers the ubiquitin from a conserved cysteine residue located at the 
carboxyl end of the HECT domain, to a lysine residue in a target protein. 
Figure 1.3. Nedd4 and Nedd4-2 structural homology. Both contain a calcium/lipid binding 
domain (C2), 3-4 tryptophan rich WW domains, and a catalytic HECT domain. 
Nedd4 family-interacting protein 1 and 2 (NDFIPs 1 and 2) 
The Nedd4 family-interacting proteins 1 and 2 (NDFIP 1 and 2) are small membrane proteins 
that contain a PY-motif. NDFIPs and can either promote or reduce interactions between 
membrane and Nedd4 family of proteins. Furthermore, they have been shown to regulate 
catalytic activity (Mund T et al., 2009). In the brain, NDFIP 1 is abundant and shows co-
localisation with Nedd4 in neurons (Mund T et al., 2009). NDFIP 1 can induce the expression of 
both Nedd4 and Nedd4-2 into exosomes, thereby contributing to the rapid removal of proteins 
during neuronal stress and is important for survival of cortical neurons following injury and 
transient ischaemia (Lackovic et al., 2012; Sang Q et al., 2006). NDFIPs have also been 
implicated to play an important role in neuronal iron homeostasis. Studies have shown that 
Nedd4 and Nedd4-2 can regulate the divalent metal (ion) transporter (DMT1) (Garrick MD et 
al., 2012), with abnormal levels of iron resulting in significant protein aggregation, oxidative 
stress and ultimately neuronal death (Howitt et al., 2009). Finally, NDFIPs can associate with 
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EGF receptor and PTEN (phosphatase and tensin homolog deleted on chromosome 10), 
therefore exerting a physical and functional role in signalling cascades (Mund et al., 2010).  
Physiological roles for Nedd4 family of proteins 
The initial physiological role for Nedd4 family of proteins was identified in Liddle’s syndrome, 
a hereditary form of extreme hypertension (Botero-Velez et al., 1994). Liddle’s syndrome 
occurs due to a mutation in the proline rich region of the epithelial sodium channels (ENaCs), 
resulting in loss of Nedd4-2 mediated channel ubiquitination. ENaCs are therefore up-regulated, 
and sodium re-absorption increased in the kidney, giving rise to the hypertension observed in 
these patients (Fotia et al., 2002; Rauh et al., 2006). Nedd4 and Nedd4-2 are now known to 
regulate a large number of proteins, transporters and ion channels, with differential substrate 
specificity (Yang et al., 2010).  
This thesis focuses on investigating the physiological role of Nedd4 and Nedd4-2 in the central 
nervous system; with the core biological processes investigated focusing on growth and 
development, memory and cognition and motor function.  
Cells that make up the CNS 
The central nervous system is composed of many cell types, principally neurons and glia. 
Neurons are responsible for neurotransmission, forming synapses with other neurons to form a 
complex network necessary for their physiological functions. The pre-synaptic compartment of 
a neuron allows for the synthesis and release of neurotransmitter. The post-synaptic 
compartment contains ion channels and receptors that enable the initiation and propagation of 
action potentials (Kandel et al., 2000).  
Glia function as support cells and can be classified into many different types, each with an 
important role. Astrocytes are the most abundant glial cell and have a number of integral roles. 
Astrocytes are capable of maintaining a stable external environment by the rapid removal of 
neurotransmitters following release, and maintain stable level of ions. They can also provide 
structural support to neurons, and form an important barrier, the blood brain barrier. 
Oligodendrocytes are important for myelination of neurons (Kandel et al., 2000). Microglia are 
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specialised glial cells of the macrophage lineage that are capable of phagocytosis and are the 
first line of immune defence within the CNS (Kandel et al., 2000).  
1.3 GROWTH AND DEVELOPMENT 
Nedd4 and Nedd4-2 have an important role in the regulation of growth and differentiation in 
both peripheral and neural tissue. This is achieved due to interaction between Nedd4 and 
Nedd4-2 with receptors and/or adaptor proteins critical for normal growth signalling. Nedd4 
seems to have a more significant role in overall growth and development, which is highlighted 
by the severe growth retardation evident in Nedd4 heterozygous and homozygous knockout 
mice, which is most likely due to, reduced IGF-1 signalling (Figure 1.5). 
Figure 1.4. Reduced Nedd4 levels results in severe growth retardation. Growth retardation 
observed in Nedd4 knockout (-/-) and heterozygous (+/-) mice when compared to wild-type 
controls (+/+) at embryonic day 16.  
Insulin-growth factor-1 Receptor (IGF-1R) 
The insulin-like growth factor axis is comprised of three ligands; insulin like-growth factor 1 
(IGF-1), insulin-like growth factor 2 (IGF-2) and insulin, that bind two closely related tyrosine 
kinase receptors; IGF-1 receptor and insulin receptor. The main role of the IGF-1 is in the 
regulation of fetal and postnatal growth in peripheral and neuronal tissues (Baker et al., 1993; 
Lupu et al., 2001). In the CNS, IGF-1 is produced by all cell types and found in most region of 
the brain including the cortex, hippocampus, cerebellum, hypothalamus, brain stem and spinal 
cord (Bach et al., 1991). Since IGF-1 has important roles in growth and development highest 
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expression levels are observed during the perinatal period. Conversely in the adult brain levels 
are substantially reduced (Bondy et al., 1993). IGF-1 acts with highest affinity with its cognate 
IGF-1 receptor (IGF-1R) to activate phosphoinositide 3-(PI-3) kinase and downstream Akt 
(Protein Kinase B) and extracellular signal-regulated kinase (ERK) signalling pathways required 
for cellular events such as gene transcription, protein synthesis, apoptosis and proliferation 
(Fernandez et al., 2012).  
Nedd4 promotes growth via IGF-1 mediated signaling 
Nedd4 has been shown to have a positive effect on IGF-1 signalling, by ubiquitinating the 
growth factor receptor-bound protein 10 (Grb10) (Monami et al., 2008; Morrione et al., 1999; 
Vecchione et al., 2003). When Grb10 is bound to IGF-1R, inhibition of tyrosine kinase activity 
occurs, preventing downstream signalling cascade. Therefore, by removing the Grb10 from 
IGF-1R, Nedd4 is able to oppose the actions of Grb10 and thus promotes IGF-1 mediated 
signaling (Monami, Emiliozzi et al. 2008). Indeed in Nedd4 knockout mice, body weights are 
reduced by 64-68% (as expected) and in the heterozygotes body weights are reduced by 15-20% 
(Cao et al., 2008).  
The peripheral growth retardation observed in the Nedd4 knockout mice may also affect CNS 
growth. This may be due to direct actions of IGF-1 on receptors located on neurons, or indirect 
by mediation of blood supply and nutrient availability to neurons, however this has yet to be 
investigated. 
Epidermal growth factor receptor (EGFR) 
Epidermal growth family consist of structurally related ligands including epidermal growth 
factor (EGF), transforming growth factor-Į (TGF-Į), amphiregulin, heparin-binding EGF (HG-
EGF) and epiregulin (EPR) (Lee et al., 1995). This family of proteins are essential for growth, 
differentiation, maintenance and repair of many tissues including the nervous system (Xian et 
al., 1999). They bind to the integral tyrosine kinase receptor, EGF-1R (or ErbB-1) (Prigent et 
al., 1992). The EGF-R forms heterodimers with 3 closely related receptors, ErbB2/c-neu, ErbB3 
and ErbB4 (Lee et al., 1995). The ErbB tyrosine kinase receptors can be activated either by EGF 
or the neuregulin family of proteins. The neuregulin family, in particular Neuregulin-1 (NRG1) 
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acting via ErbB4 receptor, has been shown to be crucial for neural development and synaptic 
plasticity (Krivosheya et al., 2008; Mei et al., 2008).  
Expression of EGF ligands and receptors within the CNS 
The expression of EGF ligands and EGF-R receptor in the brain is variable, for instance TGF-Į
is most highly expressed in the CNS, and considered the primary ligand for EGF-R in the 
developing and adult brain. Highest expression of TGF-Į is seen in the striatum, hippocampus, 
brainstem and olfactory bulb (Lazar et al., 1992; Seroogy et al., 1991). Messenger RNA 
(mRNA) expression for HB-EGF peaks in early postnatal period and is located in the cortical 
plate, hippocampus, cerebellar Purkinje neurons and thalamus in the developing brain 
(Kornblum et al., 1999). The regional expression of EGF-R is similar to TGF-Į but temporally 
similar to HB-EGF-R (Kornblum et al., 1999). With the early and widespread expression of 
EGF-R and its ligands in the developing brain, it is not surprising that the EGF family are 
important for genesis, differentiation, migration and survival of neuronal populations in the 
embryonic brain (Kornblum et al., 1997). Evidence also exists showing the importance for EGF-
R ligands in survival of post-mitotic neurons. For instance, mice lacking EGF-R show profound 
brain defects including the development of progressive neurodegeneration (Sibilia et al., 1998). 
This illustrates that modulation of the ligands or the receptor can have important physiological 
outcomes in the CNS.  
Nedd4 promotes growth via EGF mediated signaling 
In response to EGF, Nedd4 has been shown to cause the ubiquitination of endocytic proteins and 
targets them for proteasomal degradation, leading to the enhancement of EGFR mediated 
signalling. Like IGF-1 mediated signalling, the regulatory mechanism involves an indirect 
mechanism, that is Nedd4 and Nedd4-2 bind to an ubiquitin-binding protein ACK (activated 
Cdc42-associated tyrosine kinase, also know as Tnk2) (Chan et al., 2009; Lin et al., 2010). The 
C-terminus of ACK contains a PPxY motif allowing for interactions with Nedd4 and Nedd4-2, 
although both are able to bind, it is primarily Nedd4 that is responsible for ubiquitination of 
ACK in cells, having a 10 fold higher activity than Nedd4-2 (Lin et al., 2010). Whether Nedd4 
has a role in the ErbB4/NRG1 pathway remains unknown, there is some evidence to show that 
ErbB4 is ubiquitinated by AIP4/Itch, a Nedd4 family member (Omerovic et al., 2007). These 
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findings suggest that Nedd4 and to some extent Nedd4-2 may be pivotal for neuronal growth 
and differentiation. 
Transforming Growth Factor-β (TGF-β) 
So far, Nedd4 has shown a predominant role in the modulation of signalling necessary for 
growth and differentiation. However Nedd4-2 is a negative regulator of TGF-β intracellular 
signalling. The TGF-β family of proteins function to regulate cellular growth, differentiation 
and apoptosis (Roberts et al., 1990). TGF-β can bind to either TGF-β type I and type II 
receptors, and upon binding induces the phosphorylation of Smad2 and Smad3. Once 
phosphorylated, Smad2 and 3 translocate to the nucleus where they bind to transcription factors 
and control transcription of target genes (Heldin et al., 1997). Nedd4-2 can ubiquitinate TGF-β
type I receptors directly (Kuratomi et al., 2005) but can also ubiquitinate Smad 2 and 3 (Gao et 
al., 2009). These data suggest that Nedd4-2 has a significant role in modulating the intracellular 
signalling of TGF-β, and can therefore play a role in growth of neuronal tissue, but also 
apoptosis. 
Neurotrophin Receptors 
The neurotrophins are a group of growth factors important for the developing and mature 
nervous system (Huange et al., 2001). Neurotrophins comprise of nerve growth factor (NGF), 
brain derived neurotrophic factor (BDNF), and neurotrophin 3 and 4 (NT-3 and 4). 
Neurotrophin signalling occurs through 2 main classes of receptors, the high affinity Trk 
(tyrosine kinase) and the low affinity p75NTR co-receptor (Allen et al., 2006). All neurotrophins 
are able to signal through p75 NTR, however, each neurotrophin has a higher affinity for the 
different Trk receptors, TrkA, TrkB and TrkC. The mature form of nerve growth factor (NGF-β) 
signals through TrkA, BDNF through TrkB, and NT3/4 through TrkC preferentially. NGF 
provides trophic support to a major group of neurons, the basal forebrain cholinergic neurons 
(BFCN) (Hefti et al., 1989). The BFCNs provide cholinergic input to the areas associated with 
memory, especially the hippocampus and amygdala, which contain both TrkA (Steininger et al., 
1993) and p75 NTR (Batchelor et al., 1989). 
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Nedd4-2 interaction with TrkA receptors  
The TrkA receptors contain a PPxY motif in the C-terminal domain that allows Nedd4-2 
binding. Once bound, direct ubiqutination results in the regulation of receptor turnover 
(Georgieva et al., 2011). Nedd4-2 specifically targets TrkA, with no effect observed on TrkB, 
TrkC or p75 NTR receptors (Arevalo et al 2006). As expected, when Nedd4-2 is deleted an 
accumulation of TrkA receptors is evident in the early and late endosomal stages suggesting the 
disruption of the trafficking to degradative pathways (Yu et al., 2011). Studies to date have 
shown that ubiquitination of neurotrophin receptors is indeed complex, but very little is known 
regarding the in vivo physiological implications of NGF-mediated modulation of Trk signalling 
by Nedd4-2.  
Nedd4 and Nedd4-2 growth and development 
Nedd4 and Nedd4-2 have important roles in regulating signalling pathways involved in growth 
and differentiation. The consequences of reduced Nedd4 levels for growth are evident in mice 
where levels of Nedd4 are reduced (heterozygous) or removed (knockout), with severe growth 
retardation evident. The in vivo effect within the central nervous system remains largely 
unknown and warrants investigation. 
1.4 MEMORY AND COGNITION 
Cognitive processes associated with learning, memory and anxiety are complex, with a 
multitude of proteins involved in maintaining neuronal integrity necessary for the changing 
needs of neurons during these processes. Ubiquitination is gaining interest as a mechanism to 
regulate proteins and receptors necessary for memory and cognitive processes (Chain et al., 
1999; Fioravante et al., 2011a). Currently, very little is known regarding which E3 ligases are 
involved and indeed in Nedd4 or Nedd4-2 contribute to the mechanisms of learning and 
memory, and will be addressed in this thesis.  
The hippocampus is important for memory and cognition 
The hippocampus is well regarded to be central for memory and learning processes. However 
the hippocampus forms connections with other brain regions such as the amygdala and 
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hypothalamic-pituitary axis, and therefore plays a role in anxiety and stress responses (Dedovic
et al., 2009). In addition, it is now accepted that the hippocampus does not function as a unitary 
structure, but it can be broadly subdivided into the dorsal and ventral portions, which have 
distinct roles (Dedovic et al., 2009; Fanselow et al., 2010). Evidence to support this view arose 
from a number of studies, including anatomical where the dorsal and ventral hippocampus have 
distinct inputs (Dedovic et al., 2009; Fanselow et al., 2010). Additionally, lesion studies in 
rodents show that a disruption in the dorsal hippocampus results in impaired spatial memory 
(Moser et al., 1995), whereas disruption in the ventral hippocampus alters stress and emotional 
behaviour (Moser et al., 1995). Finally, previous studies have demonstrated that there are two 
perforant paths from the entorhinal cortex, the ‘superior’ and ‘inferior’ that target the dorsal and 
ventral hippocampus respectively (Fanselow et al., 2010). This suggests that networks involving 
the dorsal and ventral portions of the hippocampus are also distinct. 
Subdivisions and connections of the hippocampus 
The hippocampus is multilayered with a densely packed pyramidal layer, where pyramidal 
neurons are located extending their apical and basal dendrites above and below this layer. The 
hippocampus can be subdivided into 4 main segments along its longitudinal axis, in accordance 
to the afferent inputs; CA1, CA2, CA3 and dentate gyrus (DG) regions. The hippocampus has 
connections to several subcortical areas, with the major cortical input arising from the perirhinal 
and postrhinal cortices through the entorhinal cortex (EC). The subiculum, which sits adjacent 
to CA1 regions is considered the major output region, and sends projections to the thalamus, 
hypothalamus, septum and EC (Figure 1.6). It is also important to consider that the 
hippocampus has projections to the amygdala, which enables the emotional component of 
memory. 
45
Figure 1.5. Schematic illustration of the main regions of the hippocampus. The entorhinal 
cortex (EC) is intimately connected to the hippocampus, with projections to dentate gyrus (DG) 
and CA3 region through the perforant path (pp). The DG can send projections to the CA3 region 
through mossy fibres (mf) and CA1 regions via Schaffer collaterals (sc). The CA1 sends 
projections to the EC, and can receive input from the EC, DG and CA3 regions. The CA2 region 
lies in between CA1 and CA3 regions, where the pyramidal layer is not densely packed. D, 
dorsal; L, lateral. Adapted from (Grove et al., 1999).
Synaptic plasticity and long-term potentiation (LTP) 
Synaptic plasticity is the change in strength between two neurons in response to an increase or 
decrease in activity. One of the best characterised and extensively studied example of synaptic 
plasticity is long-term potentiation (LTP) in the hippocampus, which is regarded as the cellular 
mechanism for memory and learning. LTP is an excitatory process requiring glutamate as the 
neurotransmitter, acting on NMDA (N-methyl-D-aspartate) and AMPA (Į-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid) receptors located on the post-synaptic compartment. 
Glutamate is released by the pre-synaptic compartment and binds to both AMPA and NMDA 
receptors to enable neurotransmission to occur. Glutamate binding to AMPA receptors 
(AMPAR) is necessary to initiate an important influx of Na+ ions required to remove the Mg2+
block at NMDA receptors. Once the Mg2+ block is removed, Ca2+ influx takes place in the post-
synaptic compartment, which is essential for the initiation of gene transcription, signalling 
events such as the insertion of more AMPARs. Therefore the insertion of additional AMPARs at 
the cell membrane increases the strength of the synapse, as subsequent release of glutamate will 
have a greater and faster response, ultimately strengthening the excitatory post-synaptic 
potential (EPSP) (Figure 1.7). 
EC 
sc 
pp 
mf 
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Thus the regulated insertion but also removal of AMPA receptors is integral in the dynamic 
process of LTP and thus memory and learning, therefore, AMPA receptors are continuously 
trafficked (endocytosed, recycled and re-inserted) into and out of the membrane. (Sprengel, 
2006). Scaffolding complexes including post-synaptic density-95 (PSD-95) are implicated in 
this trafficking of AMPARs, indirectly via transmembrane AMPA regulatory proteins (TARPs) 
such as stargazin (Bats C et al., 2007; Bhattacharyya S et al., 2009; Elias et al., 2008; Stein et 
al., 2010). LTP is dependent upon glutamate and thus the density of AMPA receptors at the 
synapse determines the availability of glutamate binding sites and therefore the level at which 
they synapse can be excited. A wealth of evidence has provided strong support for density of 
AMPARs with LTP and memory formation (Makino et al., 2009; Malinow, 2003; Malinow et 
al., 2002). 
Figure 1.6. Insertion of AMPA receptors (AMPAR) into post-synaptic compartment is 
necessary for LTP to occur. Upon glutamate binding to AMPAR, the influx of sodium ions 
(Na+) results in the removal of Mg2+ block from the NMDA receptors (1). This enables the 
influx of calcium ions to occur through NMDA receptors, with calcium initiating gene 
transcription and insertion of more AMPAR into the post-synaptic membrane (2). Continuous 
stimulations that occur during the process of LTP results in synaptic changes such as increased 
levels of AMPARs that are facilitated by PSD-95 scaffolding proteins via TARPs such as 
stargazin (3). This increases the synaptic plasticity by enhancing the signal between the pre- and 
post-synaptic compartments. 
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The role of ubiquitination in memory and learning 
Synaptic activity and dynamic post-synaptic modifications such as dendritic growth and 
regulated turnover of molecules such as glutamate receptors underpin memory formation. It is 
now well established that consolidation of long-term memory requires de novo protein 
synthesis, as well as protein degradation for the fine tuning of synapses required for memory 
and learning (Artinian et al., 2008; Fonseca et al., 2006). The UPS is now well accepted to have 
a major function in LTP and memory formation, with proteasome inhibition resulting in the 
prevention of LTP initiation (Dong C et al., 2008) and therefore reducing capacity for memory 
formation (Fioravante et al., 2011b; Lopez-Salon et al., 2001). The underlying molecular 
determinants of LTP are complex, however as already discussed the trafficking of AMPA 
receptors at the cell surface is a critical component.  
Regulation of glutamate receptors 
AMPA receptors are ligand gated, and can either be tetrameric, homomeric or heteromeric and 
are assembled from four different subunits (Glu1-4). It is these subunits that differ in the C-
terminal domain and allow for protein interactions with other molecules in the synapse such as 
scaffolding proteins. The combination of these subunits leads to the formation of distinct 
receptors subtypes, that are dependent on cell type, brain region and are developmentally 
specific (Sato et al., 1993). Glu4 only appears to be expressed during development, and in the 
mature brain AMPARs are predominantly composed of two distinct combinations (Glu1/2 and 
Glu2/3) (Martin et al., 1993). The C-terminus of the Glu1 subunit is able to interact with PDZ 
proteins important for exocytosis (Sheng, 2001). AMPA receptors are clustered in the post-
synaptic density (PSD), which provides a structural and spatially restricted association with 
scaffolding and other adapter proteins. These protein interactions have a significant impact on 
the activity dependent alteration in dynamic cycling of AMPARs in the PSD (Man et al., 2000; 
Sprengel, 2006).  
As already discussed, NMDA receptors are critical for initiating LTP. As with AMPA, NMDA 
receptors are also comprised of many different subunits (GluN1-3), which confer differences in 
opening specificity, CNS distribution and magnesium sensitivity (Monyer et al., 1994). NMDA 
receptors comprised of GluN2D subunit are likely to have a specific role in synapse 
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formation/elimination both during development and in the adult brain (Gautam et al., 2013). 
Recently, Nedd4 was shown to interact with GluRN2D subunit of NMDA receptors (Gautam et 
al., 2013), with currently unknown physiological outcomes. This provides further support for 
the potential importance of Nedd4 in memory, learning and synaptic plasticity. 
Ubiqutination as a method of regulating AMPA receptors 
For a long time ubiquitination has been suggested to be the mechanism that marks AMPA 
receptors to be endocytosed and/or degraded (Schwartz, 2003). Recently, Nedd4 was shown to 
target the Glu1 subunit of AMPA receptors in an activity dependent manner and thus plays an 
important role in the regulation of AMPA receptor densities in the post-synaptic membrane 
(Hou et al., 2011; Lin et al., 2011; Schwarz et al., 2010) (Figure 1.8).  This has important 
implications in synaptic change, such as plasticity required for the fundamental processes of 
learning and memory, with Nedd4 having a potentially important role. 
Figure 1.7. Nedd4 interacts with the GluR1 subunit of AMPARs in an activity dependent 
manner, and therefore can regulate the trafficking (insertion and removal) of AMPARs in the 
post-synaptic membrane. 
Nedd4 and Nedd4-2 targets implicated in synaptic plasticity and LTP 
Serum and glucocorticoid inducible kinase 1 (SGK1) 
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SGK-1 was originally identified in a rat mammary tumour cell line, where mRNA levels 
increase dramatically in cells following exposure to serum, glucocorticoids, or both (Lang et al., 
2006; Lang et al., 2001; Webster et al., 1993). SGK-1 and its related isoforms SGK-2 and SGK-
3, share 80% amino acid sequence homology, and are members of the “AGC” subfamily which 
include protein kinases A, G and C (Webster et al., 1993) and possess a PY motifs to which 
Nedd4-2 has been shown to bind (Lang et al., 2001). SGK-1 expression is also induced by a 
large spectrum of stimuli including aldosterone (Náray-Fejes-Tóth et al., 1999; Rozansky et al., 
2009), neuronal injury (Imaizumi et al., 1994; Nishida et al., 2004), neuroexcitotoxicity 
(Hollister et al., 1997), psychophysiological stress (Murata et al., 2005) and following memory 
formation  (Tsai et al., 2002). The activation of SGKs is dependent upon phosphorylation of 
Thr-256 and Ser-422 sites on the C-terminal domain by phosphoinisitide 3-kinase (PI3-K) 
(Alessi et al., 1996). SKG has also been shown to phosphorylate similar substrates to Akt, 
which share a common consensus site (RXRXXS/T). Nedd4-2 contains this consensus site, and 
SGK-1 has been shown to phosphorylate Nedd4-2 and result in the inactivation of the ligase 
activity (Debonneville et al., 2001). 
SGK-1 and LTP 
SGK-1 is highly expressed in the hippocampus and important during long-term spatial memory 
formation. This is achieved by up-regulating expression of post-synaptic density 95 (PSD-95) 
protein and thus having an important impact on expression of long-term potentiation (LTP) (Ma
et al., 2006). Previous studies have shown that SGK-1 expression in the hippocampus is 
stimulated following fear conditioning, elevated plus maze exposure and enrichment training 
(Lang et al., 2006). At the cellular level, SGK isoforms have been shown to up-regulate 
glutamate receptors such as AMPA, thereby enhancing the excitatory effects of glutamate (Lang
et al., 2009; Lang et al., 2006) and thus contributing to enhancement of LTP. An increase in 
SGK-1 levels can also increases the activity and/or abundance of many proteins, including ion 
channels and carriers such as glucose (GLUT1 and 4) and glutamate (EAAT1-5) transporters, 
which also have important implications for neuronal function (Lang et al., 2010). 
SKG-1 and glutamate clearance 
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SGK-1 is known to stimulate the expression of glutamate transporters (EAATs) (Lang et al., 
2006) to increase the re-uptake of glutamate and thus decrease excitation (Benarroch, 2010). 
Glutamate transporters, primarily located on astrocytes and some neurons maintain, extra-
cellular glutamate levels by rapid re-uptake following glutamate release. The regulation of 
glutamate levels in the brain is crucial as it regulates normal glutamate levels to sustain 
appropriate signalling. In a pathological setting, glutamate transporters are also crucial as excess 
glutamate is neurotoxic and results in neuronal cell death (Rothstein et al., 1996). The evidence 
for SKG involvement in the brain and defects in SGK contributing to alterations in proteins 
responsible for excitation of neurons is expanding and complex. However since SGK has the 
potential to regulate the activity of Nedd4-2 the importance of this interaction in the CNS is 
profound and warrants further investigation.  
Excitatory amino acid transporters (EAATs) 
As already discussed, glutamate is the major excitatory neurotransmitter in the brain, with rapid 
clearance required for normal neuronal function. The re-uptake of glutamate is essential and 
occurs via excitatory amino acid transporters (EAATs). There are five types of glutamate 
transporters EAAT 1-5 with differential expression. EAAT1  (also known as glutamate amino 
acid transporter, GLAST) and EAAT2 (glutamate transporter 1, GLT-1) are the two most 
abundant of the main transporters in the brain and are primarily located on astrocytes (Lehre et 
al., 1995), but can also be found on oligodendrocytes (Pitt et al., 2003), microglia (López-
Redondo et al., 2000) and macrophages (Rimaniol et al., 2000), with EAAT 3 being primarily 
neuronal. 
Regulation of glutamate transporters 
Tight regulation of EAAT1 and 2 is important as illustrated by neurological diseases, which in a 
large part arise due to alterations in transporter levels. For example, patients with amyloid lateral 
sclerosis have decreased EAAT2 in the brain and spinal cord (Maragakis NJ and JD. 
2006(Bristol et al., 1996). In Alzheimer’s disease patients, EAAT1 levels are reduced, while 
with animal models, reductions in both EAAT1 and 2 protein levels are observed (Masliah et 
al., 2000). Furthermore, EAAT1 is found to be co-expressed with tau in cortical pyramidal 
neurons (Scott et al., 2002) and accumulation of tau observed in EAAT2 expressing neurons 
51
(Thai, 2002). Increases in glutamate levels are also evident in both people afflicted with 
Parkinson’s disease and animal models of Parkinson’s disease (Meredith et al., 2009). In a 
mouse model of Huntington’s disease, glial aggregates of mutant huntingtin are associated with 
a decrease in EAAT2 expression (Shin et al., 2005). These disorders all share in common a 
decrease in the clearance of glutamate which is suggested to contribute to the excitotoxicity and 
neurodegeneration (Maragakis NJ et al., 2006). Impaired glutamate clearance can also produce 
neuronal hyper-excitability associated with epilepsies and seizures. This is exemplified in 
EAAT2 (GLT-1) knockout mice, which have lethal spontaneous seizures due to uncontrolled 
extracellular glutamate (Tanaka et al., 1997).  
Since glutamate transporters affect synaptic levels of glutamate, changes in expression and/or 
levels of these transporters can have a profound indirect effect on LTP. For instance, increased 
levels of glutamate transporters, by increasing levels of re-uptake, can substantially reduce 
glutamate levels able to act on NMDA and AMPA receptors, thereby reducing 
neurotransmission. 
Nedd4-2 regulation of glutamate transporters 
One important regulatory mechanism of glutamate transporters is ubiquitination. Nedd4-2 is 
able to regulate glutamate transport in Xenopus oocytes with Nedd4-2 found to be co-expressed 
with both EAAT1 and 2. Furthermore, when Nedd4-2 is overexpressed a substantial reduction 
in glutamate-induced currents is observed (Boehmer et al., 2003; Boehmer et al., 2006). These 
findings indicate that Nedd4-2 mediates the ubiquitination and down-regulation of both EAAT1 
(GLT-1) (García-Tardón et al., 2012) and EAAT2 (GLAST) (Boehmer et al., 2006), and thus 
may be important in maintenance of adequate levels of glutamate transporters and thus 
regulating levels of glutamate at the synapse. This could have implications for glutamatergic 
neurotransmission required for processes such as LTP and cognitive functions.  
Growth Factors important for memory and cognition 
IGF-1 
As already discussed IGF-1 is important for overall growth and differentiation, however IGF-1 
is also important in the mature brain for cognitive processes. This is best illustrated in rodents 
where the Igf1 gene is disrupted. These Igf1 knockout mice have substantial cognitive 
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impairments including learning and memory deficits (Cheng et al., 2003). Neurons involved in 
these cognitive processes shown abnormalities such as reduced dendrite length, with the 
morphological abnormalities likely due to growth retardation in response to reduced IGF-1 
signalling. Humans can also exhibit Igf1 deletions which can also produce cognitive 
impairments (Woods et al., 1997). Numerous studies have investigated the impact of IGF-1 
mediated signalling in learning and memory, and found that not only is IGF-1 (acting via the 
IGF1-R) important during hippocampal development (Liu et al., 2009a), but it also increases 
neurogenesis (number of neurons) and synaptogenesis (number of synapses) in the postnatal 
dendate gyrus of the hippocampus (O'Kusky et al., 2000). Furthermore, IGF-1 exerts trophic 
effects on glutamatergic neurons, and contribute to hippocampal dependent LTP (Llorens-
Martin et al., 2009; Trejo et al., 2007). Neural plasticity is important under normal physiological 
conditions such as the adaptation that occurs following memory and learning, in addition to 
changes due to injury and degeneration. Therefore any disruptions in IGF-1 signalling, as seen 
in Nedd4 heterozygous and knockout mice, can have an effect on learning and memory 
outcomes. 
Neurotrophins and memory and learning 
The basal forebrain cholinergic neurons (BFCNs) provide cholinergic input to the areas 
associated with memory, especially the hippocampus and amygdala, and contain both TrkA 
(Steininger et al., 1993) and p75 NTR (Batchelor et al., 1989). Studies have shown that age-
related cognitive decline is linked to atrophy or loss of these cholinergic neurons in the basal 
forebrain (Armstrong et al., 1993; Fischer et al., 1992). Furthermore, abnormalities in NGF 
transport to BFCN have been implicated to contribute to the neurodegeneration seen in 
Alzheimer’s disease (Calissano et al., 2010; Cuello et al., 2010; Whitehouse et al., 1981) and 
Downs syndrome patients (Delcroix et al., 2004). When NGF is infused the rescue of age 
dependent memory deficits and reduced degeneration of BFCN is evident (Fischer et al., 1991). 
Finally, mice heterozygous for the knockout of the NGF gene show a reduction in cholinergic 
neurons with accompanying spatial memory deficits (Chen et al., 1997). These studies all 
highlight the importance of NGF as a tropic factor both during development but also in the 
mature brain essential for normal cognitive function. 
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We know that Nedd4-2 interacts with TrkA receptor and therefore changes in levels of Nedd4-2 
may have profound effects on cognitive processes associated with the hippocampus, such as 
learning and memory and to date have not been investigated. 
Voltage-gated Calcium Channels (Cav) 
The main pathway by which calcium enters excitable cells is by voltage-gated calcium channels 
(Cavs) (Catterall et al., 2005). With intracellular calcium regulation crucial for LTP and thus 
learning and memory, the regulation of voltage-gated ion channels is important. There are three 
main types of Cavs (Cav1-3) with differential expression in tissues and cell types (Catterall et al., 
2005). Their composition is complex, and consists of four or five distinct subunits with the Į1
subunit being the largest and important for pore conduction, voltage sensing and gating 
properties. The Į1 subunit is organised into four homologous domains (I-IV), with six 
transmembrane regions within in each domain (Catterall et al., 2005). The CavĮ1 subunit can 
also associate with accessory or auxillary subunits such as Cavȕ and CavĮ2į, and thus can affect 
biophysical properties and trafficking of these channels (Dolphin, 2003; Dolphin, 2009). 
Previous studies have shown that phosphorylation of Cavȕ2 subunit can regulate the expression 
of Cav1 and Cav2 channels at the plasma membrane (Viard et al., 2004). The L-type or Cav1 
voltage gated ion channels are comprised of four distinct members: Cav1.1, Cav1.2, Cav1.3 and 
Cav1.4 (Ertel 2000), of these Cav1.2 and Cav1.3 are primarily expressed in the nervous system 
(Calin-Jageman et al., 2008).  
Interaction between Nedd4 and voltage-gated calcium channels  
Recently, Nedd4 was shown to ubiquitinate Cav1.2 channels. The overexpression of Nedd4 
results in reduced Cav currents, expression of Cav1.2Į1 as well as the total expression of the 
accessory subunits Cavȕ2 and CavĮ2į1 (Rougier et al., 2011). This study also highlighted that 
Cavȕ is essential for Nedd4-mediated degradation of newly synthesized Cav channels. This 
finding is extremely important, as Cav channels have been shown to be important in regulating 
membrane excitability and intracellular signal transduction including gene transcription in the 
brain (Calin-Jageman et al., 2008). Furthermore, calcium has been shown to bind to the C2 
domain of both Nedd4 and Nedd4-2 and releases the auto-inhibition (Rougier et al., 2011; Wang
et al., 2010). This suggests that Nedd4 and possibly Nedd4-2 have important interactions with 
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calcium and can therefore regulate calcium signalling pathways which are important for 
neuronal excitability.  
Calcium and LTP 
As already discussed calcium influx through NMDA receptors is essential for the induction of 
LTP and thus memory formation (Moosmang S et al., 2005). It is not surprising therefore that 
Cav1.2 is predominantly expressed in pyramidal neurons of the hippocampus (Di Biase V et al., 
2011; Lacinova et al., 2008). In a mouse line where the CACNA1C (Cav1.2) gene was 
inactivated in the hippocampus and neocortex, a deficit in protein-synthesis dependent spatial 
memory was observed (Moosmang S et al., 2005) as a result of Cav1.2 modulation of CA1 
pyramidal neuron spiking patters (Lacinova et al., 2008). The increase in intracellular 
concentration of calcium during LTP stimulates the activation of ERK/CREB pathways as well 
as triggering the transcription of genes producing the long-lasting changes in synaptic plasticity 
(West et al., 2001). For example, the rise in levels of intracellular Ca2+ can activate CamKII 
producing a multitude of effects; protein synthesis, cytoskeletal changes, and changes in 
AMPAR receptor activity and density, all crucial processes for the maintenance of LTP, and 
thus contributing to synaptic plasticity (Figure 1.9). 
It is therefore not surprising that alterations in neuronal excitability would result due to changes 
in intracellular calcium, either by increased or decreased density of NMDA receptors and (Cavs) 
channels. These changes will affect firing patterns of neurons and thus synaptic change 
(including plasticity) that can underlies cognitive behaviour. With Nedd4 being able to regulate 
the levels of newly synthesised Cav1.2 channels in the plasma membrane and thus affecting 
calcium signalling further investigation is required by the examination of behavioural outcomes.  
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Figure 1.8. Calcium plays a central role during synaptic plasticity, influencing gene 
transcription and thus protein synthesis, cytoskeletal changes such as MAP2 phosphorylation, 
signalling for GluR1-AMPAR insertion into the plasma membrane, and enhancing AMPAR 
activation by enhancing conductance. Calcium entry into the post-synaptic neuron is conducted 
via NDMA receptors, as well as voltage-gated calcium channels. Adapted from West, Chen et 
al. 2001. Although Nedd4 is not known to interact with NMDA receptors, their activation is 
necessary for Nedd4 mediated changes associated with synaptic plasticity. 
Cytoskeletal changes that occur during synaptic plasticity 
Orchestrated remodelling of the cytoskeleton is a feature of neuronal outgrowth involving both 
actin filaments and microtubules. MAP1 and MAP2 are microtubule-associated proteins, which 
have many functions in axons and dendrites, including stabilization of microtubule structure as 
well as acting as scaffolds for the growth of neurons (Gu J et al., 2008). The regulation of MAPs 
is important, not only during neuronal outgrowth and synaptogenesis but also in mature neurons 
where adaptive changes occur during plasticity required for memory, learning and following 
injury. MAP1 is primarily located in both axons and to a lesser extent in dendrites, however 
MAP2 is restricted to the cell bodies and dendrites. MAP2 comprises a large component of 
dendrites, and is associated with the synaptic changes that occur during memory and learning.  
MAP2 can also anchor regulatory proteins such as protein kinase A (PKA), critical for CREB 
(cAMP response element-binding protein) signalling, and is thought to be the major PKA 
anchoring proteins in neurons (Zhong H et al., 2009). Using in silico analysis, data from our 
56
laboratory show that MAP2 possesses a PY motif, and Nedd4-2 binding was demonstrated in 
PC12 cells (unpublished data). Furthermore, when the PC12 cells were treated with a 
proteasome inhibitor (MG 132) a significant increase in levels of MAP2 and α-tubulin was 
evident. A proteomic approach also supports these findings, with MAP2 identified as a target for 
both Nedd4 and Nedd4-2 (Persaud et al., 2009).  There is currently no evidence to suggest that 
MAP1 is a target of either Nedd4 or Nedd4-2. However, Nedd4 and Nedd4-2, may play direct 
roles in cytoskeletal remodelling by regulating the levels of these proteins that modulate the 
structural stability of the cytoskeleton.  
Proteins associated with neuronal growth and branching 
Nedd4 involved in regulation of axonal growth and branching 
Two important studies were recently published highlighting an important role for Nedd4 in axon 
growth and branching. The first study identified PTEN (phosphatase and tensin homolog deleted 
on chromosome 10) as a Nedd4 substrate which when down regulated, promotes axon branching 
in Xenopus retinal ganglion cells (Drinjakovic et al., 2010b). PTEN is an important regulator of 
PI-3 kinase signalling pathway, as mentioned previously crucial for growth, cell survival and 
differentiation. In neurons, the downstream signalling pathways of PI-3 kinase can function to 
regulate cytoskeletal dynamics and thus are important in neuronal morphology (Cosker KE et 
al., 2007). To test the functional role of Nedd4 in axonal growth, the HECT domain of Nedd4 
was mutated, resulting in an E3 ligase that does not have the ability to transfer ubiquitin to target 
proteins. Retinal ganglion cells containing mutant Nedd4 produced axons lacking elaborate 
terminal arbours and axons lost their branching potential. Furthermore, down-regulating PTEN 
in these retinal ganglion cells rescued the Nedd4 loss of function defect (Drinjakovic et al., 
2010b).  
Nedd4 involved in regulation of dendrite growth and branching 
The second study focused on the regulation of Nedd4 in dendrite development. A conditional 
Nedd4 knockout mouse was developed to examine dendrite development and synaptic function. 
Lack of Nedd4 was shown to result in impaired dendritogenesis, reduced dendrite arborisation, 
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reduced synaptic transmission and reduced synaptic numbers in vivo. Furthermore, Rap2A was 
identified as a novel Nedd4 substrate, important for the dendrite abnormalities observed in 
Nedd4 knockout mice (Kawabe et al., 2010). 
  
This data shows that Nedd4 is able to regulate growth of both axons and dendrites and thus 
affect the pre and post-synaptic compartments. It is likely that such abnormalities in axons and 
dendrites observed in the Nedd4 knockout mice would have an effect on cognition but this has 
not yet been determined. 
Voltage-gated ion channels 
Plasma membrane voltage-gated ion channels are critical for the normal patterns of excitability 
in many cells including neurons. They are located along the axon and at synapses where they 
initiate and propagate action potentials, set resting membrane potential and control 
neurotransmitter release, and thereby regulate neuronal excitability. This large family of ion 
channels comprise of voltage-gated sodium (Navs), potassium (Kavs), chloride (ClC) and 
calcium (Cavs), with many subtypes being differentially expressed. Voltage-gated ion channels 
contain several transmembrane domains, which are arranged around a central ion conducting 
pore and a C-terminal domain, which is integral for protein-protein interactions crucial for the 
regulation of cell surface expression. The levels at the plasma membrane are tightly regulated 
from a dynamic pool, which requires co-ordinated insertion, retention and removal to maintain 
appropriate levels of excitation. This trafficking of ion channels involves protein-protein 
interactions with a PPxY motif contained in most of the voltage-gated ion channels, which 
suggest Nedd4 and Nedd4-2 might be interacting (Table 1.1). As already discussed, Nedd4 can 
regulate Cav1.2, and thus may be implicated to have an essential role during learning and 
memory. In terms of the other voltage-gated channels, there is data showing both Nedd4 and 
Nedd4-2 interact with a number of channels and regulate channel density. However, there is no 
evidence showing direct interactions with neuronal subtypes, but it is likely that Nedd4 and/or 
Nedd4-2 may be integral in regulating these channels in neurons. This would suggest that 
Nedd4 and Nedd4-2 could be critical in the most basic neuronal function, excitability.  
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Table 1.1. PY motifs contained in voltage-gated ion channels .
Nedd4 and Nedd4-2 may play a central role in synaptic plasticity, LTP, and therefore memory and 
learning 
There is now a large body of evidence for a multitude of targets for both Nedd4 and Nedd4-2 
implicating them to play an integral role in the growth, and differentiation of neurons but also 
for synaptic plasticity. This forms a complex picture, and to date there is no evidence of the 
physiological effects for Nedd4 and Nedd4-2 in learning, memory other cognitive aspects such 
as anxiety. With the substantial interest in ubiquitination of molecular components necessary for 
learning and memory, it seems likely that changes in Nedd4 and Nedd4-2 levels may have 
profound effects and will be investigated in this thesis. 
1.5 MOTOR FUNCTION 
Movement (voluntary and involuntary) occurs due to a complex integration of several regions 
within the CNS that regulate spatial and temporal patterns of muscle contraction. Intentional or 
voluntary movements are largely initiated by the motor cortex, and descend through the spinal 
cord (via motor neurons) to innervate muscles that enable movement (Kandel et al., 2000). The 
interface between neurons and the muscle, the neuromuscular junction is also critical for the 
delivery of movement (Kandel et al., 2000). Cortical and subcortical regions including the basal 
ganglia and cerebellum can also modulate these descending motor pathways (Kandel et al., 
2000). To date there is no data to shown whether Nedd4 or Nedd4-2 are expressed in these 
regions of the brain, however key possible targets regulated by Nedd4 and Nedd4-2 that are 
expressed in these locations and were investigated in this thesis. 
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Motor Cortex 
The motor cortex is comprised of the primary, premotor and supplementary cortices, which 
together allow for the planning, control and final execution of voluntary movement (Kandel et 
al., 2000). Like the rest of the cortex, the motor cortex is comprised of layers formed during 
development. In layer V of the motor cortex, pyramidal neurons are found that descend through 
the spinal cord and synapse on motor neurons to form the corticospinal tract (Kandel et al., 
2000).  
Spinal Cord 
The spinal cord contains tracts that descend to innervate, motor neurons that in turn innervate 
peripheral tissue including skeletal muscle required for voluntary movement. Motor neurons 
receive cortical input primarily from the motor cortex, and send projections to the skeletal 
muscle via the neuromuscular junction (Kandel et al., 2000). In Nedd4 knockout embryos, 
motor neuron numbers are reduced and abnormalities are evident in the neuromuscular junctions 
(NMJ), such as reduced capacity to depolarize (Liu et al., 2009b). Interestingly, Nedd4 was 
found not to be expressed in motor neurons, however this suggests that Nedd4 may be integral 
in the formation and/or stabilization and function of the NMJ and therefore have an important 
role in motor function. 
Basal Ganglia 
The basal ganglia are a group of nuclei including the striatum (caudate nucleus and putamen), 
globus pallidus, substantia nigra (pars reticulate and compacta), and subthalamic nucleus. The 
basal ganglia has many functions, with the regulation of voluntary motor control being 
particularly important. Overall, there is complex circuitry with motor cortical input, received by 
predominantly the striatum, is integrated and modulated before thalamic projections are sent 
back to the motor cortex (Kandel et al., 2000) (Figure 1.10). In order to understand, this 
complex circuitry it is important to briefly discuss each of the components, and their 
contribution to motor function. 
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Figure 1.9. Schematic representation of basal ganglia circuitry. The basal ganglia receives input 
from the motor cortex via the stratum, and is modulated by one of the many nuclei including 
globus pallidus (interna, GPi and externa, GPe), substantia nigra (pars compacta, SNpc and 
reticulata, SNr), and subthalamic nucleus that regulates feedback to the thalamus and thus back 
to the motor cortex.  
The Striatum, Globus Pallidus and Subthalamic Nucleus 
The striatum is the largest basal ganglia nuclei, composed of > 90% inhibitory GABAergic 
(gamma-aminobutyric acid) medium spiny interneurons. The striatum receives direct excitatory 
input from the motor cortex and provides major inhibitory output to substantia nigra pars 
reticulata (SNr) and globus pallidus (interna and externa; GPi and GPe). The striatum also 
receives dense innervation from the substantia nigra pars compacta (SNpc), where dopaminergic 
neurons project and release dopamine that binds to either dopamine receptors (D1 and D2), to 
inhibit or excite neurons of the striatum. It is important to note that neurons that have D1 or D2 
receptors are segregated to the direct and indirect pathways, respectively (Thibault et al., 2013). 
Globus pallidus also contain predominantly inhibitory (GABAergic) and can be subdivided into 
the internal (GPi) and external (GPe) compartments. Both GPi and GPe receive afferent input 
from the striatum, but their targeted projections are distinct. For instance, GPi sends inhibitory 
projections to the thalamus, and GPe inhibitory projections to the subthalamic nucleus. The 
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main role of subthalamic nucleus is to provide excitatory projection to both substantia nigra pars 
reticulate (SNr) and GPi (Kandel et al., 2000). 
Substantia nigra 
Substantia nigra is composed of two segments, pars compacta (SNpc) and reticulata (SNr). SNr 
is largely composed of GABAergic inhibitory neurons that inhibit both the thalamus and SNpc. 
SNpc on the other hand contains dopaminergic neurons, which project to the striatum and can 
provide both inhibitory and excitatory input. These neurons degenerate in patients afflicted with 
Parkinson’s disease, where a loss in dopamine results in the classic symptoms: resting tremor, 
rigidity, bradykinesia and gait abnormalities (Dauer et al., 2003; Jankovic, 2008; Sulzer, 2007; 
Vernier et al., 2004). The interaction between SNpc and striatum is important as once dopamine 
is released into the striatum it is imperative that dopamine is rapidly taken up by dopamine 
transporters (DAT). Dopaminergic neurotransmission will be investigated in this thesis, due to 
the interaction between Nedd4-2 and DAT and discussed in more detail. 
Dopamine and motor function 
Dopamine is an important neurotransmitter in the brain involved in voluntary movement, but 
also for cognitive behaviours such as addiction and reward. Dopaminergic neurons originate in 
the SNpc, ventral tegmental areas and hypothalamus and project to various brain regions (Chinta
et al., 2005). Dopamine is synthesized, packed into vesicles and upon depolarization of a neuron 
is released into the synaptic cleft. Dopamine acts on dopamine receptors (D1-5) and the 
termination of dopamine signalling occurs by the DAT, which enables dopamine reuptake back 
into the cytoplasm (Jaber et al., 1997; Torres, 2006).  
Dopamine Transporter  
DAT is expressed at the plasma membrane with a dynamic pool of DAT available implying that 
the regulation (insertion and removal from the plasma membrane) is under tight control. 
Alteration in the function of DAT will ultimately affect the level of dopamine at the synapse and 
thus have major implications in dopaminergic signaling. Evidence exists for polymorphisms in 
the DAT gene in patients suffering from hyperactivity disorders such as ADHD (Krause et al., 
62
2003). Furthermore, mice containing a disrupted DAT gene display a distinct behavioural 
phenotype associated with hyperactivity due to the increased levels of synaptic dopamine (Giros
et al., 1996; Spielewoy et al., 2009). Therefore, DAT regulation is imperative for normal 
dopamine signalling.  
Regulation of DAT 
Until recently, the mechanism of DAT regulation at the membrane surface remained poorly 
understood. Nedd4-2 was found to co-localize with DAT, and induce PKC-dependent 
endocytosis (Sorkina et al., 2006). Although DAT does not contain the typical PPxY motif, 
Nedd4-2 must be able to ubiquitinate DAT either through an atypical motif or by an indirect 
mechanism, such as an intermediate protein.  This study also identified that both WW3 and 
WW4 domains are critical for this interaction.  More recently, Nedd4-2 was shown to conjugate 
the ubiquitin via Lys63 site producing multi-monoubiquitination and/or poly-ubiquitination of 
DAT (Vina-Vilaseca et al., 2010). The effect of Nedd4-2 mediated DAT regulation on 
dopamine levels and/or behaviour has not been characterized in vivo. Nedd4-2 is likely to have 
profound effects on dopamine signalling, with decreased levels of Nedd4-2 in heterozygous 
mice perhaps resulting in increased cell surface levels of DAT, which may lead to decreased 
synaptic levels of dopamine. 
Cerebellum and motor co-ordination 
The cerebellum is an important region of the brain primarily responsible for fine-tuning of 
movements ensuring that voluntary movement occurs with accurate timing and specificity. 
Although the cerebellum does not initiate movement it makes a large contribution to motor co-
ordination, postural control, motor learning and maintenance of gait (Kandel et al., 2000). The 
cerebellum is composed largely of two neuron types; granule cells and Purkinje neurons. 
Granule cells are located in the tightly packed granule cell layer. Granule cells send projections 
rising horizontally into the molecular layer where they synapse on Purkinje cell dendrites, and 
are termed parallel fibres (Manto et al., 2001). Parallel fibres are excitatory and use glutamate as 
a neurotransmitter. Granule (glutamatergic) cells receive input via mossy fibres, which carry 
information from the cerebral cortex (via pontine nucleus) and spinal cord, and therefore allow 
for the integration of stimuli from cortex, and sensory information to make adjustments 
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necessary for accurate movement (Manto et al., 2001). Mossy fibres make excitatory synapses 
with granule cells and cells of the deep cerebellar nucleus (DCN) (Manto et al., 2001). Purkinje 
neurons, which are located in a single layer, are large projection neurons that have extensive and 
elaborate dendritic branches extending into the molecular layer (Manto et al., 2001). Purkinje 
neurons are inhibitory (GABAergic), and output from the cerebellum, by projecting to cells of 
the DCN. Climbing fibre also provide direct synaptic input to Purkinje neurons, with 
information from spinal cord, brainstem and cerebral cortex (via inferior olivary nucleus) 
(Manto et al., 2001) (Figure 1.11). 
Figure 1.10. Schematic illustration of cells and fibres that comprise the complex cerebellar 
circuits. The cerebellum is composed of three principle layers; granule cell layer (GC), Purkinje 
cell layer (PC) and molecular layer (ML). The large Purkinje cells (neurons, PC) send extensive 
dendritic branches into the molecular layer, where they make excitatory synapses with parallel 
fibres of granule cells (GC). Purkinje neurons are the sole output of the cerebellum, sending 
inhibitory projections to the deep cerebellar nuclei (DCN). Dendrites from Purkinje neurons also 
receive climbing fibre input from the cerebral cortex, spinal cord and brain stem (via inferior 
olivary nucleus). Mossy fibres carry information from motor cortex and spinal cord and synapse 
onto granule cells. Purkinje cell dendrites also receive inhibitory input from interneurons located 
in the molecular layer. 
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Purkinje cell function 
The main function of Purkinje neurons is to integrate motor and sensory information through 
two main synapses; parallel fibres and climbing fibres. These fibres are excitatory and release 
glutamate, which act predominantly on AMPA receptors (AMPARs) to stimulate neuronal 
excitability of Purkinje neurons (Evans, 2007). Central to this calcium has an important function 
both pre-synaptically, to control level of neurotransmitter (glutamate) release by climbing and 
parallel fibres, but also post-synaptically where the regulation of excitability and initiation of 
events necessary for synaptic plasticity is required for motor learning (Empson et al., 2012). The 
expression levels of AMPARs are also crucial in determining levels of neuronal excitability of 
Purkinje neurons (Evans, 2007). 
Calcium and Purkinje neurons 
The granule cell-Purkinje neuron synapse (via parallel fibres) is important as glutamate is 
released and acts on AMPA receptors to modulate level of Purkinje neuron excitability and thus 
extent of inhibition received by DCN. Purkinje neurons show a distinct electrophysiological 
activity, having both simple (when activated by parallel fibres) and complex (when activated by 
climbing fibres) spikes (De Schutter et al., 2009; Manto et al., 2001). Calcium is extremely 
important for Purkinje cell activity, and it is not surprising that voltage-gated calcium is present 
on Purkinje neurons to allow for the influx of calcium during neuronal activity (Kitamura et al., 
2012). The regulation of calcium is therefore imperative for Purkinje neurons to maintain 
normal and adequate levels of neuronal excitability.  
Voltage-gated Ca2+ channels 
Voltage-gated Ca2+ channels are also essential for the maintenance of normal calcium levels 
both in the pre and post-synaptic compartment. In Purkinje neurons a deficiency in calcium 
signalling can have profound motor control deficits (Ito, 2002). As already discussed, Purkinje 
neurons are inhibitory GABAergic neurons with calcium signalling being important for the 
release of GABA at deep cerebellar nuclei terminals but also play a role in their spontaneous 
activity (Womack M et al., 2002). In stargazer mutant mice, which exhibit seizures and ataxic 
gait, a significant reduction in L-type Cav1.2 channels are seen at the post-synaptic membrane. 
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This can affect excitatory neurotransmission when parallel fibres synapse onto Purkinje neurons, 
and is believed to contribute to ataxia observed in the stargazer mutant mice (Leitch et al., 
2009). Motor learning requires long-term depression (LTD), which underlies synaptic plasticity 
in the cerebellum. LTD is triggered by calcium signals in postsynaptic Purkinje neurons and 
enables motor learning to occur (Finch et al., 2012; Lamont et al., 2012). As already discussed, 
Nedd4 is able to regulate the levels of newly synthesised Cav1.2 channels in the plasma 
membrane and may therefore play an essential role in Purkinje neuron and cerebellar function.  
AMPA Receptors and Purkinje cell function 
AMPA receptors (AMPARs) are located in the dendrites of Purkinje neurons where they allow 
the facilitation of glutamate by granule cell parallel fibres. The trafficking of AMPARs like in 
the hippocampus can have profound effects on neuronal function. Evidence from mutant mouse 
models (stargazer) show that when AMPARs are lost at the granule cell-Purkinje cell synapses 
severe ataxia can result (Shevtsova et al., 2012). With evidence of Nedd4 mediated regulation of 
AMPARs, this further supports the potential role for Nedd4 in motor function and gait. 
Purkinje neurons involved in disorders of the cerebellum 
Abnormalities in Purkinje neuron function are seen in a multitude of movement disorders in 
both human diseases and rodent models. The most abundant class of movement disorders arising 
due to cerebellar dysfunction in humans are termed ataxias. There are many subtypes with 
different clinical outcomes and pathological causes that are beyond the scope of this thesis. 
Most of the molecular mechanisms are understood with the use of mouse models. What these 
disorders have in common however is an abnormality in cerebellar function, with Purkinje 
neuron degeneration being particularly prevalent. 
Spinocerebellar ataxias and motor function 
Spinocerebellar ataxias are autosomal-dominant cerebellar degenerative disorders, with 
neuropathology observed in the cerebellum, brainstem, spinal cord, and basal ganglia (Matilla-
Dueñas A et al., 2010; Owada K et al., 2005). Spinocerebellar ataxias are a form of 
polyglutamine diseases characterized by CAG repeats in coding regions of genes. In patients 
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with spinocerebellar ataxia type 31, degeneration is seen in the cerebellar cortex, with particular 
susceptibility of the Purkinje cells (main projection neurons) (Owada K et al., 2005; Sakai et al., 
2010), giving rise to gait and movement abnormalities. Recently, a novel Nedd4 binding partner 
BEAN (brain expressed associated with Nedd4) was found to be disrupted in a population of 
Japanese patients with spinocerebellar ataxia type 31 (Sato et al., 2009). These important 
findings suggest that Nedd4 may be implicated in disorders of the cerebellum such as 
spinocerebellar ataxias and may extend to motor function and capacity. The interaction between 
BEAN and Nedd4 is unknown; whether Nedd4 is unable to ubiquitinate and therefore degrade 
the mutant form of the protein in these patients requires investigation. To date, BEAN has only 
been identified as being highly expressed in the brain, but little is known about its role, function 
or distribution, in particular regulation of BEAN by Nedd4. In addition, whether Nedd4 
contributes to the pathogenesis of SC31disease remains unknown.  
1.6 HYPOTHESIS AND AIMS 
The potential substrates and roles for Nedd4 and Nedd4-2 are numerous and lead to a complex 
network of signalling pathways and systems that are affected including pre- and post-synaptic 
compartments (Figure 1.12). Although the literature is vast, one limitation is that these studies 
are mostly conducted in vitro utilizing cell systems and fail to address any in vivo physiological 
effect.  
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Figure 1.11. Multitude of known and potential targets for Nedd4 and Nedd4-2 highlight the 
important roles to regulate neuronal function. The in vivo phenotype of these targets remains 
unknown however is likely due to the integration of all of these targets shown here. 
The central hypothesis of this thesis, is that Nedd4 and Nedd4-2 will have fundamental roles not 
only during the development but also in the mature adult CNS contributing to motor function, 
gait, and cognitive behaviours such as memory, learning and anxiety. It is becoming clearer that 
Nedd4 and Nedd4-2 have exclusive target substrates with no apparent redundancy and this 
would result different physiological outcomes. 
This hypothesis of this thesis was assessed by the following aims: 
Aim 1: Assess motor motor function and gait in Nedd4 heterozygous mice 
Aim 2: Assess motor function and gait in Nedd4-2 heterozygous mice 
Aim 3: Assess cognitive behaviours in Nedd4 heterozygous mice 
Aim 4: Assess cognitive behaviours in Nedd4-2 heterozygous mice 
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CHAPTER 2: NEDD4 IN MOTOR FUNCTION AND GAIT 
2.1 BACKGROUND AND RATIONALE 
Motor function 
Motor function relies on a complex network of neurons to ensure that voluntary movements are 
precise and produce intended output. Motor function requires projections from motor cortex, 
which travel via the spinal cord (motor neurons) that innervate skeletal muscle, with the 
interface between motor neurons and skeletal muscle being the neuromuscular junction. The 
basal ganglia and cerebellum provide necessary fine-tuning to ensure timing, accuracy and 
spatial aspects of   motor function are precisely executed (Figure 2.1).  
Figure 2.1. Schematic diagram showing the connections between various brain regions in 
regulating voluntary movement. Motor cortex sends projections through the spinal cord (SC), 
which synapse onto motor neurons (MN). Axons from MN then synapse onto skeletal muscle 
(SKM) via neuromuscular junctions (NMJ). The basal ganglia and cerebellum receive input 
from motor cortex, which provides important information regarding the intended movements. In 
turn they project back to the motor cortex to fine tune motor cortex output. The cerebellum also 
receives inputs directly from the spinal cord that provide postural and sensory information to 
allow the cerebellum to send accurate feedback to the motor cortex about movement in space 
and time. Arrows indicate projections from one compartment to the other. 
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Motor cortex  
The primary motor cortex is essential for the initiation and execution of voluntary movement. 
Pathways originating from the motor cortex descend through the spinal cord to finally innervate 
skeletal muscles resulting in voluntary movement. The motor cortex in turn receives feedback 
from the basal ganglia and cerebellum to fine tune motor output. Abnormalities in the motor 
cortex that occurs following brain damage or stroke, results in abnormal innervation of skeletal 
muscle and thus abnormal motor output (Cheung et al., 2012). The level of feedback from both 
the thalamus (via basal ganglia) and from the cerebellum is tightly regulated with abnormalities 
in these regions also contributing to motor disturbances. The expression of Nedd4 within the 
motor cortex has not been investigated. 
Basal ganglia  
The basal ganglia, is composed of a group of nuclei located within the brain that form complex 
neuro-circuitry, with overall modulation of motor output. Essentially, the basal ganglia 
determine the level of inhibition received by the thalamus that in turn regulates the level of 
excitatory feedback to the motor cortex. It was important to examine each of these regions more 
specifically in order to understand how abnormalities can result in motor dysfunction.  
Substantia nigra 
Substantia nigra is divided into two distinct regions; pars compacta and pars reticulata. Pars 
compacta (SNpc) neurons are predominantly involved in motor function. SNpc neurons produce 
dopamine and are identified using an antibody against tyrosine hydroxylase (rate-limiting 
enzyme for dopamine synthesis), and these neurons principally project to striatum. Pars 
reticulata (SNpr) on the other hand, does not contain dopaminergic neurons and are composed 
of predominantly GABAergic neurons, which project to areas such as thalamus and mediate 
output back to the motor cortex. SNpr, can also inhibit SNpc via collaterals. The loss of SNpc 
neurons is seen in Parkinson’s disease and contributes to the motor abnormalities associated 
with this debilitating disorder (Dauer et al., 2003). 
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Striatum 
Dopaminergic neurons originating from substantia nigra pars compacta (SNpc), project to 
striatum where their terminate on medium spiny interneurons (comprise >90% of neurons in this 
region). Once dopamine is released in the striatum, it binds to dopamine receptors, whilst excess 
dopamine is rapidly removed by the dopamine transporter (DAT). Nedd4-2 is known to 
modulate DAT (Sorkina et al., 2006; Vina-Vilaseca et al., 2010), so it was necessary to 
determine whether DAT and Nedd4 are located in the same region and whether any changes 
were observed. 
Nedd4 and motor function 
There are a number of neuronal targets for Nedd4 that can have important implications for 
motor function, loco-motor activity and gait. The first piece of evidence came from embryonic 
Nedd4 knockout mice, where abnormalities in the neuromuscular junctions were evident. These 
abnormalities included reduced capacity to depolarize and reduced number of motor neurons in 
the spinal cord that innervate the skeletal muscle at the neuromuscular junction (Liu et al., 
2009b). Since the neuromuscular junctions are at the interface of skeletal muscle and neurons, 
alterations may impact on motor capacity and thus interfere with voluntary movement. 
IGF-1  
The second piece of evidence revolves around the importance of Nedd4 in IGF-1 mediated 
signaling. Alterations in IGF-1 signaling have been identified in both patients’ and in rodent 
models of ataxias (Fernandez et al., 2005; Torres-Aleman et al., 1996). For example, patients 
with spinocerebellar ataxia type 3 (SCA3) have lower IGF-1 levels and a strong association 
between insulin binding protein (IGFBP3) levels and length of the CAG repeat (Saute et al., 
2011). Rodent models of cerebellar ataxias are well characterized, and represent excellent 
models for human disease. In two mutant mice, weaver and lurcher, IGF-1 levels were found to 
be significantly reduced (Vig et al., 1994; Yao et al., 2008). Furthermore, IGF-1 administered 
systemically has been shown to restore motor, gait abnormalities and delay and restore Purkinje 
neuron degeneration (Tolbert et al., 2003; Vig et al., 2006). 
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IGF-1 in the cerebellum 
The cerebellum is a critical region of the brain highly involved in gait, motor control and motor 
learning. The ataxia diseases and models all share common characteristic of degeneration in 
Purkinje neurons, that ultimately affect output from cerebellum to motor cortex to fine-tune 
motor output. It is therefore not surprising that the cerebellum, a region critical for gait contains 
both IGF-1 and its receptors and the Purkinje neurons able to synthesize endogenous IGF-1 
(Aguado et al., 1992; Bondy et al., 1992; Zhang et al., 1997).  
In addition to ataxia diseases, IGF-1 has also been shown to be critical in other degenerative 
disorder of the central nervous system that can also impair motor function and gait. For 
example, in a mouse model of ALS (SODG93A), muscle specific IGF-1 is located at the 
neuromuscular junction and involved in the inflammatory response in spinal cord, and thus 
impacts on the survival of motor neurons, and more importantly delays the onset of movement 
deficits (Dobrowolny et al., 2005). When IGF-1 was delivered by adeno-virus into the spinal 
cord of SODG93A mutants, significant protection was observed (Lepore et al., 2007).  
AMPA receptors 
More recently Nedd4 was shown to mediate the endocytosis of AMPA receptors. AMPARs 
mediate the majority of fast excitatory (glutamate) neurotransmission, and thus are an important 
factor in regulating neuronal excitability. The importance of the insertion and removal of 
AMPARs at the post-synaptic membrane of neurons is crucial for motor learning and co-
ordination. This is highlighted in the stargazer mutant mouse, where AMPARs are significantly 
reduced in cerebellar Purkinje neurons, and associated with the development of severe ataxias in 
these mice (Barad et al., 2012; Menuz et al., 2008). 
Calbindin-D28k 
The calcium buffering protein Calbindin-D28k, may also be an important Nedd4 target. Since, 
Nedd4 activity can be regulated by calcium, an important interaction with the proteins 
responsible for regulating intracellular calcium levels may exist. Calbindin-D28k heterozygous 
mice have profound motor control deficits that exist due to alterations in Purkinje neuron 
function (Ito, 2002). 
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BEAN 
Finally, the novel Nedd4 interacting protein, BEAN (Brain expressed associated with Nedd4) 
was disrupted in a Japanese population of spinocerebellar ataxia type 31 patients. The BEAN 
protein contained of a complex penta-nucleotide repeat sequence the length correlating to age of 
onset and severity of disease (Sato et al., 2009). Very little is known about spinocerebellar 
ataxia type 31, however it is clear that this type of ataxia is late onset, purely cerebellar ataxia 
and the third most common adult onset cerebellar ataxia in Japan (Ishikawa et al., 2011).  
Examination of motor function  
To determine the contribution of Nedd4 to motor function behavioural assessment can be used 
to examine many facets of motor function. Firstly it is important to determine basal locomotor 
activity and this can be accomplished with the use of locomotor cells. This test is useful in 
measuring explorative behavior, and can be a useful indicator of increased or decreased activity. 
For instance, increased activity is seen in rodent models of hyperactivity disorders associated 
with increased dopamine levels in the basal ganglia (Durieux et al., 2012; McCullough et al., 
1992; Russell et al., 2005). Motor capacity, balance and co-ordination can also be examined 
using the Rota-Rod test. It assesses the ability of a mouse to remain on a rotating rod as the 
speed of rotation increases. Results from Rota-Rod can provide an indication of motor neuron 
function and basal ganglia dysfunction (Russell et al., 2005). 
Gait analysis 
Maintenance of normal gait patterns is largely controlled by the cerebellum, which ensures that 
movements are accurate, timely and balanced. As already discussed, IGF-1 and AMPAR have a 
strong contribution to normal cerebellar function, and due to the known interaction between 
Nedd4 with these targets, a potential role for Nedd4 in gait is likely. Gait analysis can be 
evaluated using the automated system DigiGait. Using the DigiGait system investigation into 
static (placement of paws) and dynamic (timing of movements) phases of gait can be assessed. 
One major advantage of DigiGait over other gait analysis systems is the ability to determine 
walking speed of the treadmill. Normal walking speed for mice ranges between 15-25 cm/sec, 
with changes in speed altering some gait parameters (Clarke et al., 1999), and as such different 
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walking speeds can be used to evaluate normal walking speed (15 cm/sec) and a more 
challenging speed (i.e running, 30 cm/sec). 
Gait parameters 
Examination of gait parameters requires investigation of both spatial and temporal indices, 
including overall stride in duration and length. One stride can also be subdivided into the phases 
that comprise it including; stance, swing, brake and propel (Figure 2.2). 
Figure 2.2. Stride parameters assessed by DigiGait. Braking phase of stride begins with initial 
paw contact with the belt, once maximum contact is reached; the propulsion phase begins and 
ends with the lift off by the toes (A). One complete stride is comprised of braking, propulsion 
and swing phases. Stance is defined by the duration of time the paws are in contact with the belt 
(B).  
It is important to measure each of these phases of stride as they have important contributions to 
overall gait. For instance, the swing phase of stride measures the acceleration of motion and can 
be an indicator of joint mobility. Propulsion measures the initiation and acceleration of motion, 
with breaking measuring the deceleration of motion. Older methods such as footprint analysis 
can provide a measure of overall stride, but changes in stride could be due to alterations in one 
or more of the components of stride and cannot provide important insights into which aspect is 
affected. In addition, fore and hind paws are principally important for the different components 
of stride, for example the fore paws are predominantly used for propulsion and hind paws more 
effective for braking during rodent locomotion. 
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Alterations of one or more of these parameters can be associated with severe conditions.  For 
instance, in arthritic mice and rodent pain models an increase in swing duration is observed 
(Plaas et al., 2011; Simjee et al., 2004). In addition, in animal models for Down syndrome and 
following ethanol exposure increases in propulsion duration (Hampton et al., 2004; Kale et al., 
2004), and decrease in braking durations (Kale et al., 2004) are observed.   
Stance duration measures the time that paws are in contact with the belt. In humans with 
cerebellar diseases such as ataxia, an increase in stance duration is observed which is believed to 
be a compensatory measure to maintain stability (Stolze et al., 2002). Other clinical signs of 
cerebellar ataxia include increases in stance width, irregularities in number of steps, increases in 
cadence (steps/min), increases in foot angle and increases duration of double limb support which 
will be discussed below (Stolze et al., 2002). 
Spatial gait parameters 
Spatial gait parameters include stride length and stance width (Figure 2.3), which measure the 
size of the stride and the width of the paws when in contact with the belt. The variability of 
stride length provides further information on ability to maintain consistency during successive 
strides. This is exemplified in patients and rodent models of Parkinson’s disease (PD), where a 
decrease in stride length is accompanied by increased variability stride to stride in affected 
individuals and rodent lesion models (Amende et al., 2005a; Hausdorff et al., 1998; Hausdorff
et al., 2000). Stance width measures the distance between both fore and hind limbs. Increases in 
stance width and stance duration are clinical features of cerebellar ataxias. Increases in these 
parameters are thought to be a compensatory measure to improve stability during locomotion 
(Stolze et al., 2002).  
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Figure 2.3 Gait parameters to identify stride length, width, and angle dynamics
Step frequency and angle dynamics 
As already mentioned, increases in cadence (steps/sec) is an important clinical hallmark in 
patients with cerebellar ataxia (Stolze et al., 2002). The DigiGait system can measure both the 
total number of steps taken but also cadence (number of steps per second) (Figure 2.3). Paw 
angle dynamics can also be investigated including; paw angle (that compares left and right paw 
angles), absolute paw angles (that compares paw angle in relation to the midline of the mouse), 
paw angle variability (measures consistency of paw angle placement), step angle (differences 
between left and right paws taken into account of stride length and width) and step angle 
variability (measures consistency of step angle between successive strides). There is some 
evidence of step angle changes in patients with cerebellar ataxia, where an increase is observed 
(Stolze et al., 2002). In rodents, paw angle parameters are poorly defined or understood, with 
interpretation into human gait limited. However, studies have identified changes in angle 
dynamics in many rodent disease models. For example, an increase in paw angle (or open) 
angles are present in hind paws of ataxic mice, rodent models of spinal cord injury and 
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demyelinating diseases (Powell et al., 1999) and following collagen-induced arthritis (Vincelette
et al., 2007). In addition, increases in step angles, have been shown to reflect dysfunctional 
ataxia following prenatal alcohol exposure in rodents (Hannigan et al., 1988). 
Plantar placement 
Plantar placement is a measure of weight bearing abilities measured by paw area at peak stance. 
A decrease in paw area is an indicator of reduced weight bearing, with reductions evident in a 
mouse model of collagen-induced arthritis (Vincelette et al., 2007). Variability of paw area can 
also be measured with increases suggested to reflect a deficiency in co-ordination (Goldberg et 
al., 2010).  
Stance factor and gait symmetry  
Stance factor or the ratio between left and right fore and hind limb stance durations has been 
shown to be an accurate and consistent parameter in evaluating peripheral nerve function after 
nerve injury (Varejao AS et al., 2001). Gait can also be described as symmetrical or 
asymmetrical, with asymmetries often suggesting gait pathologies. This is evident in both 
human (Kahn et al., 2009; Sadeghi et al., 2000) and rodents (Domanskyi et al., 2011; Herbin et 
al., 2004). Symmetrical gait in rodents is determined when both limbs (on left and right side) 
behave identically, and as a pair alternate during locomotion, and as such the value should equal 
to 1. Asymmetry, when limbs move together, and as such the value measured using DigiGait 
deviates from 1.   
Hind limb shared and stance-swing ratio 
Hind paw shared stance is also known as ‘dual stance’ or ‘double support’, and is a measure of 
time that both hind paws are in contact with the belt. Studies have shown that shared stance 
times increase with stride time (Clarke KA et al., 1989), with carrageenan induced paw 
inflammation in rodents (Coulthard et al., 2002), in obese children (McGraw et al., 2000), 
Parkinson’s disease patients (O'Shea et al., 2002), and significant decreases observed in a mouse 
(R6/2) Huntington’s model (Pallier et al., 2009). Stance-swing ratio measures the ratio of 
durations between stance (contact with belt) and swing (no contact with belt). This parameter 
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can also be useful in examining ‘double support’. For instance in humans natural walking 
produces longer stance phase over swing-phase, and as speed increases so does the swing phase. 
During running, stance swing is reversed and double support disappears. There is some evidence 
suggesting that following stroke, alterations in stance swing-ratio is an useful indicator of motor 
capacity (Harris-Love et al., 2001; Roth et al., 1997).  
The cerebellum largely contributes to the regulation of gait, in particular timing of movements 
and maintenance of balance. The basal ganglia however, also play an important role, which is 
evident in disorders arising due to damage to this region. Overall, gait and motor function 
require the contribution of all CNS regions involved in the planning, execution and fine-tuning 
of voluntary movement. 
Nedd4 in the CNS 
The expression of Nedd4 within the CNS has not been defined. Nedd4 is highly expressed in the 
brain and spinal cord during early neurodevelopment (Kumar et al., 1997). The expression in 
the adult brain has never been addressed; furthermore, regional and cellular expression has 
largely remained unknown. In order to determine the neuronal contribution of Nedd4 to motor 
function, Nedd4 must be expressed in regions of the brain such as cerebellum, motor cortex, 
spinal cord, and basal ganglia. The expression patterns may also refine the role, as motor 
function and co-ordination are complex processes requiring the integration of many brain 
regions. However, the cerebellum predominantly regulates gait and co-ordination.  
These findings led to the main hypothesis of the project described in this Chapter; that Nedd4 
would have a critical role in neuronal function necessary for motor control, co-ordination and 
gait and would show abundant expression in neurons necessary for these functional behaviours. 
To investigate this hypothesis, the following aims were set: 
1) Conduct behavioural tests in Nedd4 heterozygous mice and assess basal loco-
motor activity, motor function and gait. 
2) Determine cellular and regional expression of Nedd4 in the brain and spinal 
cord required for motor related behaviours 
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3) Determine suitable targets that may be responsible for motor related 
behaviours 
2.2 METHODS 
Animals 
A Nedd4 knockout line (Nedd4 Gt(IRESBetageo)249Lex) was obtained from the Mutant Mouse 
Regional Resource Center (MMRRC). This line is derived by gene trap with a retroviral 
insertion disrupting the Nedd4 gene between exons 17 and 18 
(www.mmrrc.org/strains/11742/011742.html). The following primers were used to genotype 
mice with the Nedd4 gene disruption. Primer genoN4 WT5’ (5’ GGA GTC TTT GGA TAT 
TGT AAG AGC 3’) and genoN4 WTandKO 3’ (5’ GAG CGT GCG CCT CAC AAG TAT GA 
3’) amplify a 226bp fragment from the wild-type allele, whereas genoN4 KO5’ (5’ AAA TGG 
CGT TAC TTA AGC TAG CTT GC 3’) and genoN4 WTandKO 3’ amplify a 137bp fragment 
from the Nedd4 disruption allele.  
Male Nedd4 heterozygotes and wild-type littermate controls were bred at the IMVS animal 
facility (Adelaide, Australia) and transported to Florey Neuroscience Institutes (FNI, Melbourne 
Australia) for behavioural assessment. At least one week acclimation prior to any testing was 
observed, during this period mice were handled daily to reduce stress related behaviours. 
Animals were singly housed a week prior to testing and maintained on a 12:12 h light/dark 
cycle. Animals were also given a day rest between each round of testing to ensure that 
variability due to fatigue was not a factor.  
For motor function and gait analysis, locomotor activity, RotaRod and DigiGait were used in 2 
and 6 month old Nedd4 heterozygous and age-matched controls were used (n = 8-13). The 2 and 
6 month Nedd4 heterozygous mice are separate cohorts of mice.  In order to test mice at twelve 
months of age, 5 Nedd4 heterozygous and 5 wild-type controls were kept from the 6 month old 
cohort. These mice were tested for RotaRod and DigiGait only. These mice were tested to 
establish that gait abnormalities are reproducible, and do continue with age.  
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Motor function and gait analysis behavioural tests 
Basal Locomotor Activity  
Prior to testing mice were habituated to low-light conditions in the testing room overnight whilst 
maintaining light/dark cycles as to not disturb circadian rhythms. Mice were placed in the 
photo-optic locomotor chambers (Coulbourn Instruments, Whitehall, PA) and spontaneous 
locomotor activity assessed for 30 minutes (Truscan 2.01). Activity was measured for both 
ventral and horizontal plane: 
• Horizontal plane: distance traveled, number of moves, time spent moving 
• Ventral plane: number of rearing events and time spent rearing 
  
At the conclusion of the test, chambers were thoroughly cleaned with 70% ethanol. This is 
essential to remove foreign odour that can affect explorative behaviours. 
Rota-Rod 
A four-chamber mouse Rota-Rod (UgoBasile, Milan Italy) was used in this study. Mice were 
trained the day before the test trial.  
Training protocol: 
• Training session 1: Constant speed at the lowest speed (4 rpm) for 2 minutes 
• Training session 2: Constant speed at the lowest speed (4 rpm) for 2 minutes 
• Training session 3: Accelerating speed from 4 rpm for 2 minutes 
On average, mice required 3-4 two minute trials and mice were deemed trained when they were 
able to maintain a time of 2 minutes at accelerating speed (up to 40 rpm) without falling off. 
Mice were also given 30 minute rest periods between each trial. One of the main reasons that 
mice need to be adequately trained is their innate desire to turn around on the rotating drum, 
which can lead to mice slipping off, irrespective of motor capacity. Some mice required more 
training trials, however there was no trend to suggest that heterozygous mice required more 
training than wild-type controls.  
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Testing was conducted the following day. 
Testing protocol: 
• Test 1: Accelerating speed from 4 rpm for 2 minutes
• Test 2: Accelerating speed from 4 rpm for 2 minutes
• Test 3: Accelerating speed from 4 rpm to 40 rpm for 5 minutes 
The duration on the rotating drum from the third test (Test 3) was used for comparison. 
DigiGait Analysis 
Gait analysis was performed using computerized digital footprint analysis (DigitGait, Mouse 
Specifics Inc, USA). Parameters assessed allows for the investigation of static (placement of 
paws) and dynamic (timing of movements). The DigiGait chamber has a digital camera placed 
below a transparent belt of a motorized treadmill, and allows the capture and translation of all 
fore paw placements in the ventral plane. Spatial and temporal indices were quantified using the 
accompanying DigiGait Imaging software. Animals were placed on the treadmill and required to 
complete 4-6 strides that were used for analysis. Gait was assessed at 15 and 20 cm/sec in the 2 
month cohort and 15, 20 and 30 cm/sec in the 6 and 12 month cohort. The 6 and 12 month 
cohorts were conducted at a later stage, and due to the limited change in gait at 2 months of age, 
the speed was increased to evaluate whether a more challenging speed would uncover changes 
in gait. DigiGait therefore has the capability of examining many facets of rodent gait, and makes 
this a powerful tool to determine even subtle gait anomalies. DigiGait indices are given for each 
paw; that is left and right fore paw, and left and right hind paws separately. Fore paw values 
represent an average from left and right fore paws, and the same for the hind paws. 
Tissue Collection 
Western Blotting 
Following behavioural analysis tissue was collected for Western blotting. Mice (n = 3-5) were 
euthanized with sodium pentobarbital injection (100 mg/kg i.p.). Brains removed, weighed, and 
the two hemispheres separated. One hemisphere was homogenized to obtain whole brain lysates. 
The second hemisphere was dissected, and cerebellum, hippocampus and striatum were 
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removed and snap frozen. All samples were stored at -80°C until required. Tissue samples were 
homogenized in lysis buffer composed of 159mM NaCl, 50mM Tris-HCl, 1% Triton-X, pH 7.4 
plus Complete lysis-M protease tablet (Roche USA) and processed according to manufacturers 
instructions. Protein quantification was determined using a BSA assay (Pierce), and samples 
resolved on 8% bis-glycine gels (Biorad) and transferred to nitrocellulose membrane (Pall 
Corporation, USA).  For Nedd4 protein analysis, 150 ȝg of total protein was loaded, necessary 
due to low-level expression of Nedd4 in adult brain making it difficult to accurately measure the 
bands. For all other protein analysis, 50 ȝg of protein was loaded onto the gels. Adequate 
protein transfer was determined by staining with Ponceau-S. Membranes were then blocked 
with 5% milk powder in Tris-NaCl-Tween buffer (TBS-T) followed by overnight incubation at 
4°C with primary antibodies. Blots were washed and incubated with fluorescently tagged Alexa 
secondary antibodies and visualized using FluoroChemQMultiImage III. Blots were analyzed 
using Image J, with each gel containing both wild-type and heterozygous samples to allow 
direct measurement and comparison. ȕ-actin was used as a loading control also measured on 
each gel. Protein bands were quantified, normalized to ȕ-actin levels and then represented as % 
of control.  
Immunohistochemistry 
After behavioural analysis, mice were weighed (n = 3-7), deeply anesthetized with sodium 
pentobarbital (100 mg/kg i.p.) and perfused with 0.1M phosphate buffered saline (PBS, pH 7.2) 
followed by ice cold 4% paraformaldehyde (PFA) in 0.1M PBS. Brain and spinal cords were 
removed, weighed and placed in 4% PFA for 2 hours at room temperature, after which they 
were cryoprotected in 30% sucrose solution. Each brain was divided into two hemispheres, one 
sectioned in the sagittal plane and the other in a coronal plane and used for immunohistohemical 
analysis. A cryostat was used to obtain frozen 50μm free floating sections of whole brain, 
sequentially selecting 1 in 6 sections. Spinal cord sections were also collected at 50ȝm in 1 in 4 
series. Sections were stored at -20°C in cryoprotectant (30% sucrose, 1% polyvinyl 
pyrolididone, and 30% ethylene glycol) solution. Brain and spinal cord sections were washed 4 
times in PBS and blocked for 1 hour at RT in blocking buffer (3% goat serum and 0.03% 
Triton-X 100).  Sections were washed 2 more times with PBS, then primary antibodies were 
applied in blocking buffer for 72 hrs at 4°C.  The following primary antibodies were used: 
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Antibody Function Dilution Manufacturer 
Mouse anti-NeuN Neuronal marker 1/1000 Merck-Millipore
Mouse anti-MAP2 MAP2 protein (dendritic marker) 1/1000 Sigma 
Rabbit anti-Nedd4 Nedd4 protein 1/1000 Abcam 
Rabbit anti-GluR1 GluR1 subunit of AMPARs 1/1000 Merck-Millipore
Sections were washed 4 times in PBS and incubated with secondary antibody for 1 hr at RT.  
Secondary antibodies used were all conjugated to Alexa-Flurophores (mouse-488 and rabbit-
555), and raised in goat. Sections were washed again 4 times in PBS and labelled sections 
mounted using Prolong-Gold mounting medium (Invitrogen) according to manufacturer’s 
instructions. Fluorescence labeling was visualized using a Nikon C1 confocal microscope using 
a 488nm argon and 543nm HeNe laser (Nikon Group, Tokyo, Japan). Images were acquired 
using 20x, 40x and 60x Plan-Apochromat oil immersion objectives. All images were captured 
and analyzed using Nikon Elements software.  
Statistics 
For the behavioural and western blot analysis statistical comparisons were made between the 
Nedd4 heterozygous mice and age-matched wild-type controls using unpaired Student’s t-test. 
Results were deemed significant when P < 0.05. Comparisons for the DigiGait analysis were 
conducted between the Nedd4 heterozygous mouse and the age-matched wild-type control. 
Comparison between 2, 6 and 12 months mice were not conducted due to the testing being 
conducted at different times. The gait parameters examined using DigiGait are largely 
independent, and as such Student’s t-test was used to statistically compare gait parameters, with 
results deemed significant when P < 0.05. 
2.3 RESULTS 
Body and brain weights 
Body and brain weights were measured. Nedd4 heterozygous (+/-) mice had a significant 
reduction in body weight compared to wild-type (+/+) controls at 2 (wt: 20.3 ± 0.5g; n = 8 and 
het: 17.6 ± 0.7g; n = 14; P = 0.01) and 6 months (wt: 33.0 ± 1.3g; n = 10 and het: 27.4 ± 1.1g; n 
= 10; P = 0.004), with a trend also observed at 12 months (wt: 36.4 ± 2.3g; n = 5 and het: 31.4 ±
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1.8g; n = 5; P = 0.14) (Figure 2.4A). Brain weight was also reduced in Nedd4 heterozygous 
mice at all three time points relative to controls, with significance reached at 2 and 12 months of 
age (2 month wt: 0.45 ± 0.01g; n = 6 and het: 0.39 ± 0.01g; n = 13; P = 0.003, 6 month wt: 0.47 
± 0.01g; n = 4 and het: 0.45 ± 0.01g; n = 5; P = 0.08 and 12 month wt: 0.56 ± 0.003g; n = 5 and 
het: 0.51 ± 0.02g; n = 5; P = 0.03, Figure 2.4B). To determine whether brain size was smaller 
due to deficits in neuronal developmental we evaluated brain to body weight ratio and showed 
that brain weight was reduced in a pro rata manner (2 month, wt: 0.022 ± 0.001; n = 6 and het: 
0.022 ± 0.001; n = 13; P = 0.94, 6 month, wt: 0.014 ± 0.001; n = 4 and het: 0.017 ± 0.001; n = 5; 
P = 0.35 and 12 month, wt: 0.016 ± 0.001; n = 5 and het: 0.017 ± 0.001, n = 5; P = 0.55, Figure 
2.4C). 
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Figure 2.4. Body weight was significantly reduced in Nedd4 heterozygous (+/-) mice compared 
to age-matched control (+/+) at both 2 and 6 months of age (A). Significant reduction in brain 
weight was observed at 2 and 12 months of age in Nedd4 heterozygous mice compared to age-
matched wild-type controls (B). Brain to body weight ratio was not different between Nedd4 
heterozygous and the age-matched controls at all three time points, thus showing a pro rata 
reduction in body and brain mass weight (C). Data represented as mean±SEM.  * P < 0.05, ** P 
< 0.01 and *** P < 0.001 using unpaired Student’s t-test. 
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Assessment of Nedd4 protein levels in the brain. 
Western Blotting was used to determine that Nedd4 levels were reduced by at least 50% in 
brains from Nedd4 heterozygous mice when compared to wild-type controls at 2 and 6 months 
of age (2 month old mice: 49.0 ± 11% of control; P < 0.01; n = 3-4 and 6 month old mice: 33 ± 
8%; P < 0.0001; n = 5, Figure 2.5). Tissue from 12 month old mice was not obtained. 
Figure 2.5. Nedd4 expression is reduced in whole brain lysates from 2 and 6 month old Nedd4
heterozygous mice (+/-; n = 4-5) compared to age matched wild-type controls (+/+; n = 4-5). 
Representative western blots from two months (A) and six months cohort (B). Nedd4 levels in 
whole brain lysates represented as % of control (C). Data represented as mean±SEM.  * P < 
0.05, and *** P < 0.001 using unpaired Student’s t-test.
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Activity and motor function 
Locomotor activity 
Basal locomotor activity was measured using locomotor cells and was not affected in Nedd4
heterozygous mice at either 2 or 6 months of age (Table 2.1).  
Table 2.1. No differences were observed in basal locomotor activity between Nedd4
heterozygous (+/-) and wild-type (+/+) controls, at both 2 and 6 months of age. Data represented 
as mean±SEM. 2 months: wild-type n = 8 and heterozygous n = 14, 6 months: wild-type n=10 
and heterozygous n=10. 
 2 month 6 month 
(+/+) (+/-) (+/+) (+/-)
Floor Plane     
Moves 532±12 540±13 499±16 526±11
Time (sec) 1289±19 1299±23 1307±42 1185±55
Distance (cm) 6426±239 6398±292 6857±568 6606±400
Ventral Plane     
Rears 74±11 61±15 120±16 119±19
Time (sec) 57±8 41±10 101±14 88±13
Rota-Rod assessment of motor function 
Rota-Rod is a widely used test of general co-ordination, balance and overall motor function 
based on the length of time mice can stay on a rotating drum. There was no significant 
difference in the latency to fall from the Rota-Rod between Nedd4 heterozygous mice compared 
to age-matched wild-type controls (2 month, wt: 253.9 ± 25.5 sec; n = 8 and het: 264.4 ± 16.8 
sec; n = 13, 6 month, wt: 223.4 ± 18.0 sec; n = 10 and het: 203.4 ± 25.6 sec; n = 10 and 12 
month, wt: 157.4 ± 22.0; n = 5 and het: 129.0 ± 15.3 sec; n = 5) (Figure 2.6).  There was an age 
dependent decline in motor function, which is significantly decreased between 2 and 12 month 
Nedd4 heterozygous mice (P < 0.01).  
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Figure 2.6. Latency to fall from the RotaRod was not different between Nedd4 heterozygous 
mice (+/-) and age-matched wild-type controls (+/+) at all three time points (2, 6 and 12 months 
of age). Data represented as mean±SEM. ** P < 0.01 using one way ANOVA with Newman-
Keuls multiple comparison post hoc test. 
DigiGait analysis 
Stride parameters 
2-month cohort 
At the lower speed of 15 cm/sec, duration of stride and stance in the fore paw (Figure 2.7A) and 
hind paw (Figure 2.7B) were not affected in Nedd4 heterozygous mice. The component of 
stride such as swing, brake and propulsion durations were also unaffected in both fore paws 
(Figure 2.7C) and hind paws (Figure 2.7D) in the Nedd4 heterozygous mice compared to wild-
type controls. Stride can also be examined as an overall % of stride, and again was not altered in 
both fore paws (Figure 2.7E) and hind paws (Figure 2.7F) of Nedd4 heterozygous mice 
compared to wild-type controls. At the higher speed of testing, 20 cm/sec, when stride and 
stance was examined no change was observed in fore paw (Figure 2.8A) or hind paw (Figure 
2.8B), and components of stride were also unaffected (Figure 2.8C and D), as was the 
percentage of time spent in each phase of stride (Figure 2.8E and F). Brake and propulsion as a 
percentage of stance also showed no differences in fore paws (Figure 2.9A and B) and hind 
paws (Figure 2.9C and D) at 15 and 20 cm/sec respectively. 
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Figure 2.7. At a speed of 15 cm/sec, the duration of stride and stance showed no difference 
between Nedd4 heterozygous (+/-) and age-matched wild-type controls in both fore (A) and 
hind paws (B). The duration of swing, brake and propel components of stride were also 
unchanged in fore (C) and hind (D) paws. Finally, swing, brake and propulsion can be 
represented as a % of overall stride. No differences were observed in % of swing, brake and 
propulsion in fore (E) and hind (F) paws. Data represented as mean±SEM. 
Fore Paw Hind Paw 
A B 
C D 
E F 
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Figure 2.8. At a speed of 20 cm/sec, the duration of stride and stance showed no difference 
between Nedd4 heterozygous (+/-) and age-matched wild-type controls in both fore (A) and 
hind paws (B). The duration of swing, brake and propel components of stride were also 
unchanged in fore (C) and hind (D) paws. Finally, swing, brake and propulsion can be 
represented as a % of overall stride. No differences were observed in % of swing, brake and 
propulsion in fore (E) and hind (F) paws. Data represented as mean±SEM. 
Fore Paw Hind Paw 
A B 
C D 
E F 
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Figure 2.9. Stance begins with braking and ends with propulsion, and as such braking and 
propulsion can be examined as a percentage of stance duration. At 15 cm/sec, there was no 
difference between Nedd4 heterozygous (+/-) and age-matched wild-type controls (+/+) in brake 
and propulsion as a % of stance in fore (A) and hind (B) paws. Similarly, at 20 cm/sec no 
differences were observed in brake and propulsion as a % stance in fore (C) and hind (D) paws. 
Data represented as mean±SEM.  
Fore Paw Hind Paw 
A B 
C D 
C D 
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6-month cohort 
At 6 months significant changes become apparent which are dependent on speed of locomotion. 
At the lower speed of 15 cm/sec, a significant increase in stride duration was evident in the hind 
paws of the heterozygous mice (wt: 0.36 ± 0.008 sec and het: 0.38 ± 0.008 sec; P = 0.048, 
Figure 2.10B), with no changes in the fore paws (Figure 2.10A). Stance duration was not 
changed in both fore and hind paws (Figure 2.10A and B). When components of stride were 
examined, there was no change in the fore paws (Figure 2.10C), but significant increases were 
seen in swing (wt: 0.11 ± 0.004 sec and het: 0.13 ± 0.006 sec; P = 0.02) and braking (wt: 0.04 ±
0.002 sec and het: 0.05 ± 0.003 sec; P = 0.02, Figure 2.10D) in the Nedd4 heterozygous mice 
compared to wild-type controls (Figure 2.10D). When represented as a percentage of stride, an 
increase in fore paw propulsion was evident (wt: 25.7 ± 1.2%; and het: 32.4 ± 2.5%; P = 0.03, 
Figure 2.10E), with hind paws not affected (Figure 2.10F). 
At a moderate speed of 20 cm/sec, no changes were observed in timing of stride in both fore and 
hind paws in Nedd4 heterozygous mice compared to wild-type controls (Figure 2.11A-E). At 
the highest speed of 30 cm/sec, no significant changes were evident (Figure 2.12A-E). When 
braking and propulsion as a percentage of stance was examined, there was a modest decrease in 
braking (wt: 62.4 ± 2.7 %; n = 9 and het: 52.3 ± 3.8 %; n = 10, P = 0.07) and increase in 
propulsion (wt: 35.6 ± 2.7 %; n = 9 and het: 46.8 ± 3.8; n = 10, P = 0.07) in fore paws of Nedd4
heterozygous mice compared to wild-type control at a speed of 15 cm/sec (Figure 2.13A). A 
similar trend was also observed at 30 cm/sec (Figure 2.13E), but no difference at 20 cm/sec 
(Figure 12C) or in hind paws at all three speeds tested (Figure 2.13B, D and F). 
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Figure 2.10. At 6 month of age and at a speed of 15 cm/sec, Nedd4 heterozygous mice (+/-) 
mice showed no difference in stride and stance duration in fore paws (A), however a significant 
increase is seen in the hind paws (B) when compared to age-matched wild-type controls (+/+). 
Duration of swing, brake and propulsion was not different in fore paws (C), but in the hind 
paws, a significant increase in swing and brake duration are evident in the Nedd4 heterozygous 
mice. Finally, when representing swing, brake and propulsion as a percentage of stride, a 
significant increase was observed in fore paws of Nedd4 heterozygous mice (E), with no 
differences in hind paws (F). Data represented as mean±SEM and statistical comparisons made 
using unpaired Student’s t-test. * < 0.05 and deemed significant. 
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Figure 2.11. At 6 months of age and at a speed of 20 cm/sec, no changes in stride or stance 
durations were evident between Nedd4 heterozygous (+/-) mice and age-matched wild-type 
controls (+/+) in both the fore (A) and hind (B) paws. Swing, brake and propulsion durations 
were also unchanged in fore (C) and hind (D) paws. When represented as a percentage of stride, 
no differences were found in swing, brake and propulsion in both fore (E) and hind (F) paws. 
Data represented as mean±SEM. 
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Figure 2.12. At 6 months of age and at a speed of 30 cm/sec, no alterations were evident 
between Nedd4 heterozygous mice (+/-) and age-matched wild-type controls (+/+) in fore (A) 
and hind (B) paw stride and stance durations. In addition, swing, brake and propel durations 
were not changed in both the fore (C) and hind paws (D). No differences were observed when 
swing, brake and propulsion were represented as a percentage of stride in both fore (E) and hind
(F) paws. Data represented as mean±SEM.  
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Figure 2.13. When brake and propulsion were represented as a percentage of stance, there was 
no difference between 6 month old Nedd4 heterozygous (+/-) mice and age-matched controls 
(+/+) in fore paws at 15 cm/sec (A), 20 cm/sec (C), or 30 cm/sec (E) and hind paws at 15cm/sec 
(B), 20 cm/sec (D) or 30 cm/sec (F). Data represented as mean±SEM.  
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 12-month cohort 
No difference in stride parameters was evident at 15cm/sec (Figure 2.14A-E). At 20 cm/sec 
however, Nedd4 heterozygous mice had a significant increase in hind paw braking (wt: 0.04 ±
0.004 sec and het: 0.05 ± 0.005 sec; P = 0.04) and stance (wt: 0.18 ± 0.004 sec and het: 0.21 ±
0.01 sec; P = 0.049, Figure 2.15D) durations. A modest increase in overall stride (wt: 0.30 ±
0.01 sec and het: 0.32 ± 0.01 sec; P = 0.077) duration was observed (Figure 2.15B). As seen 
with the 6 month old cohort at 30cm/sec speed some gait parameters appeared to normalize 
(Figure 2.16). The percentage of stance spent in braking and propulsion were also not changed 
at either speeds tested (Figure 2.17). The data from this 12 months cohort can only be analyzed 
cautiously, due to the low numbers in each group but further supports that gait changes are 
evident in Nedd4 heterozygous mice.    
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Figure 2.14. At a speed of 15 cm/sec, stride and stance durations were unchanged between 12 
month old Nedd4 heterozygous (+/-) mice and age-matched controls (+/+) in both fore (A) and 
hind (B) paws swing, brake and propulsion duration were also unchanged in both fore (C) and 
hind (D) paws Finally, when swing, brake and propulsion were represented as a percentage of 
stride, no differences were in both fore (E) and hind (F) paws. Data represented as mean±SEM.  
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Figure 2.15. At a speed of 20 cm/sec, fore paw stride and stance durations were unchanged 
between 12 month old Nedd4 heterozygous (+/-) mice and age-matched controls (+/+) (A). In 
the hind paws, stance duration is significantly increased in Nedd4 heterozygous mice, with 
increased time hind paws are in contact with the belt (B). Swing, brake and propulsion durations 
were also unchanged in the fore (C) paws, in hind paws however, brake duration was 
significantly increased in the Nedd4 heterozygous mice, with no changes seen in swing and 
propulsion durations (D). When stride parameters were expressed as a percentage of stride, no 
differences were apparent in both fore (E) and hind (F) paws. Data represented as mean±SEM 
and statistical comparisons made using unpaired Student’s t-test  * < 0.05 and deemed 
significant. 
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Figure 2.16. At a speed of 30 cm/sec, stride and stance duration were unchanged between 12 
month old Nedd4 heterozygous (+/-) mice and age-matched control (+/+) in fore (A) and hind
(B) paws, as were swing, brake and propulsion duration in fore (C) and hind (D) paws. Even 
when swing brake and propulsion were represented as a percentage of stride, no differences 
were observed in fore (E) and hind paws (F). Data represented as mean±SEM.  
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Figure 2.17. In 12 months mice, brake and propulsion parameters represented as a percentage or 
stance were unchanged between Nedd4 heterozygous mice (+/-) and age-matched controls (+/+) 
in fore paws (A, C and E) and hind (B, D and F) paws, at the all three speeds tested (15 cm/sec;
A and B, 20 cm/sec; C and D, and 30 cm/sec; E and F). Data represented as mean±SEM.  
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Stride length and variability 
2-month cohort 
 Stride length was not different in Nedd4 heterozygous mice (Figure 2.18A and B), which is 
consistent with no alterations in stride parameters. Stride length variability, on the other hand, 
was not changed at 15 cm/sec (Figure 2.18C) but significantly reduced at 20 cm/sec speed (wt: 
0.72 ± 0.1 cm and het: 0.50 ± 0.04 cm; P = 0.03, Figure 2.18D). This suggests that at higher 
speeds Nedd4 heterozygous mice are able to maintain stride length consistency better than the 
wild-type controls.  
6-month cohort 
At six months of age a significant increase in hind paw stride length is seen in Nedd4
heterozygous mice (5.7 ± 0.1 cm) compared to wild-type controls (5.2 ± 0.1 cm; P = 0.013) at 
15 cm/sec speed (Figure 2.19A). This is consistent with the results showing increased hind paw 
stride duration. In terms of variability, that is the maintenance of consistent length stride to 
stride, we observed a significant increase in variability of the hind paws of Nedd4 heterozygous 
mice (wt: 0.53 ± 0.06 cm and het: 0.77 ± 0.06 cm; P = 0.01) at 20cm/sec (Figure 2.19D). This 
data shows that Nedd4 heterozygous mice take on average larger strides an observation 
consistent with the increases stride duration, however are unable to maintain this consistently 
stride-to-stride. 
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Figure 2.18. The length of stride was evaluated in 2 month old Nedd4 heterozygous mice (+/-) 
and age-matched wild-type controls (+/+) at both speeds (15 and 20 cm/sec), no changes were 
observed when compared to age-matched wild-type controls (+/+) in both fore and hind paws
(A and B). Variation in stride length in both fore and hind paws was not altered at 15 cm/sec
(C). At a higher speed of 20 cm/sec, hind paw stride length variation was significantly 
decreased with no changes to fore paws (D). Data represented as mean±SEM and statistical 
comparisons made using unpaired Student’s t-test * < 0.05 was deemed significant. 
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Figure 2.19. At 6 months of age, stride length was significantly increased in the hind paws of 
Nedd4 heterozygous mice (+/-) compared to age-matched wild-type controls (+/+) at a speed of 
15 cm/sec with no changes evident in the fore paws (A). No changes in stride length were 
evident at the higher speeds of 20 cm/sec (C) or 30 cm/sec (E). Stride length variation measures 
the step-step variability and was significantly increased in the hind paws only at 20 cm/sec (D),
with no changes observed at 15 cm/sec (B) or 30 cm/sec (F). Data represented as mean±SEM 
and statistical comparisons made using unpaired Student’s t-test * < 0.05 was deemed 
significant. 
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12-month cohort 
Assessment of 12 months old Nedd4 heterozygous mice showed no changes in stride length at 
all three speeds tested (Figure 2.20A, C and E). Furthermore, stride length variability was also 
not changed at 15 cm/sec (Figure 2.20B) and 20 cm/sec (Figure 2.20D). At 30 cm/sec however, 
a significant decrease in stride length variability was seen compared to wild-type controls (wt: 
1.05 ± 0.11 and het: 0.44 ± 0.08; P = 0.002) (Figure 2.20F). This, as in the 2 months cohort 
suggests that at higher speed Nedd4 heterozygous mice are able to maintain stride-to-stride 
consistency compared to the wild-types. 
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Figure 2.20. In the 12 month cohort, there was no difference between Nedd4 heterozygous (+/-) 
and age-matched wild-type controls (+/+) in stride length in both fore and hind paws at 15 
cm/sec (A), 20 cm/sec (C) or 30 cm/sec (E). Stride length variability was not different at 15 
cm/sec (B), 20 cm/sec (D), but at 30 cm/sec a significant decrease in variability was seen in the 
hind paws (F). Data represented as mean±SEM and statistical comparisons made using unpaired 
Student’s t-test ** < 0.01 was deemed significant. 
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Stance width and variability 
Stance width measures the distance between both fore and hind limbs, and variability compares 
the distance between each successive stride.  
2-month cohort 
At two months of age, no changes were seen in the Nedd4 heterozygous mice at both speeds 
tested for either stance width or variation (Figure 2.21).  
6-month cohort 
At 6 months, there was no change in stance width (Figure 2.22A, C and E) but a significant 
increase in stance width variability in the hind paws only of Nedd4 heterozygous mice at 30 
cm/sec (wt: 0.14 ± 0.01 cm and het: 0.18 ± 0.02 cm; P = 0.032) (Figure 2.22F). Since this 
parameter evaluates the distance between the hind paw from stride-to-stride, it reflects the 
inability to maintain consistent width within each stride.  
12-month cohort 
In the 12 month cohort, there are no differences in stance width at both 15 cm/sec (Figure 
2.23A) and 20cm/sec (Figure 2.23C). At 30cm we see a marked increase of hind paw stance 
width in the Nedd4 heterozygous mice compared to wild-type controls (wt: 2.42 ± 0.13 and het: 
2.74 ± 0.08; P = 0.06) (Figure 2.23E). No changes were evident in stance width variability at all 
three speeds tested (Figure 2.23B, D and E) 
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Figure 2.21. No difference in stance width between 2 month old Nedd4 heterozygous (+/-) mice 
and age-matched wild-type controls (+/+) at both 15 cm/sec (A) and 20 cm/sec (B). Variation in 
stance width stride-to-stride was also unchanged at both 15 cm/sec (C) and 20 cm/sec (D). Data 
represented as mean±SEM.  
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Figure 2.22. No difference in stance width between 6 month old Nedd4 heterozygous mice (+/-) 
and age-matched wild-type controls (+/+) at 15 cm/sec (A), 20 cm/sec (C) or 30 cm/sec (E).
Variation in stance width stride-to-stride was unchanged at 15 cm/sec (B) and 20 cm/sec (D),
but significantly increased in the hind paws at 30 cm/sec (F). Data represented as mean±SEM 
and statistical comparisons made using unpaired Student’s t-test * P < 0.05.  
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Figure 2.23. No change in stance width was observed in 12 month old Nedd4 heterozygous 
mice (+/-) compared to age-matched wild-type controls (+/+) at 15 cm/sec (A), 20 cm/sec (C) or 
30 cm/sec (E). Similarly, no change was observed in stance width variation at 15 cm/sec (B), 20 
cm/sec (D) or 30 cm/sec (F). Data represented as mean±SEM.  
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Step frequency and angle dynamics 
The number of steps taken in all cohorts of mice was not significant different (2 months; Figure 
2.24A and B, 6 months; Figure 2.25A, C and E and 12 months; Figure 2.26A, C and E). This 
is important as keeping number of steps within range allows for consistency since each step is 
used for analysis of all aspects of gait. Step frequency however, allows us to examine the 
number of steps per second and therefore determine if stepping patterns are altered. At 2 and 12 
months of age, step frequency was not significantly affected at all speeds tested (2 month; 
Figure 2.24C and D, and 6 month; Figure 2.26B, D and F). At 6 months of age, step 
frequency was significantly reduced in the hind paws of Nedd4 heterozygous mice (wt: 3.10 ±
0.17 steps/sec and het: 2.68 ± 0.06 steps/sec; P = 0.03) at 15 cm/sec (Figure 2.25B), with no 
difference at 20 cm/sec (Figure 2.25D) or 30 cm/sec (Figure 2.25F). This finding is consistent 
with increased stride length and duration in 6 month Nedd4 heterozygous mice. It therefore 
appears, that at six month Nedd4 heterozygous mice take longer and more frequent steps than 
wild-type controls. 
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Figure 2.24. The number of steps taken was similar between Nedd4 heterozygous (+/-) and age-
matched wild-type controls  (+/+) at 2 months of age, at both speeds tested, 15 cm/sec (A) and 
20 cm/sec (B). Step frequency translates to the number of steps taken per second, and was not 
changed at both speeds, 15 cm/sec (C) and 20 cm/sec (D). Data represented as mean±SEM.  
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Figure 2.25. The numbers of steps taken were no different between 6 month old Nedd4 
heterozygous (+/-) mice and age-matched wild-type controls (+/+) at 15 cm/sec (A), 20 cm/sec
(C) or 30 cm/sec (E). The step frequency was significantly reduced in the hind paws of the 
heterozygous mice at 15 cm/sec (B), with no alterations observed at the higher speeds of 20 
cm/sec (D), or 30 cm/sec (F). Data represented as mean±SEM and statistical comparisons made 
using unpaired Student’s t-test * P < 0.05 and deemed significant. 
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Figure 2.26. The numbers of steps taken were similar between 12 month old Nedd4
heterozygous (+/-) and age-matched wild-type controls (+/+) at 15 cm/sec (A), 20 cm/sec (C) 
and 30 cm/sec (D). Similarly, step frequency was also similar between heterozygous and wild-
types at 15 cm/sec (B), 20 cm/sec (D), and 30 cm/sec (F). Data represented as mean±SEM.  
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Angle dynamics 
Angle dynamics parameters such as; paw angle (which compares left and right paw angles 
within each mouse), absolute paw angle (compares angle changes in relation to midline of the 
mouse), step angle (takes into account differences between left and right paws within stride 
length and width), and variability of both paw and step angles (consistency between strides) 
were evaluated.  
Paw angle and paw angle variation were not different at 2 months of age (Figure 2.27A and B). 
Absolute paw angle on the other hand was increased in the fore paws of the Nedd4 heterozygous 
mice compared to wild-type controls (wt: 4.6 ± 0.8 deg and het: 7.1 ± 0.9 deg; P = 0.06) (Figure 
2.28A). Fore paw step angle was also increased (wt: 51.9 ± 3.1 deg and het: 61.0 ± 2.6 deg; P = 
0.04) in Nedd4 heterozygous mice compared to wild-type controls (Figure 2.28C). No 
difference was evident in the hind paws (Figure 2.28B and D) or in terms of variation (Figure 
2.28E and F). 
At 6 months of age, paw angle was not different at all three speeds tested (Figure 2.29A, C and 
E). Paw angle variation was also unchanged at 15 cm/sec (Figure 2.29B) or 20 cm/sec (Figure 
27D) but at 30 cm/sec fore paw showed a significant decrease (Figure 2.29F). No difference in 
absolute fore paw angle was observed in Nedd4 heterozygous mice at 15 cm/sec (wt: 5.5 ± 0.9 
deg; n = 9 and het: 9.5 ± 2.3 deg; n = 10; P = 0.13) (Figure 2.30A), but a significant increase 
was observed at the higher speeds of 20 cm/sec (wt: 4.5 ± 0.9 deg; n = 10 and het: 9.3 ± 1.5 deg; 
n = 10; P = 0.01)(Figure 2.30B) and 30 cm/sec (wt: 4.5 ± 1.2 deg; n = 9 and het: 8.7 ± 1.1 deg; 
n = 10; P = 0.04)(Figure 2.30C). In terms of step angle only a significant decrease was seen in 
the hind paws of Nedd4 heterozygous mice at 20 cm/sec (wt: 54.8 ± 1.5 deg; n = 10 and het: 
48.1 ± 2.7 deg; n = 10; P = 0.046)(Figure 2.31A-F).  
Moreover, at 12 months of age no changes in any angle parameters were seen at 15cm/sec 
(Figure 2.32A and B, Figure 2.33A), 20 cm/sec  (Figure 2.33B) or 30 cm/sec  (Figure 2.33C). 
No change in step angle was evident in Nedd4 heterozygous mice compared to wild-type 
controls (Figure 2.34A-F). 
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Figure 2.27. No significant differences in paw angle were observed in 2 month old Nedd4
heterozygous (+/-) compared to age-matched wild-type controls (+/+) at 15 cm/sec (A) or 20 
cm/sec (B). Although paw area variations was not different at the lower speed of 15 cm/sec (C),
at 20 cm/sec, a significant decrease in hind paw angle variations was seen in the heterozygous 
mice (D). Data represented as mean±SEM and statistical comparisons made using unpaired 
Student’s t-test * P < 0.05 and deemed significant.
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Figure 2.28. Absolute paw angle was not different in 2 month old Nedd4 heterozygous mice 
(+/-) compared to age-matched wild-type control (+/+) at either 15 cm/sec (A) or 20 cm/sec (B).
Step angle differences become apparent at 15 cm/sec where a significant increase in the fore 
paws of the heterozygous mice was seen (C), with no changes at 20 cm/sec (D). Step angle 
variation was not different at 15 cm/sec (E) or 20 cm/sec (F). Data represented as mean±SEM 
and statistical comparisons made using unpaired Student’s t-test * P < 0.05 and deemed 
significant.
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Figure 2.29. Paw angle was unchanged in 6 month old Nedd4 heterozygous mice (+/-) 
compared to age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 20 
cm/sec (C), and 30 cm/sec (E). Variance in paw angle was significantly reduced in 
heterozygotes at 30 cm/sec (F), with no changes apparent at 15 cm/sec (B) and 20 cm/sec (D). 
Data represented as mean±SEM and statistical comparisons made using unpaired Student’s t-
test * P < 0.05.  
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Figure 2.30. Absolute paw angles were not different in 6 month old Nedd4 heterozygous mice 
(+/-) when compared to age-matched wild-type controls (+/+) at 15 cm/sec (A), but significantly 
increased in fore paws only at 20 cm/sec (B) and 30 cm/sec (C). Data represented as 
mean±SEM and statistical comparisons made using unpaired Student’s t-test * P < 0.05.
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Figure 2.31. Step angle was significantly reduced in the hind paws of 6 month old Nedd4 
heterozygous mice (+/-) compared to age-matched wild-type controls (+/+) at a speed of 20 
cm/sec (C), with no changes observed at 15 cm/sec (A), or 30 cm/sec (E). The variation in step 
angle was no different at all three speeds tested; 15 cm/sec (B), 20 cm/sec (D) and 30 cm/sec
(F). Data represented as mean±SEM and statistical comparisons made using unpaired Student’s 
t-test * P < 0.05.
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Figure 2.32. No changes in paw angle were observed in 12 month old Nedd4 heterozygous mice 
(+/-) compared to age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 
20 cm/sec (C), and 30 cm/sec (E). Similarly, variation in paw angle was also unchanged at all 
three speeds tested; 15 cm/sec (B), 20 cm/sec (D), and 30 cm/sec (F). Data represented as 
mean±SEM.  
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Figure 2.33. Absolute paw angle was not different between 12 month old Nedd4 heterozygous 
mice (+/-) and age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 20 
cm/sec (B), and 30 cm/sec (C). Data represented as mean±SEM.  
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Figure 2.34. Step angle was not different between 12 month old Nedd4 heterozygous mice (+/-) 
and age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 20 cm/sec
(C) and 30 cm/sec (E). Similarly, variation in step angle was also not different at all three 
speeds tested; 15 cm/sec (B), 20 cm/sec (D) and 30 cm/sec (F). Data represented as mean±SEM. 
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Plantar placement 
Extent of fore and hind limb plantar placement was significantly reduced in 2 month old Nedd4 
heterozygous mice illustrated by reduced paw area at peak stance in fore paws at 15 cm/sec (wt: 
0.42 ± 0.002; n = 8 and het: 0.36 ± 0.02 cm2; n = 10; P = 0.055) (Figure 2.35A) and 20 cm/sec 
wt: 0.45 ± 0.02 and het: 0.36 ± 0.02 cm2; P = 0.002) (Figure 2.35C). Paw area at peak stance 
was also reduced in the hind paws at both 15 cm/sec (wt: 0.71 ± 0.03; n = 8 and het: 0.60 ± 0.03 
cm2; n = 10; P < 0.0001) (Figure 2.35A) and 20 cm/sec (wt: 0.72 ± 0.03 and het: 0.58 ± 0.02 
cm2; P = 0.001) (Figure 2.35C).  
As Nedd4 heterozygous mice are significantly smaller than their wild-type littermates at both 
ages studied, a Pearson’s correlation was conducted (Pearson, 15 cm/sec r=0.1827; 20 cm/sec 
r=0.6168) to determine if reduced paw area is due to reduced body weight. We determined that 
this was not the case, and furthermore found that although 6 month mice were also significantly 
smaller than their age matched wild-type controls, there was no alteration in their paw area at 
peak stance (discussed below).  
At 6 months of age paw area at peak stance was not different at all three speeds tested (Figure 
2.36A, C and E) however a modest decrease was observed in the hind paws at 20 cm/sec (wt: 
0.67 ± 0.03 cm2; n = 10 and het: 0.60 ± 0.01 cm2; n = 10; P = 0.06) (Figure 2.36C). At 12 
months of age, with a slight reduction at 20 cm/sec (wt: 0.75 ± 0.08 cm2; n = 5 and het: 0.58 ± 
0.03 cm2; n = 5; P = 0.08) (Figure 2.37C) however at 30 cm/sec significant reductions were 
evident in both the fore (wt: 0.43 ± 0.04 cm2; n = 5 and het: 0.31 ± 0.02 cm2; n = 5; P = 0.03) 
and hind (wt: 0.71 ± 0.06 cm2; n = 5 and het: 0.51 ± 0.01 cm2; n = 5; P = 0.01) (Figure 2.37E) 
paws of Nedd4 heterozygous mice compared to wild-type controls. 
At 2 month of age, variation of paw area at peak stance was not different at 15 cm/sec (Figure 
2.35B). At 20 cm/sec however, hind paw area variance was significantly reduced (wt: 0.07 ±
0.001 cm2; n = 8 and het: 0.04 ± 0.007 cm2; n = 10; P = < 0.01) (Figure 2.35D). There was no 
change in paw area variability in the 6 month cohort at three speeds tested (Figure 2.36B, D 
and F). This was also the case in the 12 month cohort (Figure 2.37 B and D), with no decrease 
in fore paw area variability at 30 cm/sec (wt: 0.07 ± 0.03; n = 5 and het: 0.02 ± 0.002; n = 5; P = 
0.075) (Figure 2.37F). 
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Figure 2.35. Paw area at peak stance was significantly reduced in hind  paws and modestly 
reduced in the fore paws of 2 month old Nedd4 heterozygous mice (+/-) compared to age-
matched wild-type controls (+/+) at 15 cm/sec (A). At 20 cm/sec, both fore and hind paws paw 
area at peak stance was significantly reduced in the heterozygous mice (C). Variation in paw 
area stride-to-stride was not different at 15 cm/sec (B), however at a speed of 20 cm/sec, a 
significant reduction in variation was observed in hind paws of heterozygous mice (D). Data 
represented as mean±SEM and statistical comparisons made using unpaired Student’s t-test * P 
< 0.05, ** P < 0.01, *** P < 0.001 and deemed significant. # P = 0.055 
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Figure 2.36. No significant difference was observed in paw area at peak stance in 6 month old 
Nedd4 heterozygous mice (+/-) compared to age-matched controls (+/+) at a speed of 20 cm/sec 
(C), with no differences evident at 15 cm/sec (A), or 30 cm/sec (E). Variation in paw area at 
peak stance showed no differences at all three speeds tested; 15 cm/sec (B), 20 cm/sec (D), or 
30 cm/sec (F). Data represented as mean±SEM and statistical comparisons made using unpaired 
Student’s t-test # P = 0.06.
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Figure 2.37. Paw area at peak stance was not different between 12 month old Nedd4
heterozygous mice (+/-) and age-matched wild-type controls (+/+) at 15 cm/sec (A) and at 20 
cm/sec (C). At 30 cm/sec, a significant decrease in paw area is observed in both fore and hind 
paws of the heterozygotes (E). Variation in paw area was not different at 15 cm/sec (B), 20 
cm/sec (D), or 30 cm/sec (F). Data represented as mean±SEM and statistical comparisons made 
using unpaired Student’s t-test * P < 0.05 and deemed significant # P = 0.06
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Stance factor, gait symmetry, hind limb shared and stance-swing ratio 
At 2 months of age, Nedd4 heterozygous mice showed no difference in stance factor in the fore 
paws at 15 cm/sec (Figure 2.38A) or 20 cm/sec (Figure 2.38B). At 6 months, we see a 
significant increase in stance factor affecting the fore paws only at both 15 cm/sec (wt: 0.98 ± 
0.02; n = 9 and het: 1.06 ± 0.03; n = 10; P = 0.03) (Figure 2.39A) and 30 cm/sec (wt: 0.93 ± 
0.03; n = 9 and het: 1.05 ± 0.04; n = 8; P = 0.01) (Figure 2.39C) and no difference at 20 cm/sec 
(Figure 2.39B). Finally, at 12 months of age even with small numbers in the cohort, a 
significant increase in stance factor of the fore paws at 20 cm/sec (wt: 0.91 ± 0.03; n = 5 and 
het: 1.02 ± 0.03; n = 5; P = 0.04) was evident (Figure 2.40B). Overall, a consistent increase in 
fore paw stance factor duration with no changes in the hind paws was observed in Nedd4
heterozygous mice relative to controls. 
Gait symmetry was not affected in 2 (Figure 2.41A), 6 (Figure 2.41B) or 12 (Figure 2.41C) 
month old Nedd4 heterozygotes compared to wild-type controls.  
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Figure 2.38. No changes in stance factor were observed in 2 month old Nedd4 heterozygous 
mice (+/-) compared to age-matched wild type controls (+/+) at both 15 cm/sec (A) and 20 
cm/sec (B). Data represented as mean±SEM.  
A B 
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Figure 2.39. At 6 months of age a significant increase in stance factor was observed in the fore 
paws only of Nedd4 heterozygous mice (+/-) compared to age-matched wild-type controls (+/+) 
at 15 cm/sec (A) and 30 cm/sec (C), with no difference observed at 20 cm/sec (B). Data 
represented as mean±SEM and statistical comparisons made using unpaired Student’s t-test * P 
< 0.05 and deemed significant.  
A B 
C 
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Figure 2.40. At 12 months of age, a significant increase in stance factor was evident in the fore 
paws of Nedd4 heterozygous mice (+/-) compared to age-matched wild-type controls (+/+) at 20 
cm/sec (B), with no differences observed at 15 cm/sec (A) or 30 cm/sec (C). Data represented as 
mean±SEM and statistical comparisons made using unpaired Student’s t-test * P < 0.05 deemed 
significant.  
A B 
C 
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Figure 2.41. No differences in gait symmetry were observed at all speeds tested in 2 month (A), 
6 month (B) or 12 month (C) Nedd4 heterozygous (+/-) mice compared to age-matched wild-
type controls (+/+). Data represented as mean±SEM. 
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Hind paw shared stance, which is a measure of time that both hind paws are in contact with the 
belt was also unaffected in both 2 (Figure 2.42A) and 6 (Figure 2.42B) months old Nedd4
heterozygotes. At 12 months however, an increase in hind limb shared stance was evident 
although significance was not reached (20 cm/sec, wt: 0.06 ± 0.01 ms; n = 5 and het: 0.09 ± 0.03 
ms; n = 5; P = 0.15 and 30cm/sec, wt: 0.02 ± 0.01 ms; n = 5 and het: 0.04 ± 0.01 ms; n = 5; P = 
0.2) (Figure 2.42C).  
No difference in stance-swing ratio between Nedd4 heterozygous and wild-type controls was 
evident at 2 (Figure 2.43), 6 (Figure 2.44) and 12 (Figure 2.45) months of age at all speeds 
tested. 
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Figure 2.42. Hind paw shared stance were not different between Nedd4 heterozygous (+/-) mice 
and age-matched controls (+/+) at all three speeds tested at 2 (A), 6 (B) or 12 months of age (C). 
Data represented as mean±SEM.  
B 
A 
C 
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Figure 2.43. Ratio of stance to swing was not altered in 2 month old Nedd4 heterozygous (+/-) 
mice compared to age-matched controls (+/+) at both 15 cm/sec (A) or 20 cm/sec (B). Data 
represented as mean±SEM. 
A 
B 
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Figure 2.44. Ratio of stance to swing was not altered in 6 month old Nedd4 heterozygous mice 
(+/-) compared to age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 
20 cm/sec (B), and 30 cm/sec (C). Data represented as mean±SEM.
A 
B 
C 
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Figure 2.45. Ratio of stance to swing was not altered in 12 month old Nedd4 heterozygous mice 
(+/-) compared to age-matched wild-type controls (+/+) at all three speeds tested; 15 cm/sec (A), 
20 cm/sec (B) and 30 cm/sec (C). Data represented as mean±SEM.
A 
C 
B 
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Table 2.2. Summary of gait parameters. Arrows represent an increase or decreases in the Nedd4
heterozygous mice compared to age-matched wild-type controls. NS, not significant.  
Parameter 2 month 6 month 12 month 
Stride (sec) NS ÏHind paw  
15 cm/sec (P < 0.05) 
NS 
Stance (sec) NS NS ÏHind paw  
20 cm/sec (P < 0.05) 
Swing (sec) 
Brake (sec) 
Propel (sec) 
NS 
NS 
NS 
ÏHind paw 
15 cm/sec (P < 0.05) 
ÏHind paw  
15 cm/sec (P < 0.05) 
NS 
NS 
ÏHind paw 
20 cm/sec (P < 0.05) 
NS 
% Stride 
Swing 
Brake 
Propel 
NS 
NS 
NS 
NS 
NS 
ÏFore paw  
15 cm/sec (P < 0.05) 
NS 
NS 
NS 
% Stance 
Brake 
Propel 
NS 
NS 
NS 
NS 
NS 
NS 
Stride length (cm) NS ÏHind paw 
15 cm/sec (P < 0.05) 
NS 
Stride length 
variability 
Ð Hind paw 
20 cm/sec (P < 0.05) 
ÏHind paw 
20 cm/sec (P < 0.05) 
ÏHind paw  
30 cm/sec (P < 0.01) 
Stance width (cm) NS NS NS 
Stance width 
variability 
NS ÏHind paw 
30 cm/sec (P < 0.05) 
NS 
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Parameter 2 month 6 month 12 month 
Number of steps NS NS NS 
Step frequency 
(steps/sec) 
NS Hind paw 
15 cm/sec (P < 0.05) 
NS 
Paw angle (deg) NS NS NS 
Paw angle variation 
(deg) 
ÐHind paw 
20 cm/sec (P <0.05) 
ÐFore paw 
30 cm/sec (P < 0.05) 
NS 
Absolute paw angle 
(deg) 
NS ÏFore paw 20 and 
30 cm/sec (P < 0.05) 
NS 
Step angle (deg) ÏFore paw 
15 cm/sec (P < 0.05)
ÐHind paw 
20 cm/sec (P < 0.05) 
NS 
Step angle variation 
(deg) 
NS NS NS 
Paw area at peak 
stance (cm3) 
ÐFore paw 20 
cm/sec (P < 0.01) 
ÐHind paw 15 and 
20 cm/sec (P < 0.05 
and 0.001 
respectively) 
NS ÐFore and Hind 
paw 30 cm/sec (P < 
0.05) 
Paw area at peak 
stance variability 
ÐHind paw 
 20 cm/sec (P < 0.01) 
NS NS 
Stance Factor NS ÏFore paw 15 and 
30 cm/sec (P < 0.05) 
ÏFore paw 20 
cm/sec (P < 0.05) 
Gait Symmetry NS NS NS
Hind paw shared 
(sec) 
NS NS NS 
Stance Swing ratio NS NS NS 
139
Cellular expression of Nedd4 in the CNS associated with motor function and gait control 
Motor cortex  
Nedd4 was ubiquitously expressed in all six layers of the motor cortex. Nedd4 was mainly 
localized to the plasma membrane, surrounding the NeuN (nuclei marker) stained neurons. 
Nedd4 staining appears most abundant in the layer IV pyramidal neurons (Figure 2.46). 
Pyramidal neurons of the motor cortex are principally involved in sending axons to innervate 
motor neurons of the spinal cord. 
Figure 2.46. Confocal images taken from coronal brain section obtained from a 2 month old 
wild-type mouse  showing ubiquitous Nedd4 (red) expression in the motor cortex. Low levels of 
Nedd4 was observed surrounding NeuN (green) positive neurons in layer IV pyramidal neurons. 
Scale bar represents 50ȝm. 
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Basal ganglia  
Substantia nigra 
Nedd4 was found ubiquitously expressed within the SNpc with very little co-localization 
evident between Nedd4 and Tyrosine hydroxylase (TH) (Figure 2.47). In SNpr, Nedd4 
expression was modest with no obvious cellular localization (Figure 2.48). Overall, within the 
SN low levels of Nedd4 expression were found.  
Figure 2.47. Nedd4 (red) was expressed in low levels within the substantia nigra pars compacta 
(SNpc), with very little co-localization between dopaminergic tyrosine hydroxylase positive 
neurons (TH, green). Scale bar represents 50ȝm.
Figure 2.48. Moderate and ubiquitous expression of Nedd4 (red) in substantia nigra pars 
reticulata (SNpr). SNpr lies adjacent to SNpc where no tyrosine hydroxylase (green) staining is 
observed. Scale bar represents 50ȝm. 
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Striatum 
Nedd4 showed ubiquitous expression within the matrix (grey matter) of the striatum. No 
expression was evident in the striatosomes (white matter) (Figure 2.49).  
Figure 2.49. In the striatum Nedd4 (red) was expressed within the matrix, surrounding neuronal 
nuclei (NeuN) with no staining in the striatosomes (white matter). Scale bar represents 50ȝm. 
Spinal cord 
Low levels of Nedd4 were found in motor neurons of the spinal cord. Moderate ubiquitous 
staining was evident in the axons or fibres of the grey matter in the lumbar portion of the spinal 
cord (Figure 2.50). 
Figure 2.50. In the lumbar portion of the spinal cord, Nedd4 (red) was found to be ubiquitously 
expressed in the grey matter. Low level of co-localisation was observed between Nedd4 and 
motor neurons (NeuN, green). Scale bar represents 50ȝm.
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Cerebellum 
Nedd4 was abundantly expressed in Purkinje neurons of the cerebellum, extending to the 
dendrites (Figure 2.51). In Nedd4 heterozygous mice Nedd4 expression appeared reduced 
particularly in the 6 month group. There did not appear to be any cell loss or morphological 
changes in the cerebellum in Nedd4 heterozygous mice at both time points. 
Figure 2.51. Nedd4 (red) was highly expressed in Purkinje neurons of the cerebellum. In 
addition, Nedd4 was shown to extend into the dendrites of these Purkinje neurons as shown by 
the co-localisation with a marker for dendrites (MAP2, green). Scale bar represents 50ȝm. 
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Region  Expression 
Motor Cortex + 
Spinal Cord ++ 
SNpc + 
SNpr ++ 
Striatum ++ 
Cerebellum +++ 
Table 2.3. Qualitative analysis of Nedd4 staining intensity in regions of the brain associated 
with motor function. + low, ++ medium and +++ high. SNpc, substantia nigra pars compacta, 
SNpr, substantia nigra pars reticulata. 
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Targets for Nedd4 in motor function and gait 
GluR1 subunit of AMPA receptors 
GluR1 was examined both qualitatively (immunohistochemistry) and quantitatively (Western 
blotting) in the cerebellum from Nedd4 heterozygous and wild-type mice. 
Immunohistochemistry showed an increase in GluR1 staining around the Purkinje neuron cell 
bodies in the heterozygous mice compared to age matched wild-type controls (Figure 2.52A). 
When protein levels from whole cerebellar lysates were measured by Western blotting, a 
significant increase in GluR1 levels was found in the 6 month old Nedd4 heterozygous mice 
compared to wild-type controls (wt: 97.9 ± 36.4%; n = 3 and het: 262.8 ± 23.1%; n = 4, P = 
0.01) (Figure 2.52B and C). There was no change in levels observed in the 2 month 
heterozygous mice however, which correlates with severity of gait abnormalities. 
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Figure 2.52. Immunohistochemistry showed an increase in GluR1 (red) staining surrounding 
soma of Purkinje neurons (PN) stained with neuronal marker, NeuN (green) in the cerebellum of 
Nedd4 heterozygous mice (+/-) relative to wild-type controls (+/+) at both time points (A). 
Representative Western blots from cerebellar lysates obtained from 2 and 6 month old Nedd4
heterozygous mice (+/-) and wild-type controls (+/+) (B). Quantification of Western blot 
showed a significant increase in GluR1 levels in cerebellum from 6 month old Nedd4
heterozygous (+/-) mice compared to age-matched controls (+/+), with no change observed in 
the 2 month cohort (C). * P < 0.05, unpaired Student’s t-test. Scale bar represents 10ȝm. 
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Calbindin-D28k 
Calbindin-D28k levels were unchanged in cerebellar lysates from Nedd4 heterozygous mice at 
both 2 (wt: 100.0 ± 4.7%; n = 4 and het: 87.6 ± 12.4%; n = 3) and 6 (wt: 88.6 ± 27.0%; n = 4 
and het: 68.6 ± 3.4%; n = 5) months of age (Figure 2.53).  
Figure 2.53. Representative Western blots of Calbindin-D28k in cerebellum of 2 and 6 month 
old Nedd4 heterozygous mice (+/-) and age-matched wild-type controls (+/+). No difference 
was seen in levels of in Calbindin-D28k from cerebellum obtained from 2 and 6 month Nedd4 
heterozygous mice (+/-) compared to wild-type controls (+/+). Data represented as mean±SEM.  
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2.4 DISCUSSION 
This study has made an important contribution to the understanding of the function of Nedd4 
within the central nervous system, including behavioural outcomes, identification of regional 
and cellular expression as well as investigation of novel targets necessary for the maintenance of 
gait and motor control. Due to the lethality of the Nedd4 homozygous knockout mice any 
studies examining phenotypical changes in vivo had to be performed in heterozygous animals. 
Other groups have successfully used heterozygous animals (e.g. ataxic Moonwalker mutant) in 
identifying motor deficits when homozygous models are not viable (Becker et al., 2009). 
Conditional Nedd4 knockout mice are now available and can be used to examine the effect of 
complete removal of Nedd4 within the CNS. These knockout mice, will be extremely beneficial 
in determining in vivo effects and may indeed be superior in identifying behavioural and 
morphological outcomes. 
Nedd4 heterozygous mice had at least a 50% reduction in brain Nedd4 levels at both 2 and 6 
months of age. Closer inspection of Western blots showed an increase in Nedd4 levels in the 6 
month group relative to the 2 month cohort, however statistical comparison did not reveal 
significant changes. There is no evidence to suggest an age-dependent increase in Nedd4 levels. 
One of the first physiological characteristics that became evident in the Nedd4 heterozygous 
mice was a significant reduction in size. This has previously been reported by our collaborators, 
and is due to reduced IGF-1 mediated signaling (Cao et al., 2008). Growth disruption was 
evident in overall body and brain mass and occurred in a pro-rata manner. It is likely that these 
reductions in growth are largely mediated by reduced IGF-1 signaling in the heterozygous mice. 
IGF-1 levels were not directly measured in this study due to difficulty in obtaining a reliable 
IGF-1 assay for mouse brain, however work by our collaborator Prof. Kumar (Cao et al., 2008) 
showed that IGF-1 signaling is indeed disrupted when Nedd4 was knocked-down. The use of 
heterozygous mice suggests that although IGF-1 signaling would be affected it is unlikely to be 
at the same extent as IGF-1 knockout mice or even Nedd4 knockout mice. There was also no 
evidence that growth and differentiation of neurons were impacted, or developmental delays in 
the Nedd4 heterozygous mice, supported by morphological examinations where no obvious cell 
loss, reduced volume or reduced cell size (data not shown) was evident.  
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First basal loco-motor activity was assessed and no difference between Nedd4 heterozygous and 
age matched wild-type controls were found, showing no signs of hyper or hypo activity were 
evident that may confound other tests conducted. Next, motor capacity was assessed using the 
RotaRod and no changes present at all time points tested (2, 6 and 12 months of age). This is not 
surprising, as Nedd4 is only expressed in very low levels in motor neurons in the spinal cord and 
therefore unlikely to have a large contribution to motor output. Nedd4 is expressed abundantly 
in skeletal muscle, with a significant decrease observed in the heterozygotes at both 2 and 6 
months of age (data not shown), however morphological and structural examinations need to be 
conducted to examine the impact a reduced level of Nedd4 has on skeletal muscle fibres. At 
least in the heterozygous setting, it does not appear that the loss of Nedd4 in skeletal muscle has 
a profound effect, as both heterozygous and wild-type mice showed very similar motor capacity 
even at 12 months of age. An age-dependent decline in motor capacity was observed in both 
Nedd4 heterozygous mice and wild-type controls, which is not surprising, as motor function has 
been shown to normally decline with ageing in both rodents (Shukitt–Hale et al., 1999) and 
humans (Volkow et al., 1998). 
Although Nedd4 heterozygous mice have normal loco-motor activity and motor function, 
analysis of gait provided early and subtle changes that perhaps may not be obvious in a 
heterozygous setting or indeed may allow us to evaluate changes in gait patterns independent of 
motor function. That is, the Nedd4 heterozygous mice may never develop gross motor function 
deficits that are routinely assessed by RotaRod, but may in fact have changes in gait indicative 
of cerebellar fine motor control abnormalities. Alternatively, changes assessed by RotaRod may 
manifest at a much later stage where degenerative changes in the cerebellum are more profound. 
When gait was evaluated, significant alterations were found in Nedd4 heterozygous mice, which 
became more pronounced with age. In the context of this study, Nedd4 was shown to be 
important for gait and thus cerebellar function. In interpreting these results, previous published 
data can be used where alterations in similar gait parameters are seen in rodent models of 
disease and can therefore allow for some comparison. However, the main aim is to highlight the 
importance of Nedd4 in gait, and regions of the brain associated with gait controls. 
One of the first gait changes observed was the alteration in the timing of motion in the 
heterozygotes, suggesting abnormalities in the initiation, acceleration and deceleration of 
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motion. This is likely to occur due to altered Purkinje neuron signaling to the deep cerebellar 
nuclei, which can then affect the level of cortical inhibition (Kandel et al., 2000). This is 
supported by the abundant expression of Nedd4 in Purkinje neurons of the cerebellum. The 
Purkinje neurons are the sole neuronal output from the cerebellum, and send projections to the 
deep cerebellar nuclei. Cell loss or altered function of Purkinje neurons therefore, can have 
profound effects on gait (Diener et al., 1992). This is exemplified in the lurcher mutant mice 
where the loss of Purkinje neurons leads to ataxic gait as the feedback mechanism to the motor 
cortex is lost (Armstrong et al., 2010). The Nedd4 heterozygous mice did not show any Purkinje 
cell loss, suggesting instead that alterations in Purkinje neuron activity and/or function may 
contribute to gait abnormalities observed.  
The first target investigated was GluR1 subunit of AMPARs. The GluR1 subunit of AMPARs 
are highly expressed in Purkinje neurons with studies in stargazer mutant mouse, showing an 
almost complete loss of AMPARs at the granule cell synapses that produces severe ataxia and 
epilepsy (Shevtsova et al., 2012). Recently, Nedd4 was shown to ubiquitinate the GluR1 subunit 
of AMPARs in an activity dependent manner (Schwarz et al., 2010). Therefore, in Nedd4
heterozygous mice, GluR1 levels should be elevated due to reduced levels of ubquitination. 
When levels of GluR1 levels were measured in cerebellar lysates, there was a significant up-
regulation in Nedd4 heterozygous mice at 6 months of age. This is important as no differences 
were observed at 2 months of age where very subtle changes in gait were evident, but at 6 
months the alteration in timing of motion was evident and so were levels of GluR1. Although 
there is no evidence that Purkinje neuron activity is altered, it seems likely that this elevation in 
GluR1 levels can alter the level of excitatory feedback to the motor cortex that can have 
profound implications on gait.  
In normal (wild-type) mouse inhibitory Purkinje neuron output project to the deep cerebellar 
nuclei and the level of excitatory feedback is normalized to the motor cortex to produce normal 
gait. Previous studies have demonstrated the loss of AMPARs in the stargazer mutant results in 
a loss of inhibitory projections to the deep cerebellar nuclei, increasing the extent of excitatory 
projections to the motor cortex, resulting in ataxia, or gait deficits (Shevtsova et al., 2012). The 
results from this work provide novel evidence that the increase in AMPARs in the Nedd4 
heterozygous mice, potentiate the inhibitory output to the deep cerebellar nuclei, and thus 
reduce the level of excitation to motor cortex, resulting in extended or exaggerated gait (Figure 
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2.55). Future studies should examine Purkinje neuron activity, and determine whether AMPAR 
mediated currents are altered.  
No obvious changes in the numbers of Purkinje neurons observed in Nedd4 heterozygous mice 
further supports this view. In addition, subtle changes in dendrite structure is not unexpected 
given the effects on dendrite branching reported in Nedd4 KO mice (Kawabe et al., 2010), and 
may in part account for alterations in gait parameters.  
Figure 2.54. Schematic illustration of the hypothesized effect that Nedd4 could have on GluR1 
subunit of AMPA receptors (AMPARs) and the contribution to gait. Deep cerebellar nuclei 
(DCN). 
The contribution of voltage-gated ion channels can not be excluded as neuronal excitability can 
be altered by voltage gated Na+ channels (Navs), which are responsible for the initial 
depolarization of the action potential. For instance, deletion of Nav1.1 results in deep cerebellar 
hyper-excitability, ataxic responses and shortening of stride length (Kalume et al., 2007). This 
could be another potential target as Nav1.1 contains a functional Nedd4 binding motif (Fotia et 
al., 2004), and therefore a decrease in Nedd4 may lead to a significant increase in levels of 
Nav1.1 and thus hypo-excitability of deep cerebellar nuclei which would produce extended gait. 
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The examination of Nav1.1 channels levels is difficult due to lack of specific antibodies, and 
would certainly warrant further investigation. Voltage-gated calcium channels have also been 
recently shown to be degraded by Nedd4 (Rougier et al., 2011). This is important as anomalies 
in calcium signaling and levels of voltage-gated calcium channels are also characteristic in 
ataxic models such as stargazer (Leitch et al., 2009), ducky (Brodbeck et al., 2002) and in 
human spinocerebellar ataxias (Pietrobon, 2002). 
Calcium signaling is crucial for normal Purkinje neurons function, so in this study a target 
important for calcium homeostasis was investigated. Calbindin-D28k was chosen as a potential 
target, as is it highly expressed in the Purkinje neurons of the cerebellum and a member of a 
larger family of calcium buffering protein. In the cerebellum, Calbindin-D28k comprises 
approximately 15% of total cellular protein (Baimbridge KG et al., 1992). It is not surprising 
therefore that Calbindin-D28k knockout mice have ataxia and abnormal calcium signaling in the 
Purkinje neurons (Airaksinen et al., 1997). In the Nedd4 heterozygous mice we did not observe 
any changes in Calbindin-D28k levels in the cerebellum at both time points tested. It is therefore 
unlikely that Calbindin-D28k is a target of Nedd4 and may not have significant interactions. The 
hypothesis was that if alterations in Calbindin-D28k existed in the Nedd4 heterozygous mice, 
then alterations in intracellular calcium levels could have significant effects on Nedd4 
activation, however this does not appear to be the case.  
Calcium influx plays a crucial role in excitability of neurons, with Purkinje neurons requiring 
calcium for their complex spike patterns. With Nedd4 able to regulate newly synthesized Cav1.2 
channels, and therefore the reduced levels of Nedd4 in the heterozygotes may impact levels of 
Cav1.2 channels and thus Purkinje neuron excitability. Although, this very important target was 
not evaluated in this study, future studies should examine Cav1.2 channels in Nedd4
heterozygous to determine the consequences of Nedd4 level reduction or absence. My view is 
that both GluR1-containing AMPARs and Cav1.2 channel densities on Purkinje neuron cell 
membrane are likely to be altered in the Nedd4 heterozygous mice, with both sodium and 
calcium currents affected. Future studies, could examine both sodium and calcium currents in 
whole brain cerebellar slices to determine the extent of contribution of each of these two 
important targets to Purkinje neuron function. 
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Aside from the cerebellum, which has a major role in gait control, there are other regions of the 
brain that can also contribute. For instance alterations in stride length variability, which is a 
measure of consistency between strides, is considered a reliable index of motor decline related 
to basal ganglia dysfunction (Fernagut et al., 2002). This is illustrated by increased stride length 
variability observed in patients with Parkinson’s disease as well as rodent models of Parkinson’s 
disease, Huntington’s disease and ALS (Amende et al., 2005b; Hausdorff et al., 1998; 
Hausdorff et al., 2000; Kurz et al., 2007). In this study, Nedd4 heterozygotes showed alterations 
in stride length variability, however no basal ganglia abnormalities were evident. Furthermore, 
Nedd4 was expressed at relative low levels in regions of the basal ganglia such as SNpc, SNpr 
and striatum. These data suggest that rather than basal ganglia defects, changes in accuracy of 
movement are likely as a result of abnormal firing patterns in Purkinje neurons. 
Nedd4 heterozygous mice also showed an increase in paw angle i.e ‘splayed phenotype’ which 
has been associated with ataxia, demyelinating diseases and spinal cord injuries (Powell et al., 
1999) as well as a mouse model of lissencephaly (a disorder arising due to abnormal neuronal 
migration) (Yamada et al., 2009). Furthermore, a significant increase in step angle in fore paws 
of Nedd4 heterozygous mice was evident. Increased step angle has also been reported following 
cerebellar dysfunction due to neonatal ethanol exposure, where rats display more open or 
increased step angles with less gait symmetry (Hannigan et al., 1988). Similarly, in a mouse 
model of infantile Batten disease, which occurs due to abnormal lysosomal storage leading to 
subsequent axonal degeneration and widespread CNS neurodegeneration, an increased step 
angle is observed and occurs in conjunction with a loss of Purkinje neurons and reduced 
dendritic branching (Sleat et al., 2004). To date we have no evidence for neuronal migration or 
demyelination abnormalities in Nedd4 heterozygous mice. Furthermore, Nedd4 was not 
expressed in white matter, and therefore is unlikely to be located in oligodendrocytes and type II 
astrocytes. Some of the parameters described could also be associated with cerebellar 
dysfunction and potential involvement of AMPAR signaling. 
Finally, alterations in paw area at peak stance and stance factor were found in Nedd4
heterozygous mice. These parameters are changed following neuronal injury and inflammatory 
pain models (Piesla et al., 2009). One possible cause may be due to enhanced motor mediated 
nociception, supported by previous reports that the voltage-gated Na+ channel Nav1.7 important 
for the sensation of pain is a target of Nedd4 (Fotia et al., 2004; Ghelardini et al., 2009). A test 
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to assess responses to nociception (hotplate test), was conducted and found that there was no 
difference to thermal nociception between Nedd4 heterozygous and wild-type controls (data not 
shown). However, the hotplate test is a crude method of nociception and subjective so it may not 
allow the identification subtle changes, therefore other more sensitive tests are required such as 
von Frey.  
Previous gait analysis tools such as footprint analysis examined gait where speed of locomotion 
was not controlled or measured. It is difficult to draw comparisons between DigiGait and older 
methods for assessing gait, due to the fact that speed can be controlled. What has been 
established in both rodents and humans is that gait changes with varying speed. In some 
instances increasing speed provides a challenge to normal walking speed, however in other 
instances it may mask some gait changes by providing compensatory measures. Whether these 
points apply to the gait observed in this study remains to be determined and conclusions are 
difficult to draw. In this study gait changes became more pronounced with age. The reason for 
this remains unknown as no morphological changes such as neuronal cell loss was evident in 
regions of the brain that control gait (eg cerebellum). Further investigation is necessary to 
examine molecular changes that may exist for perhaps in Purkinje neurons that changes their 
signalling properties that may occur in an age-dependent manner. 
In this study the changes in gait identified suggest an abnormality in the function of cerebellar 
circuits, most likely to involve Purkinje neurons. It is difficult to speculate about the type of 
cerebellar dysfunction that may be present in the Nedd4 heterozygous mice based purely on 
changes in gait. Further studies are necessary to examine perhaps with electrophysiology any 
changes in calcium or sodium currents in Purkinje neurons of the heterozygous mice that may 
affect firing patters. Furthermore, examination in brain slices could be conducted to evaluate 
GluR1-mediated AMPA receptor currents and determine if any changes exist as are suggested 
with this data.  Findings for these future experiments will provide much needed mechanism to 
better understand the gait changes identified in the Nedd4 heterozygous mice 
 In conclusion, results from this chapter have identified a novel role for Nedd4 in gait control 
involving Purkinje neurons of the cerebellum. This is important as to date very little was known 
about the physiological role for Nedd4, and whether reduced levels of Nedd4 would lead to in 
vivo outcomes. Furthermore, data from this study has shown that a current known target of 
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Nedd4, GluR1 subunit of AMPA receptors, was significantly altered in the cerebellum from 
Nedd4 heterozygous mice, which may contribute to gait abnormalities observed. Finally, a novel 
protein target linked to a human disorder may be a crucial link in understanding the complex 
role of Nedd4 in neurons of the brain. Further work is required to build a better understanding of 
the complex interactions of Nedd4 with its many neuronal targets, in particular the calcium-
induced activation of Nedd4. 
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CHAPTER 3: NEDD4-2 IN MOTOR FUNCTION AND GAIT 
3.1 BACKGROUND AND RATIONALE 
This chapter explores the possible relationship between Nedd4-2 expression, the dopamine 
system and motor function. 
Dopamine transporter (DAT) 
DAT is a member of the neurotransmitter sodium symporter protein superfamily (SLC6 gene 
family) (Gether et al., 2006). DAT is expressed at the plasma membrane; however a dynamic 
pool of DAT is available implying that insertion and removal from the plasma membrane must 
be tightly regulated (Mortensen et al., 2003). Alteration in function of DAT will ultimately 
affect the level of dopamine at the synapse and thus have major implications in dopaminergic 
signaling. The importance of dopamine in motor function is best highlighted in Parkinson’s 
disease (PD), where dopamine levels are reduced due to degeneration of SNpc (dopamine 
producing) neurons. There is evidence that in Parkinson’s disease, that along side reduced 
dopamine nerve terminals there is also a reduction in levels of DAT (Booij et al., 1997; Frost et 
al., 1993).  
Abnormalities in levels of DAT are associated with many neurological disorders 
Abnormalities in DAT level and function are observed in disorders such as depression 
(Amsterdam et al., 2012; Pinsonneault et al., 2011), attention deficit-hyperactivity disorder 
(ADHD) (Hoogman et al., 2012; Roman et al., 2004), Parkinson’s disease (PD) (Ravina et al., 
2012) and addiction (Hanlon et al., 2012; Tammimaki et al., 2011). DAT gene polymorphisms 
are observed in patients suffering from hyperactivity disorders such as ADHD (Krause et al., 
2003), with most current treatments for ADHD targeting DAT. Experiments in DAT knockout 
mice also show a distinct behavioural phenotype associated with hyperactivity, due to the 
increased extracellular levels of dopamine (Giros et al., 1996; Spielewoy et al., 2009), as well as 
depression with reduced anhedonia (Perona et al., 2008) 
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Dopamine regulation and trafficking 
The de novo synthesis of DAT and export to the membrane surface of the dopamine neurons is a 
slow process with an approximate half life of 2-3 days (Kimmel et al., 2000), so neurons must 
use a range of post-translational regulatory strategies to control DAT function (Schmitt et al., 
2010). One way to modulate DAT function rapidly is to alter trafficking by redistributing DAT 
between the plasma membrane and intracellular endosomal compartments (Mortensen et al., 
2003). Phosphorylation is one example of a post-translational strategy for DAT regulation that 
can alter protein-protein interactions. It is therefore not surprising that the phosphorylation state 
of DAT can influence intrinsic activity, such as the affinity and responsiveness to ligands (eg. 
dopamine) but also membrane distribution of DAT (Mortensen et al., 2003). There are several 
protein kinases postulated to be involved in affecting DAT function including; PKC, PKA, 
PI3K, protein tyrosine kinase, Ca2+/calmodulin kinase, protein phosphatase 1, and mitogen-
activated protein kinase (MAPK) family (Foster et al., 2006; Hoover et al., 2007; Melikian, 
2004). Of these protein kinases, PKC has been most highly investigated and shown to be 
integral for endocytic trafficking of DAT to early and recycling endosomes (Sorkina et al., 
2003; Sorkina et al., 2005). Furthermore, the PKC-induced loss of DAT at the plasmalemmal 
compartment is most likely due to combination of increased clathrin-dependent endocytosis and 
decreased recycling from endosomal compartments (Loder et al., 2003).  
Ubiquitination, Nedd4-2 and Dopamine Transporters 
Aside from phosphorylation, there is now mounting evidence that ubiquitination may contribute 
to post-translational modification of DAT to regulate cell surface expression and membrane 
trafficking (Miranda et al., 2005). More importantly, Nedd4-2 was shown to be necessary for 
the ubiquitination and endocytosis of DAT, which is mediated by PKC using lysine-63 (K63) 
linked mono-ubiquitin chains (Sorkina et al., 2006). Knock down of Nedd4-2 resulted in 
suppression of ubiquitination and endocytosis of DAT in human and porcine cells. Interestingly, 
DAT does not contain the ‘typical’ PPxY motif that is recognized by the WW domain of Nedd4-
2, and therefore Nedd4-2 may either recognize other motifs not yet identified, use of 
intermediate or adapter proteins or not interact at all (Vina-Vilaseca et al., 2010).  
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The involvement of Nedd4-2 in motor function and gait 
Dopamine is a major neurotransmitter in the brain, produced by neurons located in the SNpc, 
ventral tegmental area (VTA) and arcuate nucleus (Marek et al., 1996; Seibyl et al., 1995). 
Dopamine neurotransmission is involved in many processes including; motor activity, emotion, 
motivation and cognition (Le Moal, 1995) using several pathways. Of these pathways, the 
nigrostriatal pathway which connects SNpc with the striatum and forms an important feedback 
loop necessary for the regulation of locomotion and motor function (Figure 3.1) (Chinta et al., 
2005).  
Figure 3.1. Schematic illustration of striatonigral pathway necessary for motor feedback to the 
motor cortex for motor function and gait. 
The removal of dopamine from the synapse by DAT is essential for the maintenance of normal 
dopamine levels, effectively terminating dopamine signaling (Jaber et al., 1997; Torres, 2006). 
Due to the potential role for Nedd4-2 in dopamine neurotransmission, it was necessary to 
evaluate the consequences of reduced Nedd4-2 levels with the use of heterozygous mice and 
motor function and gait. As already discussed in Chapter 2 RotaRod and DigiGait are excellent 
tests in identifying motor dysfunction and abnormalities in gait.  
DAT regulation is imperative for normal dopamine signalling. Until recently, the mechanism of 
DAT regulation at the membrane surface remained poorly understood. The effect of Nedd4-2 
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mediated DAT regulation on dopamine levels and/or behaviour have not been characterized in 
vivo. 
The findings from these studies led to the main hypothesis of this study that a 50% reduction in 
Nedd4-2 levels (using heterozygous mice) levels is sufficient to alter dopamine transporter and 
subsequent dopamine levels which may contribute to motor and gait abnormalities. To 
investigate this hypothesis, the following aims were set: 
1) Conduct behavioural tests in Nedd4-2 heterozyogous mice and assess basal 
loco-motor activity, motor function and gait. 
2) Determine cellular and regional expression of Nedd4-2 in the brain and spinal 
cord required for motor related behaviours 
3) Measure DAT and dopamine levels in striata from Nedd4-2 heterozygous mice 
relative to wild-type controls 
4) Examine brain morphology to determine if any changes are present in 
dopaminergic regions of the brain 
3.2. MATERIAL AND METHODS 
Mice 
Our collaborator Professor Sharad Kumar generated Nedd4-2 heterozygotes and wild-type 
littermate controls, and were a generous gift. Mice bred at the IMVS animal facility (Adelaide, 
Australia) and transported to Florey Neuroscience Institutes (FNI, Melbourne Australia) for 
behavioural assessment. At least one week acclimation prior to any testing was observed, during 
this period mice were handled daily to reduce stress related behaviours. Animals were singly 
housed a week prior to testing and maintained on a 12:12 h light/dark cycle. Animals were also 
given a day rest between each round of testing to ensure that variability due to fatigue was not a 
factor.  
For motor function and gait analysis, locomotor activity, RotaRod and DigiGait was used in 2 
and 6 month old Nedd4-2 heterozygous and age-matched controls were used (n = 7-15). Basal 
locomotor activity, motor capacity and gait were assessed (as described in Chapter 2). At the 
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completion of behavioural assessment mice were weighed and deeply anaesthetized with 
sodium pentobarbital injection (100 mg/kg i.p.), and tissue removed for Western blot analysis or 
immunohistochemistry. A separate cohort of mice was used for HPLC analysis at both 2 (wt: n 
= 8 and het: n = 7) and 6 (wt: n = 5 and het: n = 5) months of age.  
Western Blotting 
Whole brain (2 month, wt: n = 4 and het: n = 5; 6 month, wt: n = 5 and het: n = 4) and striata (2 
months, wt: n = 8 and het: n = 7; 6 months, wt: n = 4 and het: n = 4) were homogenized as 
described in Chapter 2. Briefly, after protein separation on SDS-page gels, membranes were 
probed with, rabbit anti-Nedd4-2 (1:1000; generated in Kumar laboratory), DAT (1:1000; 
Merck-Millipore), and chicken anti-β-actin (1:1000; Abcam) used as a loading control. Blots 
were washed and incubated with mouse-Alexa 488 (1:1000, Invitrogen) and chicken-Alexa 647 
(1:1000, Invitrogen). Blots were visualized using FluoroChemQ MultiImage III (Alpha 
Innotech, USA), and analysed using Image J Software. 
Immunohistochemistry 
For immunohistochemistry, 2 (n = 5) and 6 (n = 5) month old Nedd4-2 heterozygous and wild-
type littermates (n = 4, n = 5 and n = 3, respectively) were used. Frozen 50μm thick free-
floating coronal sections were incubated with primary antibodies. The following antibodies were 
used: 
Antibody Function Dilution Manufacturer 
Mouse anti-NeuN Neuronal marker 1/1000 Merck-Millipore 
Mouse anti-MAP2 MAP2 protein (dendritic 
marker) 
1/1000 Sigma 
Rabbit anti-Nedd4-2 Nedd4 protein 1/1000 Gift from Prof Sharad 
Kumar 
Mouse anti-Tyrosine 
hydroxylase (TH) 
The rate limiting enzyme in 
dopamine synthesis 
1/1000 Merck-Millipore 
Rat anti-Dopamine 
transporter (DAT) 
Dopamine transporter 1/1000 Merck-Millipore 
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Primary antibodies were visualized with Alexa-conjugated secondary antibodies, mounted using 
Prolong-Gold with DAPI mounting medium (Invitrogen). Stained sections were visualized using 
a Nikon C1 confocal microscope using a 488nm argon and 543nm HeNe laser (Nikon Group, 
Tokyo, Japan). Images were acquired using a 40x Plan-Apochromat oil immersion objective 
with identical gain settings applied for all groups. All images were captured and analyzed using 
Nikon Elements software. 
High Performance Liquid Chromatography (HPLC) 
Isolation of brain tissue 
For HPLC, mice were euthanized with sodium pentobarbital injection (100 mg/kg i.p.). The 
brain was removed, placed on ice and the striatal region rapidly dissected on a chilled plate. 
Striatal tissue obtained was weighed so that 3-5mg of tissue was transferred to a glass 
homogenizer containing 200ȝl of extraction buffer (4M Perchloric acid, 0.008M sodium 
metabisulphate, 0.002M disodium ethylenediaminetetra-acetic acid (EDTA), MilliQ water to 
bring volume to 100ml). Samples were homogenized until a homogenous solution is produced 
and sonicated to rupture vesicular membranes. Samples were then spun at 10,500g for 5 
minutes, and the supernatant transferred to a fresh tube. The samples were spun a further two 
times, to ensure all debris was eliminated. Samples were stored at -80°C until required.  
HPLC 
For HPLC analysis, 40ȝl of sample was transferred to a HPLC recovery vial. Standards for 
dopamine and L-DOPA were made in the same extraction buffer used for sample preparation. 
The mobile phase was composed of 70mM monopotassium phosphate, 0.5mM EDTA di-
sodium salt, 8mM octane sulfonic acid sodium salt, 170ml HPLC grade methanol, to a final 
volume of 1000ml and pH 3. The flow rate was 500ȝl/min with reverse phase C18 columns. 
HPLC analysis was conducted on striatal samples from both 2 and 6 month Nedd4-2
heterozygous mice and wild-type control for total (intracellular and extracellular) dopamine and 
DOPAC levels, to indicate whether dopamine levels and metabolism is affected. 
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Statistics 
For the behavioural and western blot analysis statistical comparisons were made between the 
Nedd4 heterozygous mice and age-matched wild-type controls using unpaired Student’s t-test. 
Results were deemed significant when P < 0.05. 
3.3. RESULTS 
Body and Brain weights 
Body weight of both 2 (24.1 ± 0.7; n = 16) and 6 month (30.6 ± 1.1; n = 10) Nedd4-2
heterozygous mice was not changed when compared to wild-type controls (26.0 ± 0.4; n = 8 and 
29.8 ± 0.8; n = 10, P = 0.09 and P = 0.56 respectively) (Figure 3.2A). Furthermore, brain 
weight was also similar between 2 (0.43 ± 0.007; n = 13) and 6 month (0.44 ± 0.01; n = 10) 
Nedd4-2 heterozygous mice and wild-type controls (0.45 ± 0.004; n = 8 and 0.44 ± 0.005; n = 9; 
P = 0.18 and P = 0.60 respectively) (Figure 3.2B).  
Figure 3.2. No difference in average body weight was evident between Nedd4-2 heterozygous 
mice (+/-) compared to age-matched wild-type controls (+/+) at both 2 and 6 months of age (A). 
Similarly, no differences in brain weights were evident (B). Data represented as mean±SEM.   
A B 
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Nedd4-2 whole brain levels 
Nedd4-2 levels were significantly reduced in whole brain from 2 (wt: 100.0 ± 19.1%; n = 4 and 
het: 33.3 ± 6.9%; n = 7, P = 0.003) and 6 (wt: 100.1 ± 12.4%; n =5 and het: 48.1 ± 10.6%; n =4, 
P = 0.018) months old Nedd4-2 heterozygous compared to wild-type controls (Figure 3.3).  
Figure 3.3. Representative whole brain Western blots showing Nedd4-2 expression from 2 (A)
and 6  (B) month old Nedd4-2 heterozygous mice (+, -); n = 4-7) and age matched wild-type 
controls (+/+) (A). Nedd4-2 levels were significantly reduced by at least 50% in Nedd4-2
heterozygous mice (+/-; n = 4-7) compared to age-matched wild-type controls (+/+; n = 4-5) 
(C). Nedd4-2 levels in whole brain lysates represented as % of control. Data represented as 
mean±SEM.  * P < 0.05, and ** P < 0.01 using unpaired Student’s t-test. 
Locomotor activity  
Basal loco-motor activity assessment with locomotor activity cells showed no difference 
between Nedd4-2 heterozygous mice and their wild-type littermates at both 2 and 6 months of 
age (Table 3.1).  
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Table 3.1. No change was observed in basal loco-motor activity between Nedd4-2 heterozygous 
(+/-) and age matched wild-type (+/+) controls at both 2 and 6 months of age. Data represented 
as mean±SEM. 2 months: wild-type n = 8 and heterozygous n = 15, 6 months: wild-type n = 10 
and heterozygous n = 10. 
 2 months 6 months 
(+/+) (+/-) P value (+/+) (+/-) P value 
Floor Plane      
Moves 583±10 563±7 0.09 551±6 573±11 0.09 
Time (sec) 1164±27 1160±19 0.90 1219±36 1202±40 0.75 
Distance (cm) 5131±230 5414±259 0.48 6167±442 5667±381 0.40 
Ventral Plane     
Rears 73±12 77±8 0.75 89±9 96±14 0.68 
Time (sec) 68±12 71±8 0.85 74±8 83±10 0.49 
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Motor capacity 
Motor capacity was measured with the RotaRod test where an age-dependent decline in motor 
capacity was observed in Nedd4-2 heterozygous mice compared to age-matched controls. This 
was illustrated by a significant decrease in latency to fall in the 6 month Nedd4-2 heterozygous 
mice (230.4 ± 12.3; n = 10) compared to wild-type controls (278.9 ± 10.6; n = 10, P = 0.008). 
Latency to fall at two months showed no differences (wt: 249.6 ± 16.4; n = 8 and het: 235.1 ± 
13.5; n = 16, P = 0.52) (Figure 3.4). 
Figure 3.4. Motor function capacity was assessed with RotaRod with no changes observed 
between 2 month old Nedd4-2 heterozygous mice (+/-) and age-matched wild-type controls 
(+/+). A significant reduction was observed in 6 month heterozygous mice compared to the age-
matched controls. Data represented as mean±SEM. * < 0.05 using unpaired Student’s t-test. 
DigiGait 
Stride parameters 
At 2 months there was no alterations in stride parameters (dynamic phase) between Nedd4-2 
heterozygous and wild type controls, including no overall difference in stride duration, or in 
swing, brake or propulsion phases. Stance duration where the paws are in contact with the belt 
was also not different (Table 3.2). No differences in stance parameters were evident when the 
percentage of time the paws were in braking or propulsion phase were examined (Table 3.3). 
Similarly at 6 months, stride parameters (Table 3.4) and stance parameters (Table 3.5) were not 
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different in Nedd4-2 heterozygous mice relative to wild-type controls. No differences were 
evident at both speeds tested (15 and 20 cm/sec). For details of parameters examined please 
refer to Figure 2.2 (Chapter 2). 
Table 3.2. Stride parameters in Nedd4-2 heterozygous (+/-) and wild-type (+/+) control mice at 
2 months of age at speeds of 15 and 20 cm/sec. Data represented as Mean±SEM. 
Indices 15 cm/sec 20 cm/sec 
Stride duration (sec) (+/+) n = 7 (+/-) n = 15 P value (+/+) n = 7 (+/-) n = 15 P value
Fore paw     
Swing 0.11±0.01 0.10±0.004 0.59 0.09±0.003 0.09±0.003 0.90 
Brake 0.12±0.01 0.12±0.01 0.62 0.09±0.01 0.09±0.01 0.91 
Propel 0.11±0.01 0.10±0.01 0.54 0.07±0.01 0.08±0.01 0.47 
Stance 0.23±0.01 0.23±0.004 0.79 0.17±0.04 0.17±0.01 0.32 
Stride 0.34±0.02 0.33±0.01 0.63 0.26±0.01 0.26±0.01 0.50 
Hind paw     
Swing 0.18±0.1 0.09±0.002 0.56 0.08±0.03 0.08±0.003 0.42 
Brake 0.05±0.01 0.05±0.003 0.76 0.05±0.003 0.04±0.003 0.26 
Propel 0.17±0.03 0.19±0.01 0.33 0.13±0.01 0.14±0.01 0.24 
Stance 0.22±0.03 0.25±0.01 0.34 0.18±0.003 0.18±0.01 0.52 
Stride 0.40±0.05 0.34±0.01 0.11 0.25±0.003 0.26±0.01 0.35 
Fore paw     
% Propel 33.8±3.5 31.5±1.9 0.54 28.1±3.2 31.0±2.1 0.44 
% Swing 31.9±0.6 31.3±0.7 0.69 35.4±0.8 34.2±0.9 0.45 
% Brake 34.4±3.4 37.2±1.9 0.44 36.6±3.3 34.8±2.1 0.64 
% Stance 68.2±1.6 68.8±0.7 0.69 64.6±0.8 65.8±0.9 0.45 
Hind paw     
% Propel 48.6±7.4 56.6±1.3 0.14 50.1±2.0 52.3±1.2 0.35 
% Swing 36.7±9.6 27.2±0.7 0.16 30.6±1.1 31.2±0.9 0.70 
% Brake 14.7±2.5 16.1±1.1 0.54 19.3±1.1 16.5±1.0 0.12 
% Stance 63.3±9.6 72.8±0.7 0.16 69.4±1.1 68.8±0.9 0.70 
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Table 3.3. Stance parameters in Nedd4-2 heterozygous (+/-) and wild-type (+/+) control mice at 
2 months of age at speeds of 15 and 20 cm/sec. Data represented as Mean±SEM. 
Indices 15 cm/sec 20 cm/sec 
(+/+) n = 7 (+/-) n = 15 P value (+/+) n = 7 (+/-) n = 15 P value
Fore paw 
Stance 
  
% Brake 50.4±5.0 54.0±2.7 0.50 56.5±5.1 52.8±3.1 0.52 
% Propel 49.6±5.0 46.0±2.7 0.50 43.5±5.1 47.2±3.1 0.52 
Hind paw
Stance 
    
% Brake 23.3±1.5 22.2±1.6 0.68 27.8±1.9 23.9±1.5 0.14 
% Propel 76.7±1.5 77.8±1.6 0.68 72.2±1.9 76.1±1.5 0.14 
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Step frequency and angle dynamics 
Number of steps taken and stride frequency were not different between Neddd4-2 heterozygous mice relative 
to wild-type controls at both ages (Table 3.8 and 3.9, respectively). When paw angle dynamics were 
examined, no differences were observed at 2 months of age (Table 3.8). At 6 months of age however, a 
subtle but significant decrease in fore paw angle was observed (at 20 cm/sec), and paw angle variation 
significantly increased (at 30 cm/sec) (Table 3.9).  
Table 3.8. Stride frequency, number of steps and angle dynamics in Nedd4-2 heterozygous (+/-) and wild-
type (+/+) control mice at 2 months of age at speeds of 15 and 20 cm/sec. Data represented as Mean±SEM.  
Indices 15 cm/sec 20 cm/sec 
(+/+) n = 7 (+/-) n = 15 P value (+/+) n = 7 (+/-) n = 15 P value
Fore paw     
Stride Frequency (steps/sec) 3.0±0.14 3.1±0.06 0.76 3.9±0.09 3.9±0.10 0.76 
# Steps 4.5±0.12 4.4±0.10 0.77 4.4±0.07 4.5±0.06 0.77 
Hind paw     
Stride Frequency (steps/sec) 2.7±0.31 3.1±0.07 0.10 4.0±0.07 3.9±0.12 0.17 
# Steps 3.9±0.45 4.3±0.12 0.34 4.6±0.17 4.4±0.08 0.47 
Fore paw     
Paw angle (°) -0.9±1.44 -2.0±0.70 0.44 -1.4±1.00 -2.4±1.78 0.59 
Paw angle Variance 17.5±3.94 19.3±2.46 0.69 25.1±6.90 26.6±6.73 0.90 
Absolute paw angle 7.4±1.58 6.2±0.67 0.43 4.9±1.99 6.6±0.99 0.25 
Step angle (°) 54.8±4.17 52.5±2.73 0.65 55.8±3.23 55.9±2.32 0.99 
Step Angle Variance 15.1±2.54 14.2±1.70 0.75 12.9±1.79 12.4±1.23 0.81 
Hind paw     
Paw angle (°) -2.8±2.59 -2.3±1.31 0.84 -2.2±0.99 1.3±1.63 0.18 
Paw angle Variance 18.6±5.64 27.4±4.28 0.25 17.7±2.79 26.6±5.66 0.31 
Absolute paw angle 16.2±2.97 13.1±0.98 0.23 15.8±1.32 12.3±1.15 0.08 
Step angle (°) 57.9±4.67 55.4±1.91 0.56 57.0±1.25 58.5±1.11 0.38 
Step Angle Variance 12.1±2.11 15.9±1.03 0.09 15.2±0.90 15.4±0.81 0.93 
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Plantar placement and Stance Factor 
There was no difference in the extent of plantar placement in fore and hind paws of Nedd4-2 heterozygous 
mice relative to age-matched wild-type controls at both 2 and 6 months of age. This was exemplified by no 
changes in paw area at peak stance and stance factor (Table 3.10 and 3.11, respectively).  
Table 3.10. Stride frequency, number of steps and angle dynamics in Nedd4-2 heterozygous (+/-) and wild-
type (+/+) control mice at 2 months of age at speeds of 15 and 20 cm/sec. Data represented as Mean±SEM. 
Indices 15 cm/sec 20 cm/sec 
(+/+) n = 7 (+/-) n = 15 P value (+/+) n = 7 (+/-) n = 15 P value
Fore paw     
Paw area at peak stance (cm2) 0.49±0.04 0.44±0.01 0.09 0.44±0.03 0.42±0.02 0.55 
Paw area at peak stance Variance 0.06±0.02 0.04±0.01 0.16 0.03±0.01 0.03±0.002 0.29 
Stance Factor 1.0±0.05 1.0±0.02 0.34 1.0±0.05 1.0±0.02 0.87 
Hind paw     
Paw area at peak stance (cm2) 0.75±0.02 0.71±0.02 0.26 0.72±0.05 0.70±0.03 0.77 
Paw area at peak stance Variance 0.08±0.01 0.07±0.01 0.84 0.07±0.01 0.06±0.01 0.67 
Stance Factor 0.9±0.10 1.0±0.03 0.08 1.1±0.04 1.1±0.03 0.34 
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Gait symmetry, hind limb shared and stance-swing ratio 
Gait symmetry, hind limb shared and stance-swing ratio were not changed in Nedd4-2 heterozygous mice 
compared to age-matched wild-type controls at both 2 and 6 month of age (Table 3.12 and 3.13, 
respectively). 
Table 3.12. Stride frequency, number of steps and angle dynamics in Nedd4-2 heterozygous (+/-) and wild-
type (+/+) control mice at 2 months of age at speeds of 15 and 20 cm/sec. Data represented as Mean±SEM. 
Indices 15 cm/sec 20 cm/sec 
(+/+) n = 7 (+/-) n = 15 P value (+/+) n = 7 (+/-) n = 15 P value
Gait Symmetry 1.4±0.43 1.0±0.01 0.16 1.0±0.03 1.0±0.01 0.59 
Hind limb shared 0.2±0.02 0.2±0.01 0.21 0.1±0.02 0.1±0.01 0.99 
Fore paw     
Stance/Swing 2.2±0.15 2.2±0.08 0.85 1.9±0.06 2.0±0.08 0.40 
Hind paw     
Stance/Swing 2.4±0.44 2.7±0.10 0.31 2.4±0.18 2.3±0.10 0.70 
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Nedd4-2 expression in CNS regions associated with motor function 
The expression of Nedd4-2 was examined in the motor cortex, spinal cord, cerebellum, substantia nigra pars 
compacta (SNpc), substantia nigra pars reticulate (SNpr) and striatum. These regions are all necessary for 
initiation, control and execution of voluntary movement.  
Motor Cortex 
Nedd4-2 expression was abundant in the motor cortex with highest levels observed in pyramidal neurons of 
layer V. These large neurons were identified based on morphology and stained with neuronal marker, NeuN. 
As expected a decrease in Nedd4-2 expression was evident in the heterozygous mice compared to wild-type 
controls. Qualitatively, it appeared there was a decrease in the number of neurons in the cortex of the 
heterozygous mice, however quantification was not performed. 
Figure 3.5. Nedd4-2 (red) is abundantly expressed in motor cortex from 2 month old wild-type mouse, 
particularly in cell body of layer V pyramidal neurons (NeuN, green). (+/-) Nedd4-2 heterozygous mice and 
(+/+) wild type controls. Scale bar represents 50ȝm.
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Spinal cord 
Nedd4-2 expression was examined in the ventral portion of the lumbar spinal cord, and showed high 
expression within NeuN positive motor neurons. Nedd4-2 was predominantly expressed in the cell body, 
with no expression seen in the nucleus or projections of these motor neurons. In the Nedd4-2 heterozygous 
mice there appears to be a reduction in the numbers of motor neurons, although numbers have not been 
quantified. 
Figure 3.6. Nedd4-2 (red) is abundantly expressed in motor neurons (arrow) in the ventral horn of the lumbar 
spinal cord. Motor neurons were stained with the neuronal marker NeuN (green), and co-localization was 
evident in the merged image between Nedd4-2 and NeuN (arrow). (+/-) Nedd4-2 heterozygous mice and 
(+/+) wild-type controls. Scale bar represents 50ȝm. 
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Cerebellum 
Nedd4-2 was expressed in all three layers of the cerebellum. Interestingly it appeared that Nedd4-2 is 
predominantly found in the cell body (or soma) of Purkinje neurons with very little co-localization evident 
between the dendrite marker MAP2 and Nedd4-2. 
Figure 3.7. Nedd4-2 (red) was expressed in the cerebellum in all three layers; granule cell layer (GCL), 
Purkinje neuron (PN) layer and molecular layer (ML). Nedd4-2 is mainly localized in cell bodies of neurons, 
with no staining observed in dendrites from Purkinje neurons, highlighted by the lack of co-localization 
between Nedd4-2 and MAP2. (+/-) Nedd4-2 heterozygous mice and (+/+) wild-type controls. Scale bar 
represents 50ȝm.
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Substantia nigra  
The expression of Nedd4-2 in the substantia nigra was evaluated in both the pars compacta (SNpc) and 
reticulata regions (SNpr). The figure below indicates the boundaries between SNpc and SNpr, with SNpc 
neurons expressing tyrosine hydroxylase (TH), which was not present in SNpr (Figure 3.8). 
Figure 3.8. Nedd4-2 (red) expression was found in both the SNpc (substantia nigra pars compacta) shown by 
tyrosine hydroxylase staining (TH, green) and SNpr (substantia nigra pars reticulata). Scale bar represents 
100 ȝm. 
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Substantia nigra pars compacta (SNpc) 
Higher magnification images show that Nedd4-2 was abundantly expressed in neurons located in SNpc, with 
co-localization between Nedd4-2 and tyrosine hydroxylase (TH). Nedd4-2 and TH expression were evaluated 
in brain slices from 2 and 6 month old Nedd4-2 heterozygous mice and age-matched wild-type controls. 
Quantitative measurements of SNpc positive neurons were not conducted, but no evidence of cell loss was 
seen (Figure 3.9).  
Figure 3.9. Nedd4-2 (red) was abundant in high levels in dopaminergic neurons (TH, green) of substantia 
nigra pars compacta (SNpc). No morphological changes were evident at both 2 and 6 months of age in the 
Nedd4-2 heterozygous mice (+/-) relative to wild-type controls (+/+). Scale bar represents 50 ȝm. 
182
Substantia nigra pars reticulata (SNpr) 
Nedd4-2 expression was observed within the SNpr, in neurons negative for tyrosine hydroxylase. This 
suggests that Nedd4-2 is located in inhibitory neurons of this compartment. No morphological differences 
were observed at 2 and 6 months of age when comparing Nedd4-2 heterozygous mice and wild-type controls 
(Figure 3.10). 
Figure 3.10. At 2 and 6 months of age, Nedd4-2 (red) was abundantly expressed in SNpr, in particular in 
neurons that do not express tyrosine hydroxylase (TH, green). (+/-) Nedd4-2 heterozygous and (+/+) wild-
type controls. Scale bar Scale bar represents 50 ȝm.
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Striatum 
Nedd4-2 was primarily expressed in the cell bodies of medium spiny interneurons of the striatum. No Nedd4-
2 staining was evident in the striatosomes (ST) indicating that Nedd4-2 is absent in white matter tracts 
(Figure 3.11). 
Figure 3.11. Nedd4-2 (green) appears mainly localized around the cell bodies of what appears to be medium 
spiny interneurons located within the striatum. No Nedd4-2 was found in the striatosomal region (ST). 
Dopamine transporter (DAT) (red).  Scale bar represents 50 ȝm. 
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Dopamine transporter levels (DAT) 
DAT is primarily located in the striatum where it facilitates the re-uptake of dopamine. DAT 
levels appear up regulated in Nedd4-2 heterozygous mice at 2 and 6 months of age (Figure 3.12).  
Figure 3.12. DAT immunohistochemistry in the striatum showed an up-regulation in staining 
intensity in 2 and 6 month old Nedd4-2 heterozygous (+/-) compared to wild-type controls (+/+). 
Scale bar represents 10 ȝm. 
However in comparison to Figure 3.12, when striatal DAT levels were measured by Western blot, 
no difference was found in the total level of DAT between the Nedd4-2 heterozygous mice and 
wild-type controls at both 2 (wt: 100.1 ± 17.6%; n = 8 and het: 94.6 ± 16.3%; n = 7; P = 0.83) 
and 6 (wt: 100.0 ±11.8%; n = 4 and het: 67.5 ± 19.8%; n = 4, P = 0.21) month of age (Figure 
3.13).  
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Figure 3.13. Representative Western blot of dopamine transporter (DAT) in striatum of 2 and 6 
month old Nedd4-2 heterozygous mice (+/-, n = 4-7) and age-matched wild-type controls (+/+, n 
= 4-8). No significant difference was observed in DAT levels at both 2 and 6 months of age. 
DAT levels represented as % of wild-type control. Data represented as mean±SEM.  
Dopamine levels and dopamine turnover 
Dopamine levels were significantly reduced in striatum from both 2 (1629 ± 439; n = 7) and 6 
month old (2010 ± 461; n = 5) Nedd4-2 heterozygous mice compared to wild-type controls  (2 
month: 3101 ± 272; n = 8, P = 0.01 and 6 month: 3682 ± 432; n = 5, P = 0.03) (Figure 3.14). 
DOPAC, the main metabolite of dopamine, was also significantly reduced in 2 month Nedd4-2
heterozygotes (319  ± 108; n = 7) compared to wild-type controls (952 ± 102; n = 8, P = 0.0009). 
Although we see a modest reduction in the 6 month heterozygous (wt: 645 ± 76; n = 5 and het: 
405 ± 118; n = 5, P = 0.13) mice, this did not reach significance. Dopamine turnover is 
significantly decreased in 2 month Nedd4-2 heterozygous mice (0.20 ± 0.03; n = 6) compared to 
wild-type controls (0.31 ± 0.02; n = 8, P = 0.02), with no significant difference apparent in the 6 
month cohort (wt: 0.18 ± 0.02; n = 5 and het: 0.19 ± 0.02; n = 5, P = 0.67) (Figure 3.16). 
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Figure 3.14. HPLC analysis showed a significant decrease in dopamine levels in Nedd4-2
heterozygous mice (+/-, n = 5-7) and age-matched wild-type control (+/+, n = 5-8) at both 2 and 6 
months of age. Data represented as mean±SEM. Statistical analysis was conducted using 
unpaired Student’s t-test, with * P < 0.05 and deemed significant.  
Figure 3.15. HPLC analysis showed a decrease in DOPAC from striatum in Nedd4-2
heterozygous mice (+/-, n = 7) at 2 months of age compared to age-matched wild-type controls 
(+/+, n = 8). No difference was seen in the 6 month age group. Data represented as mean±SEM. 
Statistical analysis was conducted using unpaired Student’s t-test, with *** P < 0.0001 and 
deemed significant.  
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Figure 3.16. HPLC analysis of DOPAC to dopamine ratio showed a significant decrease in 2 
month old Nedd4-2 heterozygous mice (+/-) compared to age-matched wild-type controls (+/+), 
with no change evident at 6 months of age. Data represented as mean±SEM. Statistical analysis 
was conducted using unpaired Student’s t-test, with * P < 0.05 and deemed significant.  
3.4 DISCUSSION 
The interaction between Nedd4-2 and dopamine transporter (DAT) is important for motor 
function and control, however the in vivo consequences remain unknown. Dopamine is largely 
responsible for regulatory feedback to the motor cortex from the basal ganglia, which when 
disrupted results in symptoms associated with Parkinson’s disease. These symptoms include 
rigidity, resting tremor, gait and motor disturbances due to decreased levels of dopamine. Since 
Nedd4-2 was shown to facilitate DAT trafficking, it was essential to investigate DAT and 
dopamine levels, as well as motor function and gait behaviours in Nedd4-2 heterozygous mice. 
This study is the first to characterize Nedd4-2 heterozygous mice in relation to motor function 
and gait.  
Unlike Nedd4, the Nedd4-2 heterozygous mice showed no growth phenotype with both body and 
brain weight similar between the heterozygotes and wild-type controls all both time points tested. 
Whole brain levels of Nedd4-2 were found to be decreased by at least 50% in the heterozygotes 
compared to the wild-type controls confirming that we are indeed examining the effects of a 
single allele deletion of Nedd4-2.  
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Analysis of basal loco-motor activity showed no differences between the Nedd4-2 heterozygous 
mice at both time points when compared to wild-type controls. This was somewhat surprising, as 
the hypothesis suggested that dopamine levels may be altered in these mice and should have 
resulted in alterations in basal activity. For instance, an increase in striatal dopamine transporter 
is evident in adults afflicted with ADHD (Krause et al., 2000). Furthermore, in DAT knockdown 
mice, a reduction in DAT (90% reduction) produces hyperactivity due to increased dopamine 
levels in the striatum (Zhuang et al., 2001). Due to these findings it would have been expected to 
observe a decrease in basal locomotor activity in the Nedd4-2 heterozygous mice, due to 
increased levels of DAT and decreased dopamine levels. However, since we are using a 
heterozygous model perhaps the altered levels of both DAT and dopamine was not severe enough 
to produce behavioural changes.  
Next motor function was examined and although no difference was observed at 2 months of age, 
by 6 months a significant reduction in motor capacity became evident. This suggests that at 6 
months of age, Nedd4-2 heterozygous mice have impaired motor function. In addition, gait was 
also analyzed, as gait abnormalities are often present in patients and rodent models of Parkinson’s 
disease. Interestingly, no differences in gait were apparent at both 2 and 6 months of age in the 
Nedd4-2 heterozygous mice. The parameter that is particularly relevant to dopamine activity and 
function was stride length and stride length variability, which have both been suggested to be 
accurate indicators of basal ganglia abnormalities (Fernagut et al., 2002). Nevertheless, the 
significant reduction in motor capacity warranted investigation into expression of Nedd4-2 in 
regions of the CNS involved in motor function and gait.  
The expression of Nedd4-2 was examined to determine what neuronal compartments shows high 
expression. Firstly, Nedd4-2 was highly expressed in layer V pyramidal neurons of the motor 
cortex, with these neurons synapsing onto spinal cord motor neurons, and therefore integral for 
the initiation of motor function. Nedd4 was found in the cell bodies with no staining evident in 
the nucleus of these pyramidal neurons. Nedd4-2 expression is not restricted to layer V pyramidal 
neurons with expression evident in other layers of the cortex with varying intensity. The number 
of neurons within the motor cortex also appeared reduced in the Nedd4-2 heterozygotes but was 
not quantified. Further work is necessary to determine whether the numbers of neurons are 
decreased, and to determine whether any age-related changes such as enhanced 
neurodegeneration is observed in older time points in the heterozygotes compared to the wild-
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type controls. In addition examination of other cortical regions such as the visual and sensory 
cortex also requires further investigation.  
Since pyramidal neurons of the motor cortex synapse on the motor neurons of the spinal cord, 
Nedd4-2 expression was also assessed there. Nedd4-2 was expressed in high levels in motor 
neurons in the ventral horn of the lumbar spinal cord. These neurons innervate skeletal muscle to 
execute voluntary movement. Interestingly, neuron number also appeared decreased here in the 
Nedd4-2 heterozygous mice. In order to better understand the role of Nedd4-2 in initiation and 
execution of motor function, further analysis is required to determine perhaps if any 
developmental delays occur, or whether early neuronal cell death is observed in the Nedd4-2
heterozygotes compared to wild-type controls in these two important neuronal compartments 
integral for motor function.  
In terms of motor control and regulation, the cerebellum is integral for ensuring of timing, 
accuracy and precision of movement (Kandel et al., 2000). Unlike the Nedd4 heterozygous mice, 
no gait abnormalities were evident in Nedd4-2 heterozygous mice compared to wild-type controls 
at both time points. Although some changes were evident for example, significant changes to 
stance width variance, paw angle and paw angle variance, the data shows changes the wild-type 
mice in rather than heterozygotes. This indicates that these findings may be artifacts rather than 
true changes in gait. While there was no evidence for alteration in timing, or co-ordination of 
precision of movements, Nedd4-2 was present in all three layers of the cerebellum, in granule 
cells, Purkinje neurons and the molecular layer. This suggests that Nedd4-2 may play a role in 
cerebellar function, but any changes associated with reduced Nedd4-2 levels did not manifest into 
a physiological outcome. This may be due to the small or redundant role for Nedd4-2 in the 
cerebellum, or perhaps greater levels of Nedd4-2 loss are necessary before abnormalities become 
evident.  
Due to the reduced motor capacity observed in the Nedd4-2 heterozygotes and the known 
interaction between Nedd4-2 and DAT, the expression of Nedd4-2 was evaluated in the 
substantia nigra pars compacta (SNpc) and reticulata (SNpr), as well as the striatum. Nedd4-2 
was abundant in dopaminergic neurons of SNpc with strong co-localization observed with 
tyrosine hydroxylase positive neurons. This finding is important, as it supports the role for 
Nedd4-2 in dopamine neurotransmission. Neurons of SNpc degenerate in patients afflicted with 
190
Parkinson’s disease, reducing the level of dopamine produced, and indeed these patients have 
compromised motor function. There was no evidence for reduced levels of tyrosine hydroxylase, 
cell numbers of any morphological changes within the SNpc, which suggests that the motor 
decline in the heterozygotes is unlikely due to degeneration of SNpc. So next, the expression of 
Nedd4-2 within SNpr was evaluated since neurons here provide inhibitory innervation to SNpc, 
to modulate dopaminergic neurotransmission. Interestingly, Nedd4-2 was also expressed in high 
levels of neurons within SNpr, which may therefore suggest that Nedd4-2 can also regulate 
dopamine release by the SNpc to the striatum, but again no morphological changes were evident. 
This data suggests that Nedd4-2 may play a role in dopaminergic neurotransmission. 
 Since dopamine is largely released in the striatum, most of the DAT is located in this 
compartment, so determining the expression of Nedd4-2 here was imperative. The striatum 
receives excitatory glutamatergic inputs from the cerebral cortex and the thalamus. Striatal 
neurons are largely composed of medium spiny neurons (approximately 95%) with the remainder 
composed of inhibitory interneurons (Kreitzer, 2009; Tepper et al., 2010). The dendrites of 
medium spiny neurons are covered in spines, which receive corticospinal and thalamostriatal 
inputs as well as inhibitory inputs from the GABAergic interneurons and cholinergic interneurons 
(Tepper et al., 2010). Medium spiny neurons are GABAergic large projection neurons, which 
form both ‘direct’ and ‘indirect’ pathways. The direct pathway projects to the SNpr and globus 
pallidus interna (GPi), and thus modulate the output of the basal ganglia, whereas the ‘indirect’ 
pathway projects globus pallidus externa (GPe) which in turn projects to the subthalamic nucleus, 
and thus regulates excitatory projections to SNpr and GPi. In effect the direct and indirect 
pathways have functionally opposing effects; with direct pathway disinhibiting thalamocortical 
targets and the indirect reinforces this inhibition. Therefore the balance between these two 
pathways is fundamental to basal ganglia function in regulating motor behaviours. Another 
important factor of medium spiny interneurons is that dopamine receptors are expressed among 
the two different neuronal populations involved in direct and indirect pathways (Kreitzer, 2009). 
Neurons involved in the direct pathway are enriched with D1 receptors, whereas neurons 
involved in the indirect pathway are enriched with D2 receptors (Crittenden et al., 2011). 
Dopamine can therefore regulate the balance between these two pathways, since D1 receptors 
have an overall excitatory effect and D2 receptors inhibitory. Importantly, it appears that D1 and 
D2 receptors contribute differently to functional behaviours, for example D1 receptors facilitate 
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dopaminergic contribution to learning, where as D2 are most important for motor behaviours 
(Berke et al., 2000). Nedd4-2 was found in the cell bodies of medium spiny neurons, however 
currently whether Nedd4-2 is present in D1, D2 expressing neurons or localized in both remains 
unknown. Interestingly, Nedd4-2 does not co-localize with DAT in terminals of the striatum, 
which is supported by previous studies which have shown that it is unlikely that there is a direct 
interaction between Nedd4-2 and DAT (Sorkina et al., 2006). DAT does not contain a typical 
PPXY motif and did not co-immunoprecipitate with Nedd4-2 (Sorkina et al., 2006), therefore it is 
suggested that an indirect mechanism is involved, perhaps with an intermediate or via adapter 
proteins. When DAT immunofluorescence was examined in the striatum from heterozygous 
mice, a substantial increase was observed in terminals. However, when levels of DAT were 
measured by Western blot, no differences were apparent. This is not entirely surprising as the 
total levels of DAT are unlikely to change in the heterozygous mice, but the level of endocytosis 
may be reduced, highlighted by the increased surface expression in the terminals.  
The effect of increased staining of DAT in terminals of the striatum may translate to increased 
levels of DAT present at the membrane surface, which may affect dopamine levels, due to 
increased re-uptake. HPLC analysis uncovered significant decreases in levels of dopamine in 
striatum from both 2 and 6 month old Nedd4-2 heterozygous mice compared to the age-matched 
wild-type controls. Although this is an exciting result, this is a measure of total dopamine levels 
and cannot provide conclusive evidence for intracellular versus extracellular levels. Further work 
is necessary such as biotinylated dopamine measurements to determine rate of re-uptake by DAT. 
Pharmacological tools could also be used, such as cocaine which blocks DAT to determine if 
membrane levels of DAT are indeed up-regulated due to reduced endocytosis by Nedd4-2. When 
the main metabolite of dopamine metabolism, DOPAC was measured a significant reduction was 
observed in striatum from 2 month old Nedd4-2 heterozygous mice, with a modest decrease also 
observed at 6 months of age. This may suggest that dopamine is not metabolized to the same 
extent in Nedd4-2 heterozygous mice and so that instead of metabolism, the dopamine that is 
taken up by DAT is largely packaged back into vesicles for subsequent release. Dopamine 
turnover can also be determined by examining the ratio of DOPAC to dopamine levels. A 
significant decrease was observed in the 2 month old Nedd4-2 heterozygous mice, suggesting that 
dopamine turnover is reduced, again indicating that dopamine that is taken up by DAT is largely 
re-packaged and not metabolized. No differences were observed at 6 months of age, which 
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suggests that the fate of dopamine once taken up, is repackaged and metabolized in the same 
extent between the Nedd4-2 heterozygotes and age-matched wild-type controls. 
These results can also be explained by reduced firing rate by dopaminergic neurons, which would 
result in decreased levels of dopamine released, therefore accounting for the reduced dopamine 
levels observed in the striatum from Nedd4-2 heterozygous mice. Due to the decreased levels of 
dopamine being released less dopamine is metabolized, and therefore DOPAC levels are also 
reduced, thereby affecting dopamine turnover (Grace, 1991). Data from these studies do not 
allow for discrimination between these two possibilities, and as such further work is necessary to 
explore these two scenarios. 
Overall, the HPLC data shows that Nedd4-2 heterozygous mice have reduced dopamine levels at 
both time points, but only significant indications that dopamine metabolism is affected at 2 
months of age. This is surprising, as the motor deficits are observed at the 6 month time point. 
Drawing conclusions from the HPLC data is difficult, as further experiments are required to 
verify whether there is evidence of increased DAT at the plasma membrane of dopaminergic 
terminals in the striatum, and if this translates to altered dopamine re-uptake. As well as 
examining dopamine metabolism, dopamine synthesis also requires investigation since Nedd4-2 
is abundant in tyrosine hydroxylase positive neurons of SNpc. This study focused on dopamine 
levels, and the potential role between Nedd4-2 and DAT and implications for dopamine levels 
due to re-uptake, but future studies should also examine whether Nedd4-2 plays a role in 
synthesis of dopamine which may also result in reduced dopamine levels observed in the striatum 
of both 2 and 6 month old Nedd4-2 heterozygous mice. 
Findings from this study are the first to show the in vivo consequence in Nedd4-2 heterozygous 
mice where Nedd4-2 levels are reduced by at least 50%, in particular the effects on motor 
function and gait. Behavioural testing has shown a reduced motor capacity at 6 months of age, 
with no alterations in gait or basal locomotor activity. Nedd4-2 is also highly expressed in many 
neuronal compartments associated with initiation, execution and regulation of voluntary 
movement.  
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CHAPTER 4: NEDD4 IN COGNITIVE BEHAVIOUR 
4.1 BACKGROUND AND RATIONALE 
The role for Nedd4 in cognitive function 
The multitude of targets for Nedd4 involved in synaptic plasticity suggest that it may play an 
integral role in complex neuronal interactions including; cognitive processes such as learning, 
memory and anxiety. To date, the expression of Nedd4 in regions of the brain associated with 
these processes remains largely unknown. It was important to assess what role Nedd4 plays in 
cognitive function, determine patterns of expression and highlight targets that could be involved. 
As already discussed, Nedd4 heterozygous mice have significant growth abnormalities attributed 
to decreased IGF-1 mediated signaling. In addition, Nedd4 heterozygous mice have gait 
abnormalities; in part likely due to abnormal levels of GluR1-containing AMPA receptors 
(AMPARs) at granule cell-Purkinje neuron synapses. The evidence that Nedd4 is also involved in 
axonal and dendritic growth further supports a role for Nedd4 in cognition. 
Nedd4 regulation of axonal and dendritic growth 
The growth and development of axons and dendrites is essential during development of the CNS 
but also in the mature brain where adaptive changes must occur for synaptic plasticity to take 
place. Nedd4 has been shown to be important for both axonal and dendritic growth. For instance, 
in Nedd4 knockout mice a significant impairment of dendrite growth results due to loss of 
ubiquitination of a serine/threonine kinase TNIK and the small GTPase Rap2A (Kawabe et al., 
2010). The function of Rap2A reduces the activity of the TNIK family of kinases which act to 
promote dendrite growth (Kawabe et al., 2010). So in Nedd4 knockout mice, there is the 
accumulation of Rap2A resulting in inhibition of TNIK and thus loss of dendrite growth (Kawabe
et al., 2010). The reduced complexity of dendrite arbours limits the extent of synapses that can 
form and this may have profound implications for cognition as well as other important CNS 
functions such as motor function and gait. 
In axons, Nedd4 was found to regulate levels of PTEN, and in Xenopus retinal ganglion cells 
knockdown of Nedd4 resulted in reduced axonal terminal branching (Drinjakovic et al., 2010a; 
Kawabe et al., 2010). As with dendrite branches, reduced levels of axons branches can have 
profound effect on CNS function, by reducing the potential for formation of synapses. 
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AMPA Receptors and Synaptic plasticity 
Aside from growth and development of neurons, axons and dendrites, studies have shown that 
Nedd4 is also important in the mature synapse. For example, Nedd4 can cause AMPAR 
endocytosis via the ubiquitination of glutamate subunit 1 (GluR1) occurring in an activity 
dependent manner. (Lin et al., 2011; Schwarz et al., 2010). The regulation of GluR1-containing 
AMPAR is important as modification at the synapse allows for plasticity during learning and 
memory (Boehm et al., 2006). The synaptic insertion and removal of AMPA receptors lead to the 
activity-induced glutamatergic enhancement that occurs during LTP and plasticity in vivo (Bredt
et al., 2003; Makino et al., 2009). With AMPA receptor trafficking important for long-term 
potentiation (LTP) and thus long-term memory and learning therefore Nedd4 may have important 
in vivo role in learning and memory related behaviours.  
Behavioural assessment of cognitive function 
The molecular targets and mechanisms discussed so far contribute to cognitive behaviours, 
however behavioural tests must be used to determine the in vivo consequences of alterations in 
these molecular mechanisms. Such tests include assessment of memory, learning, anxiety and 
sensory motor gating. These tests are robust and well defined, and are well supported by the 
literature. Most importantly, these tests can translate in understanding similar processes in the 
human brain. 
Memory and Learning 
Learning can be defined as the acquisition of new information, while memory is the expression of 
the acquired information. There are several types of memory, such as spatial and working 
memory. This study is particularly interested in spatial memory, as this is largely hippocampal 
based (Good, 2002). Due to the known interaction with AMPARs necessary for LTP, and LTP 
predominantly contributing to hippocampal based learning and memory it was important to 
examine spatial memory in the Nedd4 heterozygous mice. Spatial memory can be short and long-
term, with distinctive tests to examine each type. The importance of short and long-term memory 
in context of this study arise due to the emerging importance of protein degradation (by 
ubiquitination) necessary for the consolidation of short to long-term memory (Figure 4.1). Part of 
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this consolidation process requires synaptic changes to occur, such as regulation of AMPAR 
crucial for LTP and strengthening of the synapse. 
Figure 4.1. Cognitive processing of incoming information. Incoming information is initially 
stored as short-term memory but with consolidation can be converted to long-term memory. 
Ubiquitin proteasome system (UPS). 
Short-term spatial memory 
Y-maze is a test to assess memory, explorative behavior and short-term spatial memory 
performance. The test is a two-trial recognition memory test and importantly it does not rely on 
learning, instead it relies on the innate tendency of mice to explore novel environments. The Y-
maze uses spatial cues, where mice are allowed to explore two familiar arms with no access to 
the third ‘novel’ arm. Following a short period of time (between 1 to 4 hours), the novel arm 
becomes accessible and rodents with intact spatial short-term memory recognize that this arm is 
novel as indicated by the increased exploration activity in this arm (Dellu et al., 1992).  
Long-term spatial memory 
Morris water maze (MWM) was used to investigate long-term spatial memory and learning, often 
following the spatial learning component (Morris, 1984). This test relies on innate rodent 
behaviours based on the high motivation to escape the pool during the learning phase. Rodents 
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use spatial cues to navigate the shortest distance to the hidden platform. Following adequate 
display of learning, the platform can be removed, and rodents with intact long-term spatial 
memory display behaviours indicative of searching for the platform in the quadrant of the pool 
where the hidden platform was located during learning. 
Anxiety 
The elevated plus maze is routinely used to assess anxiety related behaviours in rodents. The 
elevated plus maze uses natural characteristics innate to mice for exploration of novel 
environments, and the aversion to bright and open spaces (Walf AA et al., 2007). The elevated 
plus maze measures unconditioned responses to potentially dangerous environment, and the 
degree to which the mouse avoids the open spaces (open arms of the maze) can determine anxiety 
related behaviours. 
Pre-pulse startle responses 
Startle responses to auditory stimuli is a normal physiological response in both humans and 
rodents. Reduced startle response occurs when a lower frequency auditory stimuli is placed prior 
to the test auditory stimuli. This reduction or pre-pulse inhibition shows the ability to filter or 
‘gate’ environmental information. The test used to measure pre-pulse startle responses are similar 
for rodents and humans, and so some level of translation is possible between rodent studies and 
human conditions (Swerdlow et al., 2001). The brain circuitry used to regulate pre-pulse startle 
responses is complex, and involves the hippocampus (both dorsal and ventral portions) 
(Swerdlow et al., 2000), prefrontal cortex (Yee, 1999), basolateral amygdala (Decker et al., 
1995), striatum (Kodsi et al., 1995), substantia nigra pars reticulata (Koch et al., 2000) and many 
others (Swerdlow et al., 2001).  
Pre-pulse inhibition abnormalities are observed in people with attention deficit disorders and 
people afflicted with schizophrenia (Braff et al., 2001; Parwani et al., 2000). The use of PPI 
assessment especially in transgenic mice is useful for understanding the relationship between the 
gene of interest and ability to process and filter sensory information. Alterations in PPI can be 
important indicators of altered striatal or limbic circuitry, which can form a strong basis for 
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further investigation, and characterization of the gene, regions of the brain involved and 
neurochemistry. 
Hippocampus and amygdala are important for cognitive behaviour 
The hippocampus can be divided into the dorsal and ventral portions, with these regions having 
distinct roles and contributions to cognition (Fanselow et al., 2010). As already discussed in 
Chapter 1, lesion studies have provided supporting evidence for the distinct roles of the dorsal 
and ventral portions of the hippocampus. Reciprocal connections with the amygdala are 
necessary for the processing of emotive behavior and regulation of anxiety related behaviours. 
Both the hippocampus and amygdala contain GluR1 containing AMPARs, with studies showing 
that levels of GluR1 in the amygdala can correlate with performance in elevated plus maze. In the 
hippocampus, GluR1 containing AMPARs are essential for LTP and thus memory formation. In 
terms of PPI, there is also evidence that mice lacking GluR1 AMPARs showed ‘schizophrenia-
related behaviours’ including reduced PPI response (Wiedholz LM et al., 2008).  
LTP essential for synaptic changes during long-term memory 
Long-term memory requires synaptic changes to occur to produce long lasting enhancement 
between neurons. LTP is the molecular mechanism by which this enhancement can occur, 
especially in the hippocampus. The involvement of AMPARs in LTP is well established, in 
particular the trafficking of AMPARs in and out of the membrane (Sprengel, 2006). As already 
discussed Nedd4 has been shown to target GluR1 containing AMPARs in an activity dependent 
manner (Schwarz et al., 2010) and may therefore play an important role in LTP and long-term 
memory. 
The involvement of calcium during cognitive processes 
Calcium is essential for LTP and thus learning and memory, therefore the regulation of voltage-
gated calcium channels is important. Given that Nedd4 is able to ubiquitinate and thus regulate 
newly synthesised Cav1.2 channels (Rougier et al., 2011) it may exert important effects in 
regulating intracellular calcium levels and thus impact LTP. Furthermore, calcium has been 
shown to release the auto-inhibition of Nedd4 by releasing the C2 (calcium binding domain) from 
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the HECT (catalytic domain), and thus levels of intracellular calcium can in turn affect Nedd4 
activity (Wang et al., 2010). During LTP, increases in intracellular calcium regulate membrane 
excitability and initiate intracellular signal transduction pathways necessary for maintenance of 
LTP (Calin-Jageman et al., 2008).  The impact of reduced levels or loss of Nedd4 on LTP has 
never been investigated. 
Memory and learning are fundamental cognitive processes with complex molecular component 
Given the critical function of Nedd4 during the development of the nervous system, as well as the 
multitude of targets important in the synapses of the mature brain it was appropriate to investigate 
what roles Nedd4 might play in cognitive behavior. These previous studies led to the main 
hypothesis of this study; that Nedd4 would have an essential role in neuron function necessary 
for cognitive behaviours and may regulate AMPARs to allow for synaptic plasticity associated 
with these behaviours. To investigate this hypothesis, the following aims were set: 
4) Conduct behavioural tests in Nedd4 heterozyogous mice to assess short and 
long-term memory and learning 
5) Behavioural assessment of anxiety behaviours 
6) Evaluation of sensory motor gating  
7) Determine cellular and regional expression of Nedd4 in the brain associated 
with cognitive behaviours 
8) Determine whether changes in AMPARs are altered in Nedd4 heterozygous 
brains 
9) Assess molecular mechanism of plasticity by assessing long-term potentiation 
in brain slices from Nedd4 heterozygous mice 
Tests were conducted in 2 and 6 month old Nedd4 heterozygous mice.  
4.2 MATERIALS AND METHODS 
Behavioral assessment 
Mice used for this study were previously described in Chapter 2. Cognitive behaviour followed 
the completion of the motor function and gait analysis. Testing was conducted in designated 
mouse behaviour rooms (3 x 3.5 m) at the Florey Neuroscience Institute. Tests were conducted 
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between 0900 and 1800 hours to minimize disturbance of light : dark cycle of the mice. Lighting 
levels varying upon each tests and are described for each test. Ethovision XT (Noldus) video 
tracking software was used to collect and analyze parameters in Y-maze, MWM and elevated 
plus maze. 
Y-maze  
The Y-maze apparatus was composed of three identical arms (30 cm length and 14 cm sides). 
Figure 4.2. Set up of Y-maze test, where during trial 1 mice were allowed to explore the familiar 
arms, with access to the novel arm blocked. After 2 hours, access to the novel arm was allowed 
and mice explored all three arms of the Y-maze. Extra-maze cues were placed at the end of each 
arm as shown in the schematic.
Prior to testing, mice were habituated overnight in the testing room with low lighting (10 Lux). 
For trial one, the partition is placed so that the novel arm is inaccessible. A handful of bedding 
from the home cage of the mouse is placed in the Y-maze and mouse allowed 10 minutes to 
explore the familiar arms. Two hours later, trial two is performed where the partition is removed, 
and mouse placed back into the Y-maze, with access to the novel arm for 5 minutes (Figure 4.2). 
The Y-maze was thoroughly cleaned with 70% ethanol after each mouse to eliminate foreign 
odours. Ethovision XT was used to track and collect the following data: 
• Duration time spent in novel versus familiar arms 
• Latency to enter the novel arm 
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• Number of entries in novel versus familiar arms 
These parameters can be used to evaluate explorative and spatial recognition memory. 
Morris Water Maze  
Apparatus Set up 
The MWM pool used in this study was 1.44m in diameter.  
Figure 4.3. Schematic representation of Morris Water maze set up. The hidden platform is placed 
in the home quadrant of the pool. Extra-maze cues are placed at each point; North, West, East 
and South, with three cues being two-dimensional, and the fourth a three-dimensional cue. 
MWM Testing 
The MWM test is comprised of two components: 
• Learning trial (spatial reference memory) 
• Probe trial (memory) 
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The pool is spatially separated so that the Ethovision software recognized four quadrants (NW, 
SW, SE and NE). Four extra-maze cues were used; with 3x A3 posters (2D) cues and one 3D cue 
also placed externally to the pool (Figure 4.3). These spatial cues are necessary for the mice to 
spatially navigate. The pool is filled with water (24 ± 1°C), and water based paint added in order 
to make the water opaque. The hidden platform is randomly assigned a quadrant location (‘home 
quadrant’), so that each mouse will have the hidden platform in the same location during each 
day of testing.  
Learning Trial 
The learning trial is conducted over 6 consecutive days, where mice learn to swim to the correct 
platform location showing over time decreased escape latencies and direct swim paths. Each day 
consists of four trials (max 120 sec) where the mouse is introduced into the pool from each of the 
four quadrants, and the latency to find the hidden platform recorded. On the first day however, 
since they have not encountered the hidden platform, mice are guided to the platform and allowed 
30 sec to identify the cues in relation to their location. The four trials are repeated daily for six 
days, with wild-type mice typically showing a progressive decline in the time taken to locate the 
hidden platform indicating spatial learning.  
Probe Trial 
After completion of the learning trials, the probe trial was conducted (day 7). The platform was 
removed, and the mouse introduced from the opposite quadrant to their ‘home quadrant’, and 
allowed to swim for 60 sec. A mouse that has learned and remembered the location of the hidden 
platform, will swim to the ‘home quadrant’ quickly and show a low latency to enter the hidden 
platform quadrant. They will also repeatedly enter the home quadrant, and spend more time in the 
target quadrant providing evidence for spatial memory. The platform zone can also be analyzed, 
which is the area of the platform location within the home quadrant. 
During testing, it was imperative that control procedures are strictly adhered to including 
ensuring that noise levels were kept to a minimum, maintaining one operator handling, and 
general maintenance of a stable environment ensures that stress related behaviours were kept to a 
minimum. Mice were also monitored for behaviours such as thigmotaxis, where mice tend to 
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remain close to the walls of the pool which is a sign of anxiety (Simon et al., 1994). Mice can 
also refuse to swim, whereby the float and is another indicator of anxiety. Any mice that 
exhibited any of these behaviours were excluded from testing. One wild-type and one 
heterozygous mice were excluded from testing due to abnormal learning profiles as a result of 
thigmotaxis. 
Elevated Plus Maze 
Prior to testing, mice were habituated in the testing room overnight in low light level conditions 
(9-10 Lux). On testing day, mice were placed in the center of the maze facing the closed arm and 
allowed to explore the maze for 5 minutes (Figure 4.4). Elevated plus maze was thoroughly 
cleaned with 70% ethanol between mice to remove foreign odours. 
Figure 4.4. Elevated Plus Maze schematic, showing the location of open and closed arms
Ethovision software was used to collect and analyze the following parameters: 
• Duration (time spent) in open versus closed arm 
• Number of entries in the open versus closed arm 
• Latency to enter the open arms 
• Distance and velocity traveled 
• Duration and entries into the central arm 
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Ethological assessment was also conducted where manual scoring of number of additional 
parameters that allow for breakdown of more specific indices such as anxiety itself, locomotion, 
risk assessment, decision making, vertical activity and exploration: 
• Total arm entries 
• Stretch attend postures which can be identified by two criteria: 
o Protected (mouse was located in the closed arm and central arm but explored the 
open arms) 
o Unprotected (mouse was in open arm and stretch to further explore) 
o Both protected and unprotected 
• Closed arm returns (when the mouse backs into the closed arm without committing to 
leaving the closed arm) 
These parameters can provide insight into the following behaviours: 
• Anxiety: Activity in open and closed arms including duration and entries, and total arm 
entries 
• Risk assessment: stretch attend postures, protected, unprotected and both. 
• Decision making: time spent in center zone of the maze and closed arm returns 
• Exploration and motivation: total stretch attend postures, distance and velocity 
Pre-pulse inhibition 
Mice were habituated in the test room for at least 30 minutes prior to placement in the pre-pulse 
chambers (SR Labs). These chambers measure startle of the mice that are motor based responses 
measured in milliVolts (mV). In this study we used 115 dB test stimulus (loud sound), with three 
softer sounds; 4 dB, 8 dB and 16 dB run over 4 consecutive blocks. Mice were initially exposed 
to background noise to establish base line responses, after which they were subjected to a preset 
protocol where the loud stimuli (115 dB for 40 msec) is delivered on its own or preceded by a 
weak non-startle stimuli (4, 8 or 16 dB, for 20 msec) or no stimuli at all (Figure 4.5). Raw data 
was collected by SR LAB Startle response system software, and then calculated as percentage of 
inhibition to a pre-pulse stimulus using the following formula: %PPI = (SR (115 dB) – SR (4, 8 
or 16 dB) / SR (115 dB)*100. This protocol was used in accordance to Standard Operating 
Procedures of FNI. 
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Figure 4.5. Schematic representation of pre-pulse inhibition (PPI) protocol. Startle response was 
measured (mV) in response to 115 dB auditory sound alone, and following a pre-pulse tone of 4, 
8 and 16 dB. The percentage difference between the startle response to the 115 dB tone alone and 
following pre-pulse was calculated. 
Tissue collection 
Western Blotting 
A separate cohort of mice was used to obtain hippocampal tissue for Western blot analysis. 
Briefly, mice (n = 3-5) were euthanized with sodium pentobarbital injection (100 mg/kg i.p.). 
Brains were removed, and the hippocampus dissected on ice, and stored at -80°C until required. 
Tissue samples were homogenized and processed as previously described (Chapter 2). Blots were 
incubated with an antibody against GluR1 (1/1000, Merck-Millipore) overnight at 4°C. Blots 
were washed and incubated with fluorescently tagged Alexa secondary antibodies and visualized 
using FluoroChemQMultiImage III. Blots were analyzed using Image J, with each gel containing 
both wild-type and heterozygous samples to allow direct measurement and comparison. ȕ-actin 
was used as a loading control also measured on each gel. Protein bands were quantified, 
normalized to ȕ-actin levels and then represented as % of control.  
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Immunohistochemistry 
For immunohistochemistry, sections obtained from mice described in Chapter 2 were stained and 
assessed in this study. For immunohistochemistry, 2 (n = 5) and 6 (n = 5) month old Nedd4
heterozygous and wild-type littermates (n = 4, n = 5 and n = 3, respectively) were used. Frozen 
50μm thick free-floating coronal sections were incubated with primary antibodies. The following 
antibodies were used: 
Antibody Function Dilution Manufacturer 
Mouse anti-NeuN Neuronal marker 1/1000 Merck-Millipore
Mouse anti-MAP2 MAP2 protein (dendritic marker) 1/1000 Sigma 
Rabbit anti-Nedd4 Nedd4 protein 1/1000 Abcam 
Rabbit-anti GluR1 GluR1 subunit of AMPARs 1/1000 Merck-Millipore
Primary antibodies were visualized with Alexa-conjugated secondary antibodies, mounted using 
Prolong-Gold with DAPI mounting medium (Invitrogen). Stained sections were visualized using 
a Nikon C1 confocal microscope using a 488nm argon and 543nm HeNe laser (Nikon Group, 
Tokyo, Japan). Images were acquired using a 40x Plan-Apochromat oil immersion objective. All 
images were captured and analyzed using Nikon Elements software. Images were acquired from 
the hippocampus and amygdala. The hippocampus was further subdivided into the dorsal and 
ventral portions using published delineations (Fanselow et al., 2010) (Figure 4.6).  
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Figure 4.6. Schematic illustration of delineation between dorsal and ventral portions of the 
hippocampus. Adapted from (Franklin et al., 2007). 
Long-term potentiation (LTP) recordings 
Electrophysiological recordings of LTP were conducted in whole brain slices. Brain slices at 
300ȝm thickness were obtained using a vibratome.  LTP was determined by recording fEPSPs in 
the stratum radiatum layer of the CA1 region of the hippocampus. A glass electrode filled with 
artificial cerebrospinal fluid (125 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 1 mM MgCl2, 25 
mM NaHCO3, 10 mM glucose and 2.5 mM CaCl2) was placed in the CA1 region with an 
Ag/AgCl stimulating electrode placed in the Shaffer collateral positioned toward the CA3 region. 
The potentials were amplified using an Axoclamp 2B, were pass-filtered at 1 Hz-3 kHz and 
digitized at 10 kHz (Digidata 1322A, Clampex 9.2 software, Axon instruments USA). Stimuli 
were delivered very 20 sec at varying amplitudes to produce an input-output (I/O) curve per slice. 
To determine LTP, fEPSPs that were approximately one-third of the spiking amplitude of the I/O 
curve were used and a single fEPSP recorded very 20 sec for at least 20 min in order to obtain a 
stable baseline. Four tetanic bursts (each consisting of 100 Hz stimulation) were applied for 1 sec 
followed by a 20 sec rest period between bursts, after which a single stimulus was applied very 
20 sec for 2 hours. LTP responses were normalized to the average of the baseline responses, and 
the fEPSPs analyzed in terms of their maximum rate of rise using seven-point smoothing. 
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Statistics 
For Morris water maze, the learning curve was analyzed using one-way repeated measures 
ANOVA comparing latencies to enter the home quadrant between Nedd4 heterozygous mice and 
wild-type controls. For memory probe parameters of MWM, Y-maze, elevated plus maze, PPI, 
Western blot analysis and LTP recordings an unpaired-Student’s t-test was used to statistically 
compare the Nedd4 heterozygous mice to their age-matched wild-type controls. Results were 
deemed significant when P < 0.05. 
4.3 RESULTS 
Y-maze 
Short-term spatial memory was assessed with the Y-maze where duration and entries into the 
novel during the second trial were measured. If short-term memory is preserved then no changes 
in novel arm parameters should be observed. No difference was found in duration spent in the 
novel (2 months, wt: 83.0 ± 3.3 sec; n = 8 and het: 85.4 ± 4.9 sec; n = 14; P = 0.74 and 6 months, 
wt: 88.0 ± 4.3 sec; n = 10 and het: 81.6 ± 5.2 sec; n = 10; P = 0.77) or familiar arms (2 months, 
wt: 123.7 ± 5.3 sec; n = 8 and het: 129.9 ± 8.2 sec; n = 14 sec; P = 0.60 and 6 months, wt: 156.5 
± 5.2 sec; n = 10 and het: 161.7 ± 5.6 sec; n = 10; P = 0.83) (Figure 4.7A and B, respectively). 
The percentage of time spent in the novel over the 5 minutes trial was also assessed, and no 
difference was found between Nedd4 heterozygous mice and wild-type controls at both 2 and 6 
months of age (2 months, wt: 50.1 ± 1.8 %; n = 8 and het: 52.8 ± 2.8 %; n = 14; P = 0.51 and 6 
months, wt: 29.3 ± 1.4 %; n = 10 and het: 27.2 ± 1.7 %; n = 10; P = 0.77) (Figure 4.7C and D, 
respectively).  
The number of entries into novel and familiar arms at 2 months of age, showed a decrease in the 
familiar arms by Nedd4 heterozygous (wt: 27 ± 2; n = 8 and het: 22 ± 2; n = 14, P = 0.05) mice 
compared to their wild-type controls, and no difference observed in the novel arm (wt: 17 ± 2; n 
= 8 and het: 16 ± 1; n = 14; P = 0.61) (Figure 4.8A). At 6 months old no difference was seen in 
the number of entries between Nedd4 heterozygous mice and wild-type controls in both novel 
(wt: 20 ± 3; n = 10 and het: 18 ± 3; n = 10; P = 0.94) and familiar arms (wt: 33 ± 4; n = 10 and 
het: 32 ± 3; n = 10; P = 0.81) (Figure 4.8B). 
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The latency to enter the novel arm can also be a useful indicator of short-term spatial integrity. In 
2 months old Nedd4 heterozygous mice the latency to enter the novel arm (wt: 5.2 ± 1; n = 8 and 
het: 10.0 ± 4; n = 14 sec; P = 0.05) was increased (Figure 4.9A). At 6 months of age, there was 
no difference in the latency to enter the novel arm in Nedd4 heterozygous mice compared to their 
age matched wild-type controls (wt: 9.8 ± 5.4; n = 10 and het: 14.7 ± 5.4 sec; n = 10: P = 0.53) 
(Figure 4.9B). 
Overall data obtained from the Y-maze showed that no impairment in short-term memory was 
evident in Nedd4 heterozygous mice at both 2 and 6 months of age. 
Figure 4.7. Y-maze showing duration in novel and familiar arms in 2 month and 6 month Nedd4
heterozygous mice (+/-) and age-matched wild-type controls (+/+) (A and B, respectively) and 
percentage time spent in novel arm in 2 month (C) and 6 month (D) old Nedd4 heterozygous and 
age-matched wild-type mice. Data represented as mean±SEM. 
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Figure 4.8. No difference in number of entries between Nedd4 heterozygous mice (+/-) and age-
matched wild-type controls (+/+) at both 2 (A) and 6 (B) months of age. Data represented as 
mean±SEM. 
Figure 4.9. Latency to enter the novel arm was not different between Nedd4 heterozygous (+/-) 
mice and age-matched wild-type controls (+/+) at both 2 (A) and 6 (B) months of age. Data 
represented as mean±SEM. 
Morris Water Maze 
Learning Phase 
The first phase involves the evaluation of time spent locating a hidden platform and can 
determine whether learning is affected. With time, normal learning process results in a decrease 
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in time to reach the platform. In Nedd4 heterozygous mice at 2 months of age, a significant 
increase in time taken to find the hidden platform was observed (Figure 4.10). This was evident 
at day 2 (wt: 76 ± 8; n = 7 and het: 79 ± 7 sec; n = 13, P = 0.01), day 4 (wt: 41 ± 11; n = 7 and 
het: 75 ± 9 sec; n = 13, P = 0.03) and day 6 (wt: 27 ± 5; n = 7 and het: 65 ± 10 sec; n = 13, P = 
0.007), with a modest increases on days 3 (wt: 44±9; n=7 and het: 66±9 sec; n=13) and day 5 (wt: 
35±7; n=7 and het: 58±11 sec: n=13) and no difference at day 1 (wt: 76 ± 8; n = 7 and het: 79 ± 7 
sec; n = 13), and. This data, suggests that Nedd4 heterozygous mice display a significant learning 
impairment at 2 months of age 
At 6 months of age, no impairment in learning was evident. In fact, there was no significant 
difference in time taken to locate the platform, with only a modest impairment at day 6 (wt: 35.7 
± 8.7; n = 7 and het: 56.0 ± 7.4 sec; n = 10, P = 0.06) (Figure 4.11). The data did suggest 
however that the learning profile of wild-type was affected in particular during day 4 and 5.  
Path length measured by distance travelled was unchanged between Nedd4 heterozygous mice 
and age-matched wild-type controls at both 2 and 6 months of age (Figure 4.12).  
Figure 4.10. Learning phase showing a significant increase in the latency to find hidden platform 
in 2 month old Nedd4 heterozygous (closed, +/-) mice relative to wild-type controls (open, +/+) 
mice over six trial days. Data represented Mean ± SEM of average of four trials per day. * < 0.05 
One way RM ANOVA. 
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Figure 4.11. No difference in latency to find the hidden platform between 6 month old Nedd4
heterozygous (closed, +/-) mice relative to wild-type controls (open, +/+) mice over six trial days. 
Data represented Mean ± SEM of average of four trials per day. 
Figure 4.12. Distance was not changed in Nedd4 heterozygous mice (+/-) compared to wild-type 
controls (+/+) at both 2 and 6 months of age. Data represented as Mean ± SEM.  
Probe Trial 
2 month cohort 
In the 2 months old cohort, latency to enter the home quadrant was significantly increased in the 
Nedd4 heterozygous mice (wt: 6.4 ± 1.3 sec; n = 8 and het: 23.0 ± 5.4 sec; n = 13, P = 0.03) 
suggesting that long-term spatial memory was impaired (Figure 4.13A). Nedd4 heterozygous 
mice also showed a significant decrease in the number of entries in the home quadrant (wt: 8 ± 1; 
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n = 8 and het: 5 ± 1; n = 13, P = 0.051 (Figure 4.13B) accompanied with a decrease in the time 
spent in the home quadrant that did not reach significance (wt: 16 ± 2; n = 8 and het: 11 ± 2; n = 
13, P = 0.1 (Figure 4.13C). When the platform zone was examined there were no differences in 
the latency to enter (wt: 20.9 ± 7.2; n = 8 and het: 33.4 ± 5.6 sec; n = 12), number of entries (wt: 
2.0 ± 1; n = 8 and het: 2 ± 1; n = 12) or duration (wt: 1.2 ± 0.4; n = 8 and het: 1.1 ± 0.3; n = 12) 
(Figure 4.13D, E and F, respectively).  
6 month cohort 
In the 6 months old cohort, there was no difference in the latency to enter the home quadrant 
between the Nedd4 heterozygous and their age matched wild-type controls (wt: 19.3 ± 6.8; n = 7 
and het: 27.7 ± 6.9 sec; n = 10) (Figure 4.14A). Furthermore, there was no difference in the 
number of entries (wt: 6 ± 1; n = 7 and het: 3 ± 1; n = 10) (Figure 4.14B) or duration (wt: 13.0 ±
2.2; n = 7 and het: 12.3 ± 3.1 sec; n = 10) (Figure 4.14C). When the platform zone parameters 
were examined, again no difference was found in the latency to enter (wt: 39.1 ± 7.7; n = 7 and 
het: 40.0 ± 7.0 sec; n = 10) (Figure 4.14D), number of entries (wt: 2 ± 1; n = 7 and het: 1 ± 0.3; n 
= 10) (Figure 4.14E) or duration (wt: 1.0 ± 0.4; n = 7 and het: 0.5 ± 0.2; n = 10) (Figure 4.14F). 
Overall there did not appear to be any impairment in the capacity to develop and maintain long-
term spatial memory in the Nedd4 heterozygous mice compared to their age-matched wild-types 
at 6 months of age.  
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Figure 4.12. At 2 months of age, a significant increase in latency to enter the platform quadrant 
was seen in Nedd4 heterozygous (+/-) mice compared to wild-type controls (+/+) (A). The 
number of entries into the home quadrant was also significantly increased in Nedd4 
heterozygotes compared to wild-type controls (B). No significant difference was observed in the 
time spent in the home quadrant (C). No differences were seen in latency to enter (D), number of 
entries (E) or time spent in the platform zone (F). Data represented as Mean ± SEM. * P < 0.05, 
assessed by unpaired Student’s t-test 
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Figure 4.13. At 6 months of age, no difference was seen in latency to enter the platform quadrant 
between Nedd4 heterozygous (+/-) mice compared and wild-type controls (+/+) (A). The number 
of entries into the home quadrant was significantly decreased in Nedd4 heterozygotes compared 
to wild-type controls (B). No significant difference was observed in the time spent in the home 
quadrant (C). No differences were seen in latency to enter (D), although a small reduction was 
observed in the number of entries (E) and time spent in the platform zone (F) however this did 
not reach significance. Data represented as Mean ± SEM. P < 0.05, assessed by unpaired 
Student’s t-test. 
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Elevated Plus Maze 
When anxiety measures were assessed, Nedd4 heterozygous mice at 2 month of age showed a 
significant increase in time spent in the closed (safe) arm (wt: 119.1 ± 8.7; n = 8 and het: 153.9 ±
10.9; n = 14, P = 0.04) and reduced time spent in the open (unsafe) arm (wt: 28.3 ± 7.2; n = 8 and 
het: 17.5 ± 6.5; n = 14, P = 0.30) of the maze (Figure 4.15A). This indicates that Nedd4
heterozygous mice have an increase in anxiety related behaviours compared to wild-type 
controls. Nedd4 heterozygous mice entered the open arm less (wt:  6 ± 1; n = 8 and het: 4 ± 1; n = 
14; P = 0.31) frequently than wild-type controls, however this did not reach significance (Figure 
4.15B). Time spent in the centre zone of the maze was also assessed, and no differences were 
evident P = 0.11) (Figure 4.15C). In addition, distance traveled (wt: 1392 ± 83; n = 8 and het: 
1309 ± 69; n = 14) and velocity (wt: 4.7 ± 0.3; n = 8 and het: 4.4 ± 0.2; n = 14) was unchanged 
(Figure 4.15D and E).  
At 6 months of age, no differences in duration, number of entries, time spent in centre zone, 
distance or velocity was apparent between Nedd4 heterozygous mice and wild-type controls 
(Figure 4.16). These findings suggest that anxiety related behaviours were absent in the Nedd4
heterozygous mice at this age. 
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Figure 4.14. A significant increase in time spent in the closed arm was observed in 2 month old 
Nedd4 heterozygous (+/-) mice compared to wild-type controls (+/+), accompanied with a 
marked decrease in the open arm (A). No significant difference was evident in number of entries 
in the closed or open arms (B). Time spent in the centre zone (C), distance travelled (D) and 
velocity (E) were also unchanged between the heterozygotes and wild-type controls. Data 
represented Mean ± SEM. *, P < 0.05 unpaired Student’s t-test. 
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Figure 4.15. No difference was observed in 6 month old Nedd4 heterozygous mice (+/-) 
compared to wild-type controls (+/+) in time spent in open versus closed arm (A), number of 
entries in open versus closed arms (B), time spent in the centre zone (C), distance travelled (D) or 
velocity (E). Data represented Mean ± SEM. 
A B C 
D E 
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Assessment of ethological parameters
Due to the observed change in anxiety in the 2 month cohort, ethological parameters were also 
investigated. These include; locomotor and vertical activity such as total number of entries 
(closed and open), and number of rearing events during the testing period. A slight reduction was 
observed in overall number of entrances in both open and closed arms of the maze (wt: 28.3 ±
2.0; n = 8 and het: 22.8 ± 1.8; n = 14; P = 0.07) (Figure 4.17A) but no differences in number of 
rearing events (wt: 15 ± 2; n = 8 and het: 14 ± 2; n = 14) were evident (Figure 4.17B).  
Risk assessment and decision making can also provide further information into thought 
processing that may underlie anxiety behaviours and to do this manual scoring of the number 
protected, unprotected and total (protected and unprotected) stretch attend postures was assessed. 
The number of protected (wt: 26 ± 3; n = 8 and het: 23 ± 2; n = 11), unprotected (wt: 7 ± 1; n = 8 
and het: 5 ± 2; n = 11) and total (protected and unprotected) stretch attend postures (wt: 33 ± 3; n 
= 8 and het: 28 ± 2; n = 11) (Figure 4.17C) were not different between the Nedd4 heterozygous 
mice and their wild-type controls. Closed arm returns can also provide important information on 
explorative decision making in mice, where they explore the open arms however do not commit 
to entry in the open arms. A modest decrease in the number of closed arm returns in Nedd4
heterozygous (wt: 5 ± 2; n = 8 and het: 2 ± 1; n = 11, P = 0.065) was observed (Figure 4.17D). 
Interestingly, three Nedd4 heterozygous mice never entered the open arm at all. Overall, analysis 
from ethological scoring revealed that risk making and decision-making was not altered in Nedd4
heterozygous mice. Ethological parameters were not assessed in the 6 month cohort as there was 
no change in anxiety behaviours. 
This along with no change in distance travelled and velocity shows that general activity in 
exploring the maze was not affected in the Nedd4 heterozygous mice compared to wild-type 
controls which is comparative to locomotor activity measurements in Chapter 2. 
219
Figure 4.16. A marked reduction in total arm entries was evident in the 2 month old Nedd4
heterozygous (+/-) mice compared to wild-type controls (+/+) (A). No difference in rearing 
events (B), or number of stretched attenuated responses in protected, unprotected or total (C). A 
slight reduction in closed arm returns was also present in Nedd4 heterozygous mice (D). Data 
represented Mean ± SEM. #, P = 0.07 unpaired Student’s t-test.
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Pre-pulse inhibition 
First, demonstration of auditory responses at each of the different auditory stimuli was conducted 
in the mice to determine that hearing was not impaired in both 2 month (NS wt:  8 ± 3; and het: 5 
± 2, 4dB wt:  29 ± 5 and het: 28 ± 4, 8dB wt: 41 ± 3 and het: 55 ± 9, 16dB wt: 77 ± 9 and het: 78 
± 12 and 115dB wt:  95 ± 10 and het: 109 ± 16; with n= 7 and n = 10 respectively) (Figure 
4.18A) and 6 month (NS wt: 18.4 ± 3.6 and het: 13.7 ± 1.8, 4dB wt: 82.7 ± 24.9 and het: 52.2 ±
8.9, 8dB wt: 74.9 ± 21.0 and het: 44.2 ± 7.1, 16dB wt: 51.7 ± 18.0 and het: 30.0 ± 4.9, n = 10 and 
n = 9 respectively). At 6 months of age Nedd4 heterozygous showed a significant decrease in 
startle response to the test stimuli of 115dB (wt: 133.8 ± 23.0 and het: 76.1 ± 14.6, P = 0.05) 
(Figure 4.18B). Mice that did not respond to a startle response were assumed to have an auditory 
deficit as they did not respond beyond base line levels and were excluded from analysis. A total 
of two Nedd4 heterozygous and two wild-type littermates at 2 months of age, and one Nedd4
heterozygous mouse at 6 months of age were therefore excluded from analysis.  
Figure 4.17. No difference in startle was observed in response to no startle (NS), 4 dB, 8 dB, 16 
dB and 115 dB between 2 month old Nedd4 heterozygous (+/-) mice and wild-type controls (+/+) 
(A). At 6 months of age, no significant differences were observed to all stimuli, however a 
modest reduction was present in Nedd4 heterozygotes to the 115 dB stimulus (B). Data 
represented as Mean ± SEM. * P = 0.05 unpaired Student’s t-test. 
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Next the startle responses to the test stimulus within the four block trials (response to pre-pulse 
stimulus, 115dB) were evaluated. In the 2 month cohort there was a similar response with 
decreased with time as expected between Nedd4 heterozygous and wild-type controls  (block 1 
wt: 107 ± 10 and het: 141 ± 26, block 2 wt:  103 ± 15 and het: 112 ± 18, block 3 wt: 84 ± 9 and 
het: 86 ± 11 and block 4 wt: 86 ± 13; and het: 97 ± 17; n=7 and n=10 respectively) (Figure 
4.19A). In the 6 month cohort however, a significant decrease in baseline responses were seen 
within the four block trials in the Nedd4 heterozygous mice compared to wild-type controls 
(block 1 wt: 143 ± 28 and het: 92 ± 17, P = 0.15, block 2 wt: 132 ± 23 and het: 69 ± 13, P = 0.03, 
block 3 wt: 133 ± 24 and het: 73 ± 18, P = 0.07 and block 4 wt: 128 ± 20 and het: 70 ± 13, P = 
0.03; n = 10 and n = 9 respectively) (Figure 4.19B). 
Figure 4.18. Startle responses over four block of 115 dB stimuli were not different between 2 
month old Nedd4 heterozygous (+/-) mice compared to wild-type controls (+/+) (A). Startle 
responses in 6 month old Nedd4 heterozygous mice were significantly reduced compared to wild-
types (B). Data represented as Mean ± SEM. # P = 0.07 and * P < 0.05 unpaired Student’s t-test. 
To determine the percentage of inhibition when a pre-pulse stimulus was also applied we used the 
following formula as previously described. %PPI= (SR (115dB)-SR (4,8 or 
16dB)/SR(115dB)*100. When we examined % PPI to the test stimulus (115 dB) following each 
of the different pre-pulse auditory stimuli (i.e 4, 8 and 16dB) no difference between Nedd4
heterozygous and wild-type controls at 2 months of age (4dB wt:  19 ± 3 and het: 29 ± 4, 8dB wt:
54 ± 5 and het: 49 ± 6 and 16dB wt: 68 ± 6 and het: 71 ± 5; n=7 and n=10 respectively) was 
apparent (Figure 4.20A). In the 6 month cohort, no significant difference was observed when % 
A B 
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PPI was compared between Nedd4 heterozygous and wild-type controls (4dB wt: 41 ± 10 and 
het: 31 ± 8, 8dB wt: 47 ± 8 and het: 35 ± 6 and 16dB wt: 63 ± 6 and het: 50 ± 6) (Figure 4.20B).  
Figure 4.19. Percentage of pre-pulse inhibition (%PPI) was not significantly different between 
Nedd4 heterozygous (+/-) mice and wild-type controls (+/+) at both 2 (A) and 6 months of age 
(B). Data represented as Mean ± SEM.
This data suggests that Nedd4 heterozygous mice at both 2 and 6 months of age had no alterations 
in filtering of sensory information.  
Nedd4 expression in the CNS associated with cognitive behaviours 
Hippocampus 
Nedd4 expression in the hippocampus was assessed including the following subdivision; CA1, 
CA2, CA3 and DG regions. Hippocampus was captured at location of -1.22 from Bregma and 
mouse brain atlas used as a guide (Franklin et al., 2007). Nedd4 was ubiquitously expressed in all 
layers of the hippocampus with highest level evident surrounding the cell bodies of pyramidal 
neurons, which were stained using the neuronal marker NeuN. Furthermore, all subdivisions 
showed similar patterns of expression, with a reduction in staining intensity seen in the 
heterozygous mice relative to controls in CA1, CA2, CA3 and DG (Figure 4.21, 4.22, 4.23, and 
4.24, respectively). Within the 6 month brains, Nedd4 staining intensity appeared higher, which 
may be due to differing levels of fixation during the perfusion process. The brains from the 2 and 
6 months cohorts were perfused and processed at different time, and although the 
A B 2 month 6 month 
223
immunohistochemical method were identical, differences in fixative cannot be excluded and may 
explain the increased brightness in these sections. Nevertheless, all comparisons were made 
between Nedd4 heterozygous mice relative to age-matched wild-type controls.  
Due to the prominence of Nedd4 in dendrites of Purkinje neurons, MAP2 staining was used to 
determine whether Nedd4 is also highly expressed in the dendrites of pyramidal neurons of the 
hippocampus. Surprisingly, this did not appear as pronounced as dendrites of Purkinje neurons of 
the cerebellum (Figure 4.25).  
Figure 4.20. Within the CA1 region of the hippocampus, Nedd4 (red) was found to be most 
highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). (+/-) Nedd4
heterozygous and (+/+) wild-type controls. Scale bar represents 50ȝm. 
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Figure 4.21. Within the CA2 region of the hippocampus, Nedd4 (red) was found to be most 
highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). (+/-) Nedd4
heterozygous and (+/+) wild-type controls. Scale bar represents 50ȝm. 
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Figure 4.22. Within the CA3 region of the hippocampus, Nedd4 (red) was found to be most 
highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). (+/-) Nedd4
heterozygous and (+/+) wild-type controls. Scale bar represents 50ȝm.
226
Figure 4.23. Within the DG region of the hippocampus, Nedd4 (red) was found to be most highly 
expressed surrounding cell bodies of pyramidal neurons (NeuN, green). (+/-) Nedd4
heterozygous and (+/+) wild-type control. Scale bar represents 50ȝm.
227
Figure 4.24. MAP2 (green) staining of dendrites within the hippocampus, showed some co-
localization with Nedd4 (red), in the CA1, CA2, CA3 and DG regions of a 2 month wild-type 
mouse. Scale bar represents 50ȝm.
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Nedd4 expression within the dorsal and ventral compartments of the hippocampus 
Dorsal Hippocampus 
In the CA1 region, the pyramidal layer showed disorganization and neurons appeared dispersed 
in Nedd4 heterozygous mice compared to wild-type controls, which was evident at both 2 and 6 
months of age (Figure 4.26). Although this observation was also made in the CA3 region, it was 
less prominent (Figure 4.27).  
Figure 4.25. Within the dorsal CA1 (CA1) region of the hippocampus, Nedd4 (red) was found to 
be most highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). A 
dispersion of the pyramidal layer neurons (arrow) was evident in the Nedd4 heterozygous mice 
(+/-) at both 2 and 6 months of age relative to wild-type controls (+/+). Scale bar represents 
50ȝm. 
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Figure 4.26. Within the dorsal CA3 (dCA3) region of the hippocampus, Nedd4 (red) was found 
to be most highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). (+/-) 
Nedd4 heterozygous and (+/+) wild-type controls. Scale bar represents 50ȝm.
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Ventral Hippocampus 
In the ventral hippocampus the pyramidal layer thickness appeared reduced in the Nedd4 
heterozygous mice compared to wild-type controls in the CA1 region (Figure 4.28), and 
increased in the CA3 region (Figure 4.29).  
Figure 4.27. Within the ventral CA1 (vCA1) region of the hippocampus, Nedd4 (red) was found 
to be most highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). A 
reduction in the thickness pyramidal layer (arrow) was evident in the Nedd4 heterozygous mice 
(+/-) at both 2 and 6 months of age relative to wild-type controls (+/+). Scale bar represents 
50ȝm.
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Figure 4.28. Within the ventral CA3 (vCA3) region of the hippocampus, Nedd4 (red) was found 
to be most highly expressed surrounding cell bodies of pyramidal neurons (NeuN, green). The 
pyramidal layer appeared thicker (arrow) in the Nedd4 heterozygous mice (+/-) at both 2 and 6 
months of age relative to wild-type controls (+/+). Scale bar represents 50ȝm. 
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Amygdala 
Since the amygdala is an important region crucial for anxiety related behaviours, Nedd4 
expression was examined. Nedd4 was ubiquitously expressed and found to surround NeuN 
positive neurons (Figure 4.30).  
Figure 4.29. In the central nucleus of the amygdala Nedd4 (red) was ubiquitously expressed, 
with no co-localization with neurons stained with the neuronal marker NeuN (green). (+/-) Nedd4
heterozygous compared and (+/+) wild-type controls. Scale bar represents 50ȝm.
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Hippocampal Long-term potentiation (LTP) 
Whole brain recordings showed a non significant effect of group F(1,5) = 0.82, P = 0.41 or group 
by time F(1,5) = 0.912, P = 0.38. However, when individual time points were assessed a decrease 
in the LTP potentiation from the hippocampus of 2 month old Nedd4 heterozygous mice relative 
to the wild-type controls by 120 minutes post tetanic stimulus application (wt: 1.19 ± 0.07; n = 3 
and het: 0.80 ± 0.07; n = 4, P = 0.01) (Figure 4.31). 
Figure 4.30. Fold potentiation response to tetanic stimuli (TS at time = 0) were significantly 
reduced in Nedd4 heterozygous (+/-) mice compared to wild-type controls (+/+). Data 
represented as Mean ± SEM. * P < 0.05 unpaired Student’s t-test. 
-50 0 50 100 150
0
1
2
3
4
Time (min)
P
ot
en
tia
tio
n
(F
ol
d)
(+/+)
(+/-)
*
TS
234
Molecular targets associated with cognition 
GluR1 containing AMPARs 
Due to the abnormalities seen in the 2 month old Nedd4 heterozygous mice such as impaired 
long-term spatial learning and memory levels of GluR1 were measured by Western blot, and no 
differences were seen (Figure 4.32). GluR1 levels were not measured in 6 month old cohorts, as 
no differences in cognitive behaviours became evident. 
Figure 4.31. Western blot analysis showed no differences in GluR1 levels in hippocampal lysates 
obtained from 2 month old Nedd4 heterozygous (+/-) mice and wild-type controls (+/+). Data 
represented as Mean ± SEM. 
GluR1 expression in the hippocampus 
GluR1 expression was assessed in the hippocampus from 2 and 6 month Nedd4 heterozygous 
mice and age-matched wild-type controls. Importantly, GluR1 staining showed similar pattern of 
expression as Nedd4, in that it is ubiquitously expressed and shows high expression surrounding 
the cell bodies of neurons within the pyramidal cell layer. No obvious change in staining intensity 
was evident in the heterozygous mice relative to wild-type controls at both time points, 
supporting the findings that GluR1 levels are not changes measured by Western blot. Similar 
pattern of expression was evident in the CA1, CA2, CA3 and DG regions (Figure 4.33, 4.34, 
4.35 and 4.36, respectively).  
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Figure 4.32. In the CA1 region of the hippocampus, GluR1 (red) was found to be most highly 
expressed surrounding cell bodies of pyramidal neurons (NeuN, green). No difference in staining 
intensity was evident between Nedd4 heterozygous mice (+/-) at both 2 and 6 months of age 
relative to wild-type controls (+/+). Scale bar represents 50ȝm. 
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Figure 4.33. In the CA2 region of the hippocampus, GluR1 (red) was found to be most highly 
expressed surrounding cell bodies of pyramidal neurons (NeuN, green). No difference in staining 
intensity was evident between Nedd4 heterozygous mice (+/-) at both 2 and 6 months of age 
relative to wild-type controls (+/+). Scale bar represents 50ȝm. 
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Figure 4.34. In the CA3 region of the hippocampus, GluR1 (red) was found to be most highly 
expressed surrounding cell bodies of pyramidal neurons (NeuN, green). No difference in staining 
intensity was evident between Nedd4 heterozygous mice (+/-) at both 2 and 6 months of age 
relative to wild-type controls (+/+). Scale bar represents 50ȝm. 
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Figure 4.35. In the DG region of the hippocampus, GluR1 (red) was found to be most highly 
expressed surrounding cell bodies of pyramidal neurons (NeuN, green). No difference in staining 
intensity was evident between Nedd4 heterozygous mice (+/-) at both 2 and 6 months of age 
relative to wild-type controls (+/+). Scale bar represents 50ȝm. 
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4.4 DISCUSSION 
Nedd4 is important during development of axons and dendrites, but recently evidence emerged 
supporting a role for Nedd4 in the mature brain. Nedd4 was shown to regulate AMPA receptors 
(AMPAR) at the synapse in an activity dependent manner (Schwarz et al., 2010), however, the in 
vivo implications remained unknown. As already shown, the regulation of GluR1 played an 
important role in gait and motor co-ordination, with Nedd4 heterozygous mice showing 
significant gait abnormalities. AMPAR are also crucial at synapses within the hippocampus and 
amygdala to regulate cognitive behaviours.  
This study investigated cognitive behaviours in Nedd4 heterozygous mice and examined regional 
and cellular expression within brain regions necessary for cognition. Learning and memory are 
important functions in everyday life and understanding the molecular machinery that underlie 
these processes are fundamental. Short-term memory was found to be intact in Nedd4
heterozygous mice at both 2 and 6 months of age. Long-term learning and memory however were 
significantly impaired in the 2 month old Nedd4 heterozygous mice relative to age-matched wild-
type controls. The fact that short term is intact but long term memory is affected is supported by 
studies showing that ubiqutination regulates the consolidation of short into long-term memories 
(Artinian et al., 2008). Part of the consolidation process requires changes at the synapse where 
strengthening occurs between the pre and post-synaptic compartments, including de novo protein 
synthesis but also protein degradation (Artinian et al., 2008).  
Long-term spatial learning and memory were found not to be significantly impaired in the 6 
month old Nedd4 heterozygous mice. Although these findings were initially surprising, closer 
inspection of the data indicated that the wild-type mice did not display normal learning levels that 
were seen in the 2 month cohort. Nevertheless, by day 6 a modest increase in latency to find the 
hidden platform became evident, however significance was not reached.  
Initial interpretation was that a delay in hippocampal development may have occurred and this 
contributed to the difference in long-term spatial learning and memory between the 2 and 6 
month Nedd4 heterozygotes relative to the age-matched wild-type controls. Although Nedd4 was 
found to be ubiquitously expressed in all layers of the hippocampus, and within the four main 
regions; CA1, CA2, CA3 and DG including the dorsal and ventral segments. No evidence for 
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delayed development was found. For example, an increase in the thickness of the pyramidal layer 
was found in dCA1 and vCA3 regions with a reduced layer thickness found in vCA1 region in 
Nedd4 heterozygous mice relative to wild-type controls. These differences however were 
apparent at both 2 and 6 months of age, suggesting that developmental issues are unlikely to 
explain the behavioural differences observed. Nedd4 expression was not quantified from 
immunohistochemical sections, as it is widely accepted that immunohistochemistry is semi-
quantitative (Taylor et al., 2006). Hippocampal tissue will be collected for Western blot analysis 
and future studies should measure Nedd4 levels in this important brain region. Layer thickness 
was not quantified due to the inability to accurately match sections from respective anatomical 
regions for section stained with Nedd4. 
On a molecular level, the combination of GluR containing subunits may be modified at this later 
stage of adulthood that may allow learning and memory to occur as an adaptive mechanism. To 
better understand the contribution of GluR subunits to AMPAR function and thus synaptic 
plasticity, it is important to consider how the different subunit combinations can affect the 
synapse. AMPAR are composed of four subunits (GluR1, GluR2, GluR3 and GluR4), forming 
tetramers comprised of different combinations. The composition can affect AMPAR 
permeability, for instance the presence or absence of GluR2 subunit can alter permeability to 
calcium ions. The lack of GluR2 makes the AMPARs permeable to cations including sodium, 
calcium and potassium, with the presence of GluR2 resulting in impermeability to calcium. The 
modulation of AMPARs by trafficking (including endocytosis, recycling and re-insertion) to the 
plasma membrane is also dependent upon subunit composition. Although GluR1 and GluR2 both 
play an important role in synaptic plasticity, the trafficking of AMPAR containing these subunits 
are undertaken by two pathways; the regulated and constitutive (Malinow et al., 2000; Parwani et 
al., 2000). 
In the regulated pathway, GluR1 containing AMPARs are trafficked to the plasma membrane in 
an activity dependent manner, and require NMDA receptor activation (Hayashi Y et al., 2000). 
This pathway then is crucial for long-term potentiation (LTP), and is inactive under basal 
conditions (Kessels et al., 2009). This regulatory pathway is important for the formation of new 
memories (Malinow et al., 2000). The constitutive pathway involves AMPAR that lack GluR1 
subunit, usually composed of GluR2/3 combination. These AMPARs replace GluR1 containing 
receptors in an activity independent manner, under basal conditions that function to preserve total 
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numbers of AMPARs. This pathway is important for the maintenance of new memories 
(Malenka, 2003). 
It may be possible that in the 6 month old Nedd4 heterozygous mice, synapses are saturated with 
GluR1 containing AMPARs due to decreased ubiquitination and thus endocytosis. This reduction 
in ubiquitination could be as a result of decreased Nedd4 levels but needs to be investigated. 
Changes in ubiquitination and GluR1 plasma levels could allow for the formation of new 
memories but disrupt the maintenance of these memories due to the loss of GluR2/3 replacement, 
which was not assessed in these mice. Future studies could examine the longevity of memory 
formation by repeating the probe trial several times too examine how well the maintenance of 
memory is preserved. Furthermore, examination of GluR2 and GluR3 levels may also shed light 
onto whether trafficking is altered. Finally, LTP recordings should also be performed in older 
mice (i.e 6 months) to examine whether changes to synaptic plasticity occurs. 
Due to the importance of GluR1 containing AMPARs for long-term memory, LTP was examined 
in whole brains slices from 2 month old Nedd4 heterozygous mice and age-matched wild-type 
controls. LTP is the molecular mechanism that allows for synaptic changes to occur and long-
term memories to develop. LTP was significantly reduced in Nedd4 heterozygous mice relative to 
wild-type controls. This provides strong evidence that a reduction in Nedd4 levels is not only 
sufficient to produce disruption on long-term learning and memory, but indicates that GluR1 
level mediated processes are also altered. Total GluR1 levels were measured from the 
hippocampi obtained from 2 month Nedd4 heterozygous mice and were not different relative to 
wild-type controls. Immunohistochemical analysis of GluR1 within the hippocampus showed 
similar patterns of expression between GluR1 and Nedd4, which is expected since these two 
proteins are known to directly interact. GluR1 staining intensity did not appear to have changed 
in the Nedd4 heterozygous brains compared to wild-type controls supported by the Western blot 
findings.  This is not surprising, as GluR1 levels are altered in an activity dependent manner and 
thus total levels indicates that overall GluR1 levels are not changed. Future studies could examine 
the extent of trafficking, during LTP to confirm the contribution and impact of Nedd4 level 
reduction.  
Nedd4 heterozygous mice show an increase in anxiety behavoiurs at 2 months of age compared to 
wild-type controls, with no alteration observed in 6 month old heterozygotes. The interaction 
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between Nedd4 and GluR1 may also underlie the anxiety changes observed. Previous studies 
have shown a correlation between GluR1 levels anxiety measured by elevated plus maze (Xiang
et al., 2011).  The contribution of GluR1 to anxiety is controversial with discrepancies. For 
example, some studies have shown that deletions in GluR1 results in increased anxiety 
(Bannerman DM et al., 2004; Mead et al., 2006), other studies however suggest the opposite 
(Das et al., 2008). Further investigation is required to understand fully what contribution GluR1-
containing AMPARs to anxiety like behaviours. Nedd4 was found in both the ventral portion of 
the hippocampus and amygdala, two regions of the brain necessary for the processing of emotive 
behaviours. Within the amygdala, Nedd4 was found to be ubiquitously expressed surrounding 
NeuN positive neurons. Further work is necessary to examine anxiety behaviours further, which 
may include other behavioural tests such as open field, light dark test and potentially fear based 
learning. Data from this study simply suggests that Nedd4 may be important for the regulation of 
anxiety behaviour which may be due to altered GluR1 containing AMPARs. 
Sensory motor gating assessed using pre-pulse inhibition (PPI) was investigated to determine if 
any schizophrenia like behaviours were evident in these mice. Although deregulation of 
dopamine seems to be a main contributor to pathophysiology of schizophrenia, glutamate has 
also been suggested to be extremely important. Evidence for this mainly arise from animal 
studies where NDMA (glutamate) receptor antagonists such as phencyclidine or ketamine that 
stimulates psychosis (Krystal et al., 2005; Lahti et al., 1995). Due to the involvement of Nedd4 in 
regulation of glutamatergic AMPA receptors, it was necessary to investigate these behaviours. 
No difference PPI was evident in Nedd4 heterozygous mice at either 2 and 6 months of age. One 
subtle observation however, was the decrease in basal startle responses in the 6 month Nedd4
heterozygous mice. Since acoustic startle is a motor response to an unexpected stimulus, the 
decrease in basal startle responses may be due to underlying motor deficiency in the Nedd4
heterozygous mice. Further studies need to address whether any changes in the neuromuscular 
junction can impact on startle responses, such as reduced depolarization and reduced number of 
motor neuron that innervate skeletal muscle can have an impact on movement. Finally, hearing 
and changes in auditory pathways may also need to be investigated to determine if any changes 
are evident in the Nedd4 heterozygotes. Overall data from PPI testing showed no abnormal 
behaviours relating to sensory motor gating in Nedd4 heterozygous mice at both time points 
tested. 
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 This study is the first to examine cognitive behaviours in Nedd4 heterozygous mice and 
determine expression within regions of the CNS associated with these behaviours. In vivo
implication of Nedd4 loss include long-term spatial memory and learning deficits and increased 
anxiety behaviours. GluR1-containing AMPARs may again be a pivotal target contributing to 
these findings. Since LTP is considered the molecular mechanism for memory, and dependent on 
GluR1 subunits of AMPARs, LTP recordings from brain slices provided further evidence for 
Nedd4 in cognitive behavior, with significant reduction in LTP observed in the Nedd4 
heterozygous mice.  
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CHAPTER 5: NEDD4-2 IN COGNITIVE BEHAVIOUR 
5.1 RATIONALE AND BACKROUND 
Dopamine related motor behaviours were assessed in Nedd4-2 heterozygous mice due to the 
known interaction between Nedd4-2 and dopamine transporter (DAT). Nedd4-2 was expressed in 
medium spiny neurons of the striatum, which are enriched with D1 or D2 receptors. With D1 
receptors mediated signaling implicated to be involved in a range of cognitive functions, 
assessment in Nedd4-2 heterozygous mice was warranted. Furthermore, Nedd4-2 is able to 
regulate the neurotrophin receptor TrkA, which binds to nerve growth factor also essential for 
cholinergic neurotransmission affecting hippocampal function. 
Dopamine and cognition 
Learning and memory 
As already discussed the dopaminergic system is crucial for motor function and control, however 
dopaminergic pathways have also been implicated in cognitive function. These include learning 
and memory, hedonic reactions and motivation. For instance, associative learning involves the 
dorsal striatum and removal of dopamine can affect striatal based learning (Berke et al., 2000). 
As already discussed (Chapter 3), D1 receptors within the striatum are responsible for learning 
behaviours. Dopamine is largely involved in short-term memory, which integrates moment-to-
moment information with previous experiences (Packard et al., 1994). Studies have shown that 
antagonism of D1 receptors in the prefrontal cortex, can impair memory (Sawaguchi et al., 1994).  
Schizophrenia 
Dysregulation of dopamine also plays an important role in the pathophysiology of schizophrenia, 
with all antipsychotics targeting dopamine (D2) receptors. The original ‘dopamine hypothesis’ 
suggests that increases in dopamine contribute to the cause of schizophrenia (Packard et al., 
1994). Further evidence support this theory include exposure to amphetamines exacerbating 
symptoms of schizophrenia, but also inducing psychotic symptoms in healthy individuals 
(Connell, 1958), and drugs that deplete dopamine alleviate the symptoms (Connell, 1958). 
Although in Nedd4-2 heterozygous mice dopamine levels are reduced, it is unlikely that these 
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mice will display any schizophrenia like symptoms. PPI testing could provide some information 
on whether potential changes in dopamine manifest into sensory motor gaiting abnormalities. 
Dopamine and synaptic plasticity 
There is evidence showing that activation of glutamate and dopamine receptors in the striatum 
can produce long lasting modification of synaptic excitability. This is supported by 
morphological feature of the striatum where glutamatergic and dopaminergic boutons are in close 
proximity to dendrites of medium spiny neurons (Smith et al., 1990; Starr, 1995). Dopamine 
acting on striatal spiny neurons can affect synaptic plasticity in other brain areas including the 
hippocampus (Bourtculadze et al., 1994) and cerebral cortex (Law-Tho et al., 1995).  
Intracellular recordings of cortical activation produced excitatory post-synaptic potentials 
(EPSPs) that are largely mediated by AMPA receptors (Jiang et al., 1991). Repetitive stimulation 
of corticospinal fibres can induce both long-term potentiation (LTP) and long-term depression 
(LTD), and during this repetitive stimulation a dramatic release of both dopamine and glutamate 
is observed in producing striatal synaptic plasticity (Calabresi et al., 1992; Calabresi et al., 1990), 
with D1 and D2 receptors playing an essential role. By regulating DAT, Nedd4-2 may affect 
synaptic dopamine levels that can have an important role in striatal synaptic plasticity associated 
with a range of cognitive functions, which to date has not been investigated.  
Glutamate Transporters 
Glutamate as already discussed (Chapter 4) is essential for synaptic plasticity, underlying 
learning and memory. Nedd4-2 is able regulate membrane levels of glutamate transporters 
(EAAT1 and 2), and thus may be important in maintenance of normal glutamate levels. Although 
glutamate transporters are predominantly located on astrocytes, alterations in levels of these 
transporters may have an impact on levels of synaptic glutamate. For example, a decrease in 
transporter levels can result in reduced re-uptake in glutamate, leading to excessive levels of 
synaptic glutamate and vice versa.  
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Nedd4-2 and TrkA receptors 
The neurotrophins are growth factors important for the developing and mature nervous system 
(Huange et al., 2001). The basal forebrain cholinergic system, which is composed of medial 
septum, horizontal and vertical diagonal bands of Broca, and nucleus basalis of Meynert provide 
the major cholinergic input to the hippocampus and cerebral cortex (Schliebs et al., 2011). The 
degeneration of this group of neurons underlies cognitive decline associated with ageing and 
diseases such as Alzheimer’s disease (Schliebs et al., 2011; Schliebs et al., 2006). The 
mechanism is thought to involve a decrease in NGF mediated trophic support, where it is 
required for protecting and maintaining cholinergic neurons (Dekker et al., 1991; Hefti et al., 
1985). Furthermore, studies have shown that disruptions in NGF mediated trophic support in 
terms of trafficking and ability to interact with the high affinity TrkA and low affinity p75NTR 
receptors are the main contributors to the degeneration and morphological changes associated 
with cognitive decline in both normal ageing and pathological states such as Alzheimer’s disease 
(de Lacalle et al., 1996; Delcroix JD et al., 2004). Although Nedd4-2 is known to interact with 
TrkA, cognitive behaviours or expression of Nedd4-2 in the cholinergic neurons remained largely 
unknown.  
Nedd4-2 expression in CNS regions associated with cognitive function 
As discussed in Chapter 4, the hippocampus is essential for learning and memory, divisions into 
dorsal and ventral portions showing different roles in cognition (Fanselow et al., 2010). The 
hippocampus also has important reciprocal connections with the amygdala necessary for 
processing of emotive behavior and regulation of anxiety related behaviours. Cholinergic input to 
the hippocampus from the medial septal regions is important for hippocampal based learning and 
memory, with contribution to the induction and expression of LTP (Kanju et al., 2012). Due to 
the known interaction between Nedd4-2 and TrkA receptors, the expression of Nedd4-2 should 
also be assessed in the medial septal region. 
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Behavioural assessment of cognition 
As discussed in Chapter 4, a range of behavioural tests can be used to measure short and long-
term learning and memory, anxiety and sensory motor gating. A number of important targets 
already discussed suggest that some of these behaviours are likely to be affected in mice with 
reduced Nedd4-2 levels. In particular, the interaction between Nedd4-2 and TrkA receptors 
suggests that any alterations in Nedd4-2 levels are likely to alter TrkA receptor trafficking and 
thus expression in the membrane. This does not necessarily imply that there would be a memory 
deficit; it may in fact increase memory formation. 
Unknown targets of Nedd4-2 that may be implicated for cognitive function 
It is important to consider that there may also be currently unknown targets for Nedd4-2 in 
regions such as the hippocampus to regulate other types of memory including spatial short and 
long-term memory, and learning. Furthermore, the expression of Nedd4-2 in the CNS has not 
been investigated, and as such may provide further clues to its potential roles and novel targets. 
Since Nedd4-2 has been shown to interact with DAT and TrkA receptors, both of which may 
have important implications in cognitive function lead the main hypothesis of this study; that 
Nedd4-2 would have a essential role in neuronal function necessary for cognitive behaviours 
which may be due to reduced striatal dopamine levels or disrupted NGF mediated signaling via 
TrkA receptor. To investigate this hypothesis, the following aims were set: 
1) Conduct behavioural tests in Nedd4-2 heterozygous mice to assess short and 
long-term memory and learning 
2) Behavioural assessment of anxiety behaviours 
3) Evaluation of sensory motor gating  
4) Determine cellular and regional expression of Nedd4-2 in the brain associated 
with cognitive behaviours 
Tests were conducted in 2 and 6 month old Nedd4-2 heterozygous mice.  
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5.2 MATERIALS AND METHODS 
Animals and Behavioural testing 
The same mice were used as those described in Chapter 3 ‘Nedd4-2 in motor function’. 
Behavioural tests conducted have been thoroughly described in Chapter 4 ‘Nedd4 in cognitive 
behaviours’. 
Tissue Collection 
Immunohistochemistry 
For immunohistochemistry, sections obtained from mice described in Chapter 3 were stained and 
assessed in this study. For immunohistochemistry, 2 (n = 5) and 6 (n = 5) month old Nedd4-2
heterozygous and wild-type littermates (n = 4, n = 5 and n = 3, respectively) were used. Frozen 
50μm thick free-floating coronal sections were incubated with primary antibodies. The following 
antibodies were used: 
Antibody Function Dilution Manufacturer 
Mouse anti-NeuN Neuronal marker 1/1000 Merck-Millipore
Mouse anti-MAP2 MAP2 protein (dendritic marker) 1/1000 Sigma 
Primary antibodies were visualized with Alexa-conjugated secondary antibodies, mounted using 
Prolong-Gold with DAPI mounting medium (Invitrogen). Stained sections were visualized using 
a Nikon C1 confocal microscope using a 488nm argon and 543nm HeNe laser (Nikon Group, 
Tokyo, Japan). Images were acquired using a 40x Plan-Apochromat oil immersion objective. All 
images were captured and analyzed using Nikon Elements software. 
Statistics 
For Morris water maze, the learning curve was analyzed using one-way repeated measures 
ANOVA comparing latencies to enter the home quadrant between Nedd4-2 heterozygous mice 
and wild-type controls. For memory probe parameters of MWM, Y-maze, elevated plus maze, 
and PPI an unpaired-Student’s t-test was used to statistically compare the Nedd4-2 heterozygous 
mice to their age-matched wild-type controls. Results were deemed significant when P < 0.05. 
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5.3 RESULTS 
Y-maze 
Short-term spatial memory was assessed in both 2 and 6 month old Nedd4-2 heterozygous mice. 
At 2 months of age, the time spent (wt: 150.8 ± 10 sec; n = 7 and het: 148.2 ± 6.5 sec; n = 16, P = 
0.8) in the novel arm was not different between Nedd4-2 heterozygous mice and wild-type 
controls (Figure 5.1A). Similarly, at 6 months of age time spent (wt: 86.0 ± 3.9 sec; n = 10 and 
het: 88.4 ± 2.4 sec; n = 10, P = 0.6) (Figure 5.1B) was not different. When duration spent in the 
novel arm was represented as a percentage of total duration time, no differences were evident in 
both 2 (wt: 29.8 ± 2.4%; n =10 and het: 28.9 ± 1.6%; n = 10, P = 0.77) and 6 months (wt: 28.7 ± 
1.3%; n = 7 and het: 29.5 ± 0.8%; n = 16, P = 0.61) (Figure 5.1C and D, respectively).  
The number of entries into the novel arm were also not significantly different between Nedd4-2
heterozygous mice and age-matched wild-type controls at 2 (wt: 12.7 ± 0.9; n = 7 and het: 12.8 ± 
0.8; n = 16, P = 0.9) and 6 (wt: 17.7 ± 0.7; n = 10 and het: 18.3 ± 1.0; n = 10) months of age 
(Figure 5.2A and B, respectively).  
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Figure 5.1. No difference was apparent in time spent in the novel or familiar arms between 
Nedd4-2 heterozygous (+/-) mice and age-matched wild-type controls (+/+) at both 2 (A) and 6 
month old (B) cohorts. Similarly, the percentage of time spent in the novel arm was also not 
different at both 2 (C) and 6 months of age (D). Data represented as mean±SEM. 
Figure 5.2. No difference in the number of entries was evident between Nedd4-2 heterozygous 
(+/-) mice compared to age-matched wild-type controls (+/+) at both 2 (A) and 6 months of age 
(B). Data represented as mean±SEM. 
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A non-significant increase in the latency to enter the novel arm was observed in 2 month old 
Nedd4-2 heterozygous mice compared to the wild-type controls (wt: 4.5 ± 1.9 sec; n = 7 and het: 
9.5 ± 2.1 sec; n = 16, P = 0.15), with no difference evident at 6 months of age (wt: 4.7 ± 1.0 sec; 
n = 10 and het: 5.9 ± 1.4 sec; n = 10, P = 0.49) (Figure 5.3A and B, respectively). 
Figure 5.3. A non-significant increase in latency to enter the novel arm was seen in 2 month old 
Nedd4-2 heterozygous (+/-) mice compared to age-matched wild-type controls (+/+) (A). No 
difference in latency to enter the novel arm was observed at 6 months of age (B). Data 
represented as mean±SEM. 
This data shows that short-term spatial memory was intact in Nedd4-2 heterozygous mice at both 
ages.  
Morris Water Maze 
Latency to find the hidden platform is an indicator of learning capacity, with a decrease in latency 
observed with progression of the trial days. In both the 2 and 6 month cohorts, there was no 
difference in latencies to find the hidden platform between the Nedd4-2 heterozygotes and wild-
type controls (Figure 5.4 and 5.5, respectively). 
2 months 6 months 
A B 
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Figure 5.4. No difference in latency to find the hidden platform between 2 month old Nedd4-2
heterozygous (+/-) mice compared to wild-type controls (+/+) at all trial days. Data represented 
as mean±SEM. 
Figure 5.5. No difference in latency to find the hidden platform between 6 month old Nedd4-2
heterozygous (+/-) mice compared to wild-type controls (+/+) at all trial days. Data represented 
as mean±SEM. 
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At 2 months of age, path length (distance travelled) was not different between Nedd4-2
heterozygous mice compared to wild-type controls during the learning trial (Figure 5.6). Due to 
an unforeseen error on the Ethovision set up, distance was not recorded for the 6 month old 
cohort during learning phase of the test.  
Figure 5.6. In the 2 months cohorts, no difference was observed between Nedd4-2 heterozygous 
(+/-) mice and wild-type controls (+/+) in distance travelled. Data represented as mean±SEM. 
Probe Trial 
2 month  
Following the learning phase of the test, evaluation of the latency to enter, time spent and number 
of entries in the home quadrant and platform zone can be used to determine memory. At 2 
months of age, latency to enter the home quadrant (wt: 10.0 ±2.7 sec; n = 12 and het: 20.5 ± 6.7 
sec; n = 12, P = 0.16), number of entries (wt: 8.6 ± 1.6; n = 12 and het: 8.1 ± 1.9; n = 12, P = 0.8) 
or duration (wt: 17.3 ± 2.5 sec; n = 12 and het: 12.7 ± 2.6 sec; n = 12, P = 0.2) were not affected 
in Nedd4-2 heterozygous mice compared to wild-type controls (Figure 5.7A, B and C, 
respectively). When platform zone parameters were assessed; latency to enter (wt: 28.4 ± 6.6 sec; 
n = 12 and het: 31.3 ± 7.0 sec; n = 12, P = 0.76), number of entries (wt: 3.3 ± 1.2; n = 12 and het: 
3.9 ± 1.5; n = 12, P =0.4) and duration (wt: 1.9 ± 0.6 sec; n = 12 and het: 1.4 ± 0.4 sec; n = 12, P 
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= 0.55) were also not different in the Nedd4-2 heterozygotes compared to the wild-type controls 
(Figure 5.7D, E and F). 
Figure 5.7. No difference was observed in home quadrant parameters of the probe trial including; 
latency to enter (A), number of entries (B) or time spent (C) between Nedd4-2 heterozygous (+/-) 
mice and wild-type controls (+/+). Similarly, parameters assessed in the platform zone showed no 
differences in latency (D), number of entries (E) or time spent (F). Data represented as 
mean±SEM. 
6 months 
At 6 months of age, latency to enter (wt: 19.5 ± 6.3 sec and het: 16.4 ± 2.9 sec; P = 0.7), number 
of entries (wt: 4.8 ± 0.8 and het: 6.6 ± 0.9; P = 0.15) and time spent (wt: 10.6 ± 2.0 sec and het: 
12.9 ± 1.1 sec; P = 0.3) in the home quadrant were not different between the heterozygotes 
relative to wild-type controls (Figure 5.8A, B and C, respectively). When platform zone 
parameters were investigated, latency to enter the platform zone was significantly increased (wt: 
21.7 ± 4.9 sec and het: 44.6 ± 5.5 sec; P = 0.006) (Figure 5.8D). The heterozygotes also showed 
a modest decrease in number of entries (wt: 2.1 ± 0.5 and het: 1.0 ± 0.3; P = 0.08) (Figure 5.8E), 
and a significant decrease in duration in the platform zone (wt: 1.2 ± 0.3 sec and het: 0.5 ± 0.1 
sec; P = 0.02) and relative to wild-type controls (Figure 5.8F).  
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Figure 5.8. No difference was observed in home quadrant parameters of the probe trial including; 
latency to enter (A), number of entries (B) or time spent (C) between Nedd4-2 heterozygous (+/-) 
mice and wild-type controls (+/+). When platform zone parameters were evaluated, a significant 
increase in the latency to enter the platform zone was seen in Nedd4-2 heterozygotes compared to 
wild-type controls (D). A non-significant decrease in the number of entries was seen in the 
Nedd4-2 heterozygotes (E). Finally, a significant decrease in time spent in the platform zone was 
seen in the Nedd4-2 heterozygous mice (F). Data represented as mean±SEM. Statistical analysis 
was conducted using and an unpaired Student’s t-test with * P < 0.05 deemed significant. 
Findings from the Morris water maze suggest that at 2 months of age no effect was observed in 
Nedd4-2 heterozygotes in relation to long-term spatial learning and memory. At 6 months of age, 
although learning was not affected, we did observe significant changes in parameters associated 
with the platform zone suggesting that subtle changes in memory in the heterozygotes compared 
to the wild-type controls. 
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Elevated Plus Maze  
2 month 
Anxiety was assessed in the Nedd4-2 heterozygous mice using the elevated plus maze. In the 2 
month cohort, a significant decrease in duration spent in the closed arm (wt: 167.9 ± 6.3 sec; n = 
7 and het: 136.8 ± 8.6 sec; n = 15, P = 0.03) which was associated with an increase in open arm 
duration (wt: 20.1 ± 5.3 sec; n = 7 and het: 38.0 ± 8.4 sec; n = 15, P = 0.18) (Figure 5.9A). In 
addition, there was an almost significant decrease in number of entries in the closed (wt: 21 ± 2; n 
= 7 and het: 18 ± 1; n =15, P = 0.056) versus open arms (wt: 4 ± 1; n = 7 and het: 7 ± 1; n = 17, P 
= 0.09) (Figure 5.9B), and no alteration in centre duration time (wt: 111.9 ± 7.3 sec; n = 7 and 
het: 125.2 ± 6.6 sec; n = 15, P = 0.23) (Figure 5.9C). Finally, distance (wt: 1410 ± 96 cm; n = 7 
and het: 1351  ± 69 cm; n = 15, P = 0.63) and velocity (wt: 4.7  ± 0.3 cm; n = 7 and het: 4.5  ± 0.2 
cm; n = 15, P = 0.61) were also unchanged (Figure 5.9D and E, respectively). 
Figure 5.9. In the 2 month cohort a significant decrease of time spent in the closed arm was 
observed in Nedd4-2 heterozygous (+/-) mice compared to wild-type controls (+/+), which was 
accompanied by a modest increase in time spent in the open arms (A). A non-significant increase 
in the number of entries in the open accompanied by decreased entries in closed arm was evident 
in the Nedd4-2 heterozygous mice (B). No difference was observed in time spent in the centre 
(C), or distance (D) and velocity (E). Data represented as mean±SEM. 
A B C 
D E 
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6 months 
In the 6 month cohort, no differences in time spent in open (wt: 42.7  ± 9.4 sec; n = 10 and het: 
29.8  ± 11.1 sec; n = 10, P = 0.39) versus closed (wt: 100.8 ± 18.2 sec; n = 10 and het: 116.6 ± 
13.6 sec; n = 10, P = 0.50) arms was observed when Nedd4-2 heterozygous mice were compared 
to age-matched wild-type controls (Figure 5.10A). The number of entries into the open (wt: 8.2 ± 
2.0; n = 10 and het: 5.7 ± 1.7; n = 10, P = 0.34) and closed arms (wt: 10.8 ± 1.4; n = 10 and het: 
13.7 ± 1.4; n = 10, P = 0.16) was also not different between the heterozygous mice relative to 
wild-type controls (Figure 5.10B). Time spent in the centre zone was also not different (wt: 
156.5 ± 11.7; n = 10 and het: 153.6 ± 12.3; n = 10, P = 0.87) (Figure 5.10C).
Figure 5.10. At 6 months of age no significant differences were seen between Nedd4-2
heterozygous (+/-) mice compared to wild-type controls (+/+) in time spent in the open and 
closed arm (A), number of entries (B) or time spent in the centre zone (C). Data represented as 
mean±SEM. 
Ethological Parameters 
Ethological parameters were only assessed in the 2 month old mice due to changes in anxiety. 
When total number of entries into both the open and closed arm (wt: 24.7 ± 1.4; n = 7 and het: 
24.9 ± 1.5; n = 15, P = 0.95) were evaluated no differences were observed between Nedd4-2
heterozygous mice and age-matched wild-type controls (Figure 5.11A). The number of rearing 
events was also unchanged (wt: 13.9 ±3.4; n = 7 and het: 16.3 ±2.1; n = 15, P =0.54) (Figure 
5.11B). Furthermore, the stretched attenuated responses were also not different, including 
protected (wt: 18.3 ± 1.6; n = 7 and het: 19.1 ± 1.4; n = 15, P = 0.74), unprotected (wt: 4.7 ± 1.3; 
n = 7 and het: 7.9 ± 1.6; n = 15, P = 0.23) and total (wt: 23.0 ± 2.2; n = 7 and het: 26.9 ± 1.7; n = 
15, P = 0.19) (Figure 5.11C). Finally, the number of closed arm returns (wt: 1.0 ± 0.4; n = 7 and 
A B C 
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het: 1.5 ± 0.3; n = 15, P =0.32) was also unchanged in the Nedd4-2 heterozygotes (Figure 
5.11D). Overall, ethological parameters did not show any significant differences between the 
Nedd4-2 heterozygous mice compared to wild-type controls. 
Figure 5.11. Ethological parameters assessed in 2 month old Nedd4-2 heterozygous (+/-) and 
wild-type controls (+/+) showed no differences in total number of entries (A), number of rearing 
events (B), number of stretched attenuated responses  (SAPs) (C), or closed arm returns (D). Data 
represented as mean±SEM. 
A B 
D C 
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Pre-Pulse Inhibition 
Response to auditory stimuli 
2 month cohort 
Responses to the different auditory stimuli were assessed to confirm that mice were able to hear 
the stimuli. No difference was observed in the absence of stimuli (wt: 17.7 ± 2.2mV; n = 8 and 
het: 20.2 ± 2.4 mV; n = 13, P = 0.12), and to the various pre-pulse stimuli including; 4 dB (wt: 
108.8 ± 20.8 mV; n = 8 and het: 109.8 ± 25.8 mV; n = 13, P = 0.98), 8 dB (wt: 76.4 ± 16.3 mV; n 
= 8 and het: 93.1 ± 24.6 mV; n = 13, P = 0.63), 16 dB (wt: 56.5 ± 11.8 mV; n = 8 and het: 82.2 ± 
24.6 mV; n = 13, P = 0.45) or to the startle stimuli 115 dB (wt: 152.0 ± 31.5 mV; n = 8 and het: 
132.7 ± 32.1 mV; n = 13, P = 0.69) (Figure 5.12A). Due to lack of response to the auditory 
stimuli, two Nedd4-2 heterozygous mice were excluded from analysis. These mice were excluded 
blindly. 
6 month cohort 
Similarly, responses to the auditory stimuli were not different between Nedd4-2 heterozygous 
mice compared to the age-matched controls; no stimulus (wt: 18.9 ± 2.3 mV; n = 10 and het: 18.3 
± 2.9 mV; n = 10, P = 0.89), 4 dB (wt: 85.7 ± 11.1 mV; n = 10 and het: 107.4 ± 26.0 mV; n = 10, 
P = 0.45), 8 dB (wt: 61.6 ± 7.9 mV; n = 10 and het: 73.1 ± 14.8 mV; n = 10, P = 0.50), 16 dB (wt: 
41.1 ± 4.3 mV; n = 10 and het: 53.9 ± 8.3 mV; n = 10, P = 0.20) or 115 dB (wt: 133.8 ± 11.6 mV; 
n = 10 and het: 142.7 ± 23.4 mV; n = 10, P = 0.74) (Figure 5.12B). 
260
Figure 5.12. No differences in startle responses to the different auditory stimuli in Nedd4-2
heterozygous (+/-) mice compared to age-matched wild-type controls at both 2 (A) and 6 (B)
months of age. Data represented as mean±SEM. 
Startle Response  
2 months 
Startle responses to the 115 dB stimulus was analyzed over the 4 block trials, with no difference 
observed between Nedd4-2 heterozygous mice and age-matched wild-type controls (Block 1, wt: 
214.1 ± 46.1 mV; n = 10 and het: 164.6 ± 38.5 mV; n = 10, P = 0.43, Block 2, wt: 163.4 ± 35.7 
mV; n = 10 and het: 132.1 ± 33.3 mV; n = 10, P = 0.55, Block 3, wt: 120.7 ± 26.0 mV; n = 10 
and het: 118.3 ± 31.5 mV; n = 10, P = 0.96, and Block 4, wt: 109.9 ± 26.6 mV; n = 10 and het: 
115.8 ± 27.2 mV; n = 10, P = 0.89) (Figure 5.13A).  
6 month cohort 
At 6 months of age, no differences in responses to the startle stimulus was observed between 
Nedd4-2 heterozygous mice and age-matched wild-type controls (Block 1, wt: 134.5 ± 13.8 mV; 
n = 10 and het: 149.1 ± 23.6 mV; n = 10, P = 0.60, Block 2, wt: 138.3 ± 13.7 mV; n = 10 and het: 
140.7 ± 24.5 mV; n = 10, P = 0.93, Block 3, wt: 137.8 ± 11.4 mV; n = 10 and het: 136.8 ± 24.0 
mV; n = 10, P = 0.97, and Block 4, wt: 124.8 ± 12.3 mV; n = 10 and het: 144.1 ± 25.5 mV; n = 
10, P = 0.50) (Figure 5.13B). 
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Figure 5.13. Startle responses over four blocks of 115 dB stimuli were not different between 2 
month old Nedd4-2 heterozygous (+/-) mice compared to wild-type controls (+/+) (A). Similarly, 
startle responses in 6 month old Nedd4-2 heterozygous mice were also not significantly different 
(B). Data represented as Mean ± SEM.  
Percentage of PPI 
2 month cohort 
The percentage of pre-pulse inhibition (%PPI) was not different between the Nedd4-2
heterozygous mice and age-matched wild-type controls at all pre-pulse stimuli; 4 dB (wt: 26.8 ± 
6.8 %; n = 8 and het: 14.0 ± 4.6 %; n = 13, P = 0.12), 8 dB (wt: 45.8 ± 7.0 %; n = 8 and het: 31.5 
± 6.0 %; n = 13, P = 0.15) and 16 dB (wt: 58.4 ± 5.9 %; n = 8 and het: 42.8 ± 5.8 %; n = 13, P = 
0.09) (Figure 5.14A). 
6 month cohort 
Similarly, at 6 months of age there was also no difference between Nedd4-2 heterozygous mice 
and age-matched controls at all pre-pulse stimuli; 4 dB (wt: 36.3 ± 5.9 %; n = 10 and het: 30.4 ± 
7.2 %; n = 10, P = 0.53), 8 dB (wt: 53.6 ± 5.1 %; n = 10 and het: 49.2 ± 4.9 %; n = 10, P = 0.54) 
and 16 dB (wt: 68.4 ± 2.7 %; n = 10 and het: 57.4 ± 7.6 %; n = 10, P = 0.19) (Figure 5.14B). 
A B 
2 month 6 month 
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Figure 5.14. Percentage of pre-pulse inhibition (%PPI) was not significantly different between 
Nedd4-2 heterozygous (+/-) mice and wild-type controls (+/+) at both 2 (A) and 6 months of age 
(B). Data represented as Mean ± SEM. 
Expression of Nedd4-2 in regions of the brain associated with memory, learning and anxiety 
behaviours 
Hippocampus 
Nedd4-2 expression was investigated to determine cellular expression. Nedd4-2 was most highly 
expressed in the pyramidal cell layer, surrounding cell bodies of these pyramidal neurons in all 
regions including; CA1, CA2, CA3) and DG (Figures 5.15, 5.16, 5.17 and 5.18, respectively). 
Furthermore, Nedd4-2 expression was found not to extend in the dendrites of pyramidal neurons 
shown by low level of co-localization with MAP2 dendritic marker (Figure 5.19). Interestingly 
upon closer inspection Nedd4-2 was found to stain neurons that did not express NeuN. This 
suggests that these neurons may be immature neurons or neuronal progenitors contained within 
the subventricular zone of the DG (Figure 5.21). 
A B 
2 month 6 month 
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Figure 5.15. Nedd4-2 (red) expression was highly expressed in the cell bodies of pyramidal 
neurons (NeuN, green) in the CA1 region of the hippocampus. (+/-) Nedd4-2 heterozygous and 
(+/+) wild-type controls. Scale bar represents 50ȝm.
Figure 5.16. Nedd4-2 (red) expression was highly expressed in the cell bodies of pyramidal 
neurons (NeuN, green) in the CA2 region of the hippocampus. (+/-) Nedd4-2 heterozygous and 
(+/+)wild-type controls. Scale bar represents 50ȝm. 
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Figure 5.17. Nedd4-2 (red) expression was highly expressed in the cell bodies of pyramidal 
neurons (NeuN, green) in the CA3 region of the hippocampus. (+/-) Nedd4-2 heterozygous and 
(+/+) wild-type controls. Scale bar represents 50ȝm.
Figure 5.18. Nedd4-2 (red) expression was highly expressed in the cell bodies of pyramidal 
neurons (NeuN, green) in the DG region of the hippocampus. Within the subventricular zone, 
Nedd4-2 positive neurons were evident that did not express NeuN (arrow). This suggests that 
Nedd4-2 is present in immature neurons, which are more prevalent in the Nedd4-2 heterozygous 
(+/-) mice compared to wild-type controls (+/+). Scale bar represents 50ȝm.
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Figure 5.19. Nedd4-2 (red) expression in the CA1, CA2, CA3 and DG regions of the 
hippocampus showed very little co-localization with the dendritic marker MAP2 (green) in brain 
sections obtained from 2 month old wild-type controls (+/+). Scale bar represents 50ȝm.
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Amygdala 
Due to the decrease in anxiety observed in the 2 month old Nedd4-2 heterozygous mice, 
expression was examined in the amygdala. Nedd4-2 was expressed at high levels in the cell body 
of neurons located within the basolateral nucleus of the amygdala (Figure 5.20).  As expected, 
Nedd4-2 staining intensity was reduced in the heterozygous mice relative to controls. A slight 
decrease in the number of Nedd4-2 positive neurons was evident in the heterozygous mice, 
however this requires further investigation such as cell counting. 
Figure 5.20. Nedd4-2 (red) expression in the basolateral amygdala, showing high expression in 
the cell bodies of the NeuN positive neurons (green). As expected a reduction in Nedd4-2 
staining intensity was evident in the Nedd4-2 heterozygous mice (+/-) compared to wild-type 
controls (+/+), with a slight reduction in the number of Nedd4-2 positive neurons. Scale bar 
represents 50ȝm. 
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Medial septal region 
Cholinergic neurons of the forebrain provide crucial hippocampal projections required for normal 
cognitive function. Due to the known interaction between Nedd4-2 and TrkA, it was expected 
that Nedd4-2 would be highly enriched in these neurons. At least within the medial septal (MS) 
region, Nedd4-2 was found not to be highly expressed (Figure 5.21), which was a surprising 
finding. NeuN staining was not expected within these neurons, as other markers such as choline 
acetyltransferase (ChAT) antibodies could be used to characterize the expression and co-
localization with Nedd4-2.  
Figure 5.21. Nedd4-2 (red) was not highly expressed in the medial septal (MS) region of the fore 
brain. (+/+) wild-type. Scale bar represents 100ȝm. 
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5.4 DISCUSSION 
Behavioural assessment of cognitive function in Nedd4-2 heterozygous mice was conducted 
investigating short and long-term memory, learning, anxiety and pre-pulse inhibition. Due to the 
important modulatory role for Nedd4-2 in regulating dopamine transporters (DATs), glutamate 
transporters (GLAST/GLT-1) and TrkA neurotrophin receptors, it seemed likely cognitive 
behaviours would be impacted.  
No difference in short-term memory was found when Nedd4-2 heterozygous mice were 
compared to age-matched wild-type controls at both 2 and 6 months of age. Like with Nedd4, 
there is strong evidence showing that ubiquitination contributes largely to the consolidation of 
short to long-term memory (Artinian et al., 2008). Long-term spatial learning was also assessed 
and no differences were found between Nedd4-2 heterozygous mice relative to wild-type controls 
at both 2 and 6 months of age. Long-term spatial memory however uncovered subtle changes in 6 
month old Nedd4-2 heterozygous mice, with significant changes evident when platform zone. 
This data suggest that Nedd4-2 may have some role in long-term memory formation, however the 
extent of this contribution remains to be determined. 
Since the learning and memory assessed here is largely hippocampal dependent the expression of 
Nedd4-2 within the hippocampus was investigated. Nedd4-2 was expressed predominantly in the 
pyramidal cell layer, surrounding cell bodies, with very little co-localization within dendrites. 
Interestingly, the CA3 region of the hippocampus contained the highest level of Nedd4-2, 
followed by the DG. The CA3 region is essential for encoding new short-term memories 
requiring interaction between the CA3 and DG (Kesner, 2007). The CA3 regions is also the main 
site of projection from the Ammon’s horn, with evidence showing high levels of input to the 
lateral and medial septal region and vertical band of Broca, with these regions providing 
important cholinergic and GABAergic feedback to the hippocampus (Amaral et al., 1995; 
Gaykema et al., 1991). Nedd4-2 expression therefore becomes important, as both medial septal 
and vertical band of Broca, are cholinergic neurons that are enriched with TrkA receptors, and 
mediate NGF signaling.  
Preliminary tests shown here found that Nedd4-2 was not expressed in neurons of the medial 
septal nucleus, which is one of the main regions of cholinergic input to the hippocampus 
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(Swanson et al., 1979). This was unexpected as TrkA is abundant in the medial septal region 
(Steininger et al., 1993), and the absence of Nedd4-2 in this region is surprising. TrkA however is 
also present in the striatum, where Nedd4-2 is abundantly expressed (Steininger et al., 1993).  In 
this study, other important regions of the basal forebrain cholinergic neurons were not assessed, 
and they may in fact be enriched in Nedd4-2, to regulate NGF mediated signaling via TrkA 
receptor. Overall, Nedd4-2 heterozygous mice show strong levels of expression in the 
hippocampus, suggesting an important role for memory and learning. It is likely perhaps that in 
the heterozygous setting, there is still enough Nedd4-2 present to preserve neuronal functions 
necessary for memory and learning behaviours.  
Another interesting finding was the increase in number of cells that did not stain for NeuN in the 
Nedd4-2 heterozygous mice, which was evident in the subventricular zone (SVZ) of the dentate 
gyrus. These cells expressed Nedd4-2, suggesting that Nedd4-2 may be important for 
neurogenesis, as the SVZ is site of neurogenesis (Steininger et al., 1993). Future studies could 
examine whether these cells are indeed neurons, and if so are they also doublecortin positive, a 
protein abundant in migrating and immature neurons. If this is indeed the case, then reduction in 
Nedd4-2 levels may increase neurogenesis within the SVZ of the hippocampus, which is 
potentially a very exciting result.  
Although no significant effects were observed in cognitive function in the Nedd4-2 heterozygous 
mice, the high expression of Nedd4-2 in the striatum warrants further investigation into more 
specific tests. The current tests used to evaluate cognitive function are spatial learning and 
memory tests that are largely hippocampal based. Alternatively, striatal based tests such as radial 
arm maze (Floresco et al., 1997), holeboard task (Kuc et al., 2006) and delayed spatial win-shift 
tasks (Richter et al., 2013) could be used to expand the behavioural profile tested. 
Anxiety was also investigated and at 2 months of age Nedd4-2 heterozygous mice show a 
decrease in anxiety related behaviours assessed by elevated plus maze. This finding may in part 
be due to abnormal dopamine levels and/or signaling in Nedd4-2 heterozygous mice relative to 
wild-type controls. Data from Chapter 3, showed that striatal dopamine level are reduced in both 
2 and 6 month old heterozygotes and may affect anxiety behavoiurs. There is some evidence for 
the involvement of dopamine, for example mice lacking D3 receptors show decreases in anxiety 
behaviours including increased time spent in open versus closed arm of the elevated plus maze 
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(Steiner et al., 1997). Dopamine afferents arising from the ventral tegmental area also innervate 
nuclei of the amygdala activating both D1 and D2 dopamine receptors (de la Mora et al., 2010). 
Nedd4-2 was shown (in Chapter 3) to be expressed in medium spiny neurons of the striatum, 
which are enriched with D1 and D2 receptors. Nedd4-2 expression within the amygdala was 
found in the cell bodies of neurons, with a slight reduction in the number of neurons. The 
contribution of Nedd4-2 in anxiety related behaviours warrants further investigation to 
understand the mechanism that regulates these behaviours. Furthermore, no changes in anxiety 
was observed in the 6 month old Nedd4-2 heterozygotes which also requires further 
investigation. 
As discussed in depth in Chapter 4, the dorsal and ventral portions of the hippocampus have 
distinct afferents and efferent and therefore contribute to the different aspects of cognition. 
Further characterization of Nedd4-2 expression in these regions may be conducted, however due 
to the subtle changes in long-term memory were not conducted in this study.  
Pre-pulse startle responses were not affected in Nedd4-2 heterozygous mice compared to age-
matched wild-type controls at both 2 and 6 months of age. Auditory responses were also 
unaffected, with mice producing similar startle responses to each of the startle stimuli. Pre-pulse 
inhibition (PPI), was also unchanged, which is not entirely surprising, as PPI is normally 
enhanced when there is an increase in dopamine. There was a slight (non-statistical) decrease in 
% of PPI in the 2 month old Nedd4-2 heterozygotes compared to age-matched wild-type controls, 
which may be due to decreased dopamine levels. In addition, impairment in D1/D2 receptor 
levels may also contribute to changes in PPI. Evaluation of D1/D2 receptor levels is necessary, as 
changes may also be important for motor function deficits observed in Chapter 3.  
Findings from this study provide important new insights into the role and possible functions for 
Nedd4-2 in cognitive functions. It also raises many new questions, and highlights the need to 
further investigate in more detail, how known targets may affect cognitive function. Unlike the 
Nedd4 heterozygotes, Nedd4-2 heterozygotes show very little difference in cognitive function, 
with the only alteration evident is a decrease in anxiety. Nedd4-2 is highly expressed in regions 
of the brain essential for these cognitive functions, especially the hippocampus, suggesting that it 
must have some target and role in hippocampal neuronal function. However, it seems as though 
Nedd4-2 may have some redundancy as the 50% loss of did not having a substantial effect, or 
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Nedd4-2 may be more important for neuronal development with no substantial role at the mature 
synapse. Support for the neuronal development arises from the TrkA association, which is a 
trophic receptor essential for growth and development of neurons. In addition, the expression of 
Nedd4-2 in neurons that lie within the subventricular zone of the hippocampus, which is the main 
site of adult neurogenesis also strengthens the role for Nedd4-2 for development. 
One important limitation in this study however is that the cognitive tests used do not necessarily 
assess effect of dopamine on cognition. Future studies should utilize other cognitive tests that 
better assess dopamine-mediated behaviours. For example instrumental conditioning, such as 
goal directed learning assesses the association between a response and the incentive value of the 
outcome (Balleine et al., 1998; Valentin et al., 2007).  The 5-choice serial reaction time task 
allows the assessment of learning, attention and vigilance and requires normal dopaminergic 
signaling (Robbins, 2002). Dopamine is also important for reward based and motivational 
behaviours (Wise, 2004), and so the use of operant boxes where rodents learn to push a lever to 
obtain a sugar pellet can be and be used to evaluate both reward based learning and motivational 
behaviours (Wise, 2004). The outcomes of these tests will be extremely valuable and may show 
changes in cognition that have simply not been tested here. 
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CHAPTER 6: DISCUSSION AND CONCLUSIONS 
6. Discussion 
The studies undertaken in this thesis were designed to investigate the contribution of Nedd4 and 
Nedd4-2 in the CNS. More specifically, to determine what effect reduced levels of Nedd4 or 
Nedd4-2 would have to in vivo physiological responses. This was undertaken by examining 
behavioural outcomes of Nedd4 and Nedd4-2 heterozygous mice and to determine cellular 
expression of these two proteins within the CNS. There are a large number of targets for both 
Nedd4 and Nedd4-2, with very little understanding of the contribution to physiological processes 
such as motor function, gait and cognition. 
When Nedd4 and Nedd4-2 were first characterized, they were found to share structural homology 
and target proteins containing PPXY motif, and therefore suggested that these proteins may have 
similar physiological effects. Furthermore, it was suggested they may share functional 
redundancy. What is becoming clear is that these two proteins have distinct targets and data in 
this thesis show that they also have distinct physiological phenotypes. 
The first chapter (Chapter 2) showed that Nedd4 plays an important role in gait control, with the 
heterozygous mice showing significant gait impairments. These gait changes could in part be due 
to alterations in GluR1 containing AMPA receptors, which were found to be up-regulated in the 
cerebellum from the heterozygous mice relative to wild-type controls. Although further 
experiments are required to provide more conclusive evidence, increases in AMPAR levels at the 
synapse between granule cells and Purkinje neurons could affect the level of feedback to the 
motor cortex resulting in the extended gait observed. In order to verify this hypothesis, recordings 
from whole brain slices can be conducted to measure Purkinje neuron output in response to 
stimulation. Furthermore, blocking GluR1-containing AMPARs would provide confirmation 
whether increased levels of GluR1 in the cerebellum translates to signaling abnormalities.  
Calcium makes a large contribution to Purkinje neuron signaling, and Nedd4 has been shown to 
target voltage-gated calcium channels. It cannot be excluded that alterations in intracellular 
calcium levels may exist and contributed to gait abnormalities observed in the Nedd4
heterozygous mice. It would be important to examine intracellular calcium within Purkinje 
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neurons, and determine whether plasma levels of voltage-gated calcium channels are altered in 
response to a reduction in Nedd4 levels.  
Assessment of gait and motor function in Nedd4-2 heterozygous mice (Chapter 3) showed that 
gait was not changed, but a significant deficit in motor function was evident in 6 month old 
heterozygotes relative to wild-type controls. Due to the interaction between Nedd4-2 and DAT, 
dopamine levels were measured and Nedd4-2 expression assessed in regions of the brain 
associated with dopamine signaling and motor function. Dopamine levels measured in the 
striatum were reduced in the Nedd4-2 heterozygous mice relative to the age-matched wild-type 
controls. This study measured total dopamine levels (both intra- and extracellular) and there is a 
need to examine dopamine re-uptake with labeled dopamine to examine whether intracellular 
levels are reduced.  
DAT immunohistochemistry showed increased intensity of staining in striatal fibres suggesting 
that membrane levels of DAT may be increased. Western blot measurements showed no overall 
(total) DAT levels, suggesting that although total levels remained unchanged there may still be 
increased membrane levels. Further experiments are required to elucidate whether there are 
changes at the membrane. For example, experiments can be performed using cocaine, which 
binds to DAT to elicit behavioural responses. These experiments would provide a qualitative 
method of determining whether there membrane levels of DAT are indeed increased.  
Nedd4-2 was highly expressed in neuronal compartments associated with motor function. Nedd4-
2 was expressed within neurons of the motor cortex, and motor neurons of the spinal cord. Within 
dopaminergic compartments, Nedd4-2 was abundant in dopaminergic neurons of SNpc, with 
strong co-localization with tyrosine hydroxylase, the rate-limiting enzyme for dopamine 
synthesis. What role Nedd4-2 plays in these neurons is unknown, but future studies should 
examine whether there are any contributions to dopamine synthesis, which may in part explain 
the reduced levels of dopamine in the striatum. Nedd4-2 was also found in neurons within SNpr, 
which can provide important input to SNpc to regulate dopamine release, but also to other 
regions of the basal ganglia to regulate motor output. The large proportion of dopamine is 
released in the striatum, where dopamine receptors facilitate dopamine neurotransmission. 
Dopamine receptors are located on the medium spiny neurons, which comprise over 90% of 
neurons within the striatum. Nedd4-2 was strongly expressed in the cell bodies of these neurons, 
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suggesting that some interaction with dopamine receptors is likely. Further experiments are 
required to determine whether Nedd4-2 interacts with dopamine receptors, and whether any 
changes in dopamine receptors are observed in the heterozygous mice. 
Overall data from Chapter 3 show an important role for Nedd4-2 for motor function with 
evidence that dopaminergic neurotransmission was affected. Further studies are necessary to 
determine the exact mechanism of Nedd4-2 that mediates the motor changes observed. 
Assessment of gait using the DigiGiat system is a suitable behavioural assay in analyzing rodent 
gait changes in transgenic and rodent models of human disease. Some parameters can be 
translated to changes observed in human conditions. One example is in Parkinson’s disease, 
where decreases in stride length, increases in stride length variability and abnormalities with the 
initiation and termination of voluntary movement is observed. Similarly, this is also observed in 
rodent models of Parkinson’s disease. Although the gait changes observed were small and subtle 
they were significant. In comparison with gait changes seen in rodent ataxia models they are not 
as overt, however these gait changes not readily discernable without gait measurements being 
applied.  
The contribution of Nedd4 to cognitive function was investigated in Chapter 4, with a focus on 
learning, memory, anxiety and sensory motor gating. The interest in cognitive function arose 
from numerous studies showing novel targets for Nedd4 that are implicated including growth and 
branching of axons and dendrites, but also GluR1 subunit of AMPARs. When short-term spatial 
memory was assessed in Nedd4 heterozygous mice, no differences were apparent. Long-term 
spatial learning and memory were found to be significantly impaired in 2 month old Nedd4
heterozygous mice, with very little difference observed at 6 months of age. Previous studies have 
shown that ubiquitination is necessary for the consolidation of short into long-term memories, 
and evidence from this study support this notion. The limited change observed in the 6 month 
Nedd4 heterozygous mice were surprising, however upon closer inspection of the data it became 
apparent that the wild-type mice did not display normal learning patterns, and therefore may 
confound the findings.  
Synaptic plasticity is necessary for long-term memory to occur, with LTP the molecular 
mechanism underlying synaptic changes. LTP is dependent on the insertion and removal of 
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AMPAR, with the balance producing strengthening or weakening of a synapse. GluR1-containing 
AMPARs are crucial for the activity dependent changes in synaptic plasticity involved in LTP.  
When LTP was investigated in whole brain slices from Nedd4 heterozygous mice, a significant 
impairment in LTP was evident, providing further support for Nedd4 in modulating synaptic 
plasticity necessary for consolidation of short to long-term memories. Although GluR1-containig 
AMPARs were not investigated in the LTP recordings, future studies could pharmacologically 
block these receptors to determine if levels are altered and whether this translates to changes in 
LTP that was evident.  
Nedd4 heterozygous mice showed an increase in anxiety behaviours at 2 months of age. GluR1-
containing AMPARs may also be contributing to anxiety behaviours, with previous studies 
showing a correlation between GluR1 levels and anxiety assessed by elevated plus maze. Further 
studies are necessary to evaluate what contribution Nedd4 has to anxiety. When Nedd4 
expression was investigated in the brain, Nedd4 was found in brain regions associated with 
learning, memory and anxiety. For instance, Nedd4 was expressed in the hippocampus, with the 
dorsal portion largely responsible for memory and learning and the ventral portion that has 
reciprocal connections with the hippocampus functions to mediate anxiety behaviours. Nedd4 
was expressed in the dorsal, ventral hippocampus and amygdala, areas necessary for learning, 
memory and anxiety behaviours. Subtle changes in morphology were evident, such as changes in 
pyramidal layer thickness in hippocampal regions; the extent of change needs to be more 
thoroughly investigated.  
Overall, data from Chapter 4 show that Nedd4 is important for LTP and thus synaptic changes 
associated long-term memory consolidation. It is possible that the effects of Nedd4 in cognitive 
function are largely due to the important interaction with GluR1 subunit of AMPARs. Alterations 
in AMPAR trafficking and/or levels at the membrane can impact on a number of behaviours 
including learning, memory and anxiety. Further work is necessary to better understand the 
contribution of Nedd4 to these cognitive behaviours. 
As with Nedd4, there were several key targets identified for Nedd4-2 to suggest an important role 
for cognitive function. These include TrkA neurotrophin receptor, DAT and glutamate 
transporters, with very little known with respect to physiological outcomes. The Nedd4-2
heterozygous mice showed a subtle but significant deficit in long-term spatial memory and 
276
reduced anxiety. The expression of Nedd4 was high in all compartments of the hippocampus, but 
especially in the CA3 region as well as the amygdala. No gross morphological changes became 
apparent when hippocampal or amygdala sections were examined. Due to the interaction between 
Nedd4-2 and TrkA, the medial septal regions was assessed, as this region gives rise to the bulk of 
the cholinergic efferent that innervate the hippocampus. Since TrkA is expressed in this region, 
however little or no Nedd4-2 expression was observed in the medial septal region.  TrkA is 
expression in many other regions including the striatum, where Nedd4 is abundant. Although the 
focus of this study was not to address the effect of Nedd4-2 reduction on cholinergic innervation 
and contribution of TrkA, future studies should investigate this relationship as loss of neurons in 
this region is thought to contribute to cognitive decline in Alzheimer’s disease. 
Findings from Chapter 5 show that Nedd4-2 is highly expressed within the hippocampus and 
amygdala, with decreased anxiety and subtle deficits in long-term spatial memory in Nedd4-2
heterozygous mice. 
The main findings from this thesis show for the first time the physiological outcomes of reduced 
levels of Nedd4 and Nedd4-2 in terms of motor, gait and cognitive function. Data obtained for 
this thesis also highlight that although Nedd4 and Nedd4-2 share similar structural homology, 
and interact with targets with a similar PPXY motifs, the functional outcomes are distinct. For 
instance, Nedd4 heterozygous mice show increases in anxiety whereas Nedd4-2 heterozygous 
mice have decreased anxiety behaviours. An attempt was made to investigate known targets for 
both Nedd4 and Nedd4-2 in relation to the behavioural outcomes, but it is likely that no single 
target underlies the physiological outcomes. It is likely that any alterations in behaviour are as a 
result of changes in a multitude to targets that together contribute to altered physiological 
outcomes in the heterozygous mice. 
Behavioural analysis using heterozygous mice has some important limitations. One such 
limitation is the fact that some Nedd4 or Nedd4-2 is still present and may be sufficient to 
maintain most of the neuronal function and as such the true extent of the role for Nedd4 and 
Nedd4-2 in the CNS can’t be identified. The neuronal targets for both Nedd4 and Nedd4-2 are 
numerous, and although appear discrete may involve some redundant roles. That is, 
compensatory effects may mask the phenotype. Conditional knockouts are now available and 
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future studies could utilize these mice to obtain are more comprehensive assessment of Nedd4 
and Nedd4-2 function in the CNS.  
The data presented here are also limited in that we conducted basic behavioural screens that 
identified important phenotypical changes however testing should be extended to focus on each 
type of cognitive behaviour. For instance, other cognitive behaviours could also be examined 
such as working memory, fear based learning, motivation based learning paradigms and social 
recognition/interaction test. With Nedd4-2 in particular due to the potential affects on the 
dopamine system, addictive behaviours should also be examined. Aside from cognitive test, the 
motor function test can also be extended to examine other components such as neuromuscular 
strength (using grip strength test), other balance and co-ordination test such as ledged beam and 
grid walking.  Data obtained from this study show important roles for Nedd4 and Nedd4-2 but 
also highlight the need for further testing to gain a clearer understanding into the mechanism that 
underlie these changes. Finally, comparisons with other studies are not possible as there are no 
published studies that have assessed behavioural phenotypes in Nedd4 or Nedd4-2 transgenic 
mice. 
The interest in ubiquitination in the CNS is growing with many neurological disorders now 
considered to be caused in part due to a disruption in UPS. Data presented here provide exciting 
and novel roles for these two E3 ligses within the CNS and highlight the many future 
experiments required to better understand how Nedd4 and Nedd4-2 function with their many 
neuronal targets. 
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